Sentence,class,file
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/9c/main.PMC4942736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Consumer behavior Public healthHoliday health intentionsSocial desirability bias 1.,Non-OADS,/arxiv_data1/oa_pdf/13/d9/main.PMC4942737.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.0172211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/d9/main.PMC4942737.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/d9/main.PMC4942737.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/13/d9/main.PMC4942737.pdf
[Online] Available from: http://quickfacts.census.gov/qfd/states/00000.html .,OADS,/arxiv_data1/oa_pdf/13/d9/main.PMC4942737.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/06/ofw124.PMC4942757.pdf
Available at: http://narst.dmsc.moph.go.th/ .,Non-OADS,/arxiv_data1/oa_pdf/cb/06/ofw124.PMC4942757.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/1f/ofw130.PMC4942758.pdf
Available at: http://www.who.int/tb/publications/global_report/en/ .,Non-OADS,/arxiv_data1/oa_pdf/6a/1f/ofw130.PMC4942758.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/bc/ofw122.PMC4942759.pdf
Available at: http://www.nationalacademies.org/hmd/Reports.aspx .,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/ofw122.PMC4942759.pdf
"Public Health Agency of Canada, 2013 .A v a i l a b l ea t : http://www.phac-aspc.gc.ca/nois-sinp/ projects/cdad-eng.php .",Non-OADS,/arxiv_data1/oa_pdf/f6/1b/ofw139.PMC4942760.pdf
Available at: https://www.inspq.qc.ca/infec tionsnosocomiales/spin-cd/surveillance-2014-2015 .,OADS,/arxiv_data1/oa_pdf/f6/1b/ofw139.PMC4942760.pdf
"Ministère de la Santé et des Services Sociaux du Québec,2013 .A v a i l a b l ea t : https://www.inspq.qc.ca/sites/default/ ﬁles/documents/infectionsno socomiales/protocoledacd_ v3.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f6/1b/ofw139.PMC4942760.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/1b/ofw139.PMC4942760.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/fe/ofw132.PMC4942761.pdf
Available at: http://www.eucast.org .,Non-OADS,/arxiv_data1/oa_pdf/d1/fe/ofw132.PMC4942761.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/28/ofw121.PMC4942762.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/77/ofw126.PMC4942763.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/d9/ofw128.PMC4942764.pdf
We performed the statistical analyses using the R software (ver- sion 3.2.2; http://www.cran.r-project.org ).,OADS,/arxiv_data1/oa_pdf/a9/d9/ofw128.PMC4942764.pdf
The logistic models were tested for statistical stability using the RV AideMemoire package (http://cran.r-project.org/web/packages/RV AideMemoire/ ).,OADS,/arxiv_data1/oa_pdf/a9/d9/ofw128.PMC4942764.pdf
http://www.coregroup.org/storage/documents/ Case˙Studies/CORE˙Cameroon˙ﬁnal.pdf (accessed 12 June 2016) 2009.Ebuehi 2009 {published data only} Ebuehi OM.,OADS,/arxiv_data1/oa_pdf/76/b0/CD010123.PMC4943011.pdf
Oslo: Norwegian Knowledge Centre for the Health Services; 2015. http://epoc.cochrane.org/epoc - speciﬁc-resources-review-authors.,OADS,/arxiv_data1/oa_pdf/76/b0/CD010123.PMC4943011.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/a1/5e/bmjqir-u210642-w4280.PMC4943036.pdf
"Hairs specimens were both clari ﬁed in KOH 10% for microscopic examination and cultured on Sabouraud Dextrose Agar (SDA) with cycloheximide 0.5 mg/mL and chloramphenicol 0.05 mg/mL (Lio- ﬁlchem, Italy) and incubated at 25 °C for 15 days.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.06.003 2211-7539/ &2016 International Society for Human and Animal Mycology.",Non-OADS,/arxiv_data1/oa_pdf/74/4e/main.PMC4943087.pdf
The contrast-en- hanced high-resolution chest computed tomography on hospitalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.06.004 2211-7539/ &2016 International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/bd/e4/main.PMC4943088.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/a5/main.PMC4943089.pdf
Can redoxContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.06.005 2213-2317/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/32/a5/main.PMC4943089.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/a5/main.PMC4943089.pdf
Available from: https://www.cancer.ca/~/ media/cancer.ca/CW/cancer%20information/cancer%20101/Canadi an%20cancer%20statistics/Canadian-Cancer-Statistics-2015- EN.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/86/25/onco-2016-1-295.PMC4943094.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT01582672 17.,Non-OADS,/arxiv_data1/oa_pdf/86/25/onco-2016-1-295.PMC4943094.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT02231749 18.,Non-OADS,/arxiv_data1/oa_pdf/86/25/onco-2016-1-295.PMC4943094.pdf
Available from: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/uc m501070.htm 72.,Non-OADS,/arxiv_data1/oa_pdf/86/25/onco-2016-1-295.PMC4943094.pdf
Availablefrom: https://clinicaltrials.gov/ct2/show/NCT02127710 79.,Non-OADS,/arxiv_data1/oa_pdf/86/25/onco-2016-1-295.PMC4943094.pdf
ClinicalTrials.gov Identifier: NCT01375842Available from: https://clinicaltrials.gov/ct2/show/NCT01375842 82.,Non-OADS,/arxiv_data1/oa_pdf/86/25/onco-2016-1-295.PMC4943094.pdf
"Virus                Treatment, alternative drugs                                                  Disease state (links: further information)                          (CDC & NCCN recommended 1.2015) HSV                         Acyclovir, famciclovir, valacyclovir                                                                  Active therapy, neutropenia, mucositis                                                                                                                                                                https://www.nccn.org/store/login/login.aspx?ReturnURL=                                                                                                                                                                http://www.nccn.org/professionals/physician_gls/pdf/infections.pdf VZV                         Acyclovir, famciclovir, valacyclovir                                                                  Active therapy, neutropenia                                                                                                                                                                       http://www.rch.org.au/clinicalguide/guideline_index/Chickenpox_varicella/ CMV                        Preemptive valganciclovir, ganciclovir                                                           Stem cell transplantation, treatment with alemtuzumab                                                                                                                                                                http://www.mayoclinic.org/diseases-conditions/cmv/in-depth/                                                                                                                                                                CON-20029514 CMV                        Second/third line foscarnet, cidofovir                                                          Resistant CMV (stem cell transplantation, treatment with alemtuzumab)                                                                                                                                                                https://www.nccn.org/store/login/login.aspx?ReturnURL=                                                                                                                                                                http://www.nccn.org/professionals/physician_gls/pdf/infections.pdf HBV                         Entecavir, tenofovir, lamivudine, adefovir, telbivudine                             Resolved HBV infection, HBV antigens, transplantation, anti-CD20/or                                                                                                                                                                CD52 therapy                                                                                                                                                                http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm#b12 HCV                         Ledipasvir/simeprevir and sofosbuvir, paritaprevir and ritonavir,         Transplantation, anti-CD20 therapy, corticosteroids                                 ombitasvir and dasabuvir                                                                                 http://www.hcvguidelines.org/full-report-view HIV                          Integrase inhibitors, non-nucleoside reverse transcriptase                  Chemotherapy, targeted therapy                                 inhibitors                                                                                                             http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-                                                                                                                                                                guidelines/0 Influenza A/B         Oseltamivir, zanamivir                                                                                      Influenza outbreaks (subtype specific)                                                                                                                                                                http://www.cdc.gov/flu/professionals/antivirals/antiviral-use-influenza.htm RSV                         Ribavirin                                                                                                               Neutropenia, seasonal pattern                                                                                                                                                                http://www.cdc.gov/rsv/clinical/description.html Adenovirus             Cidofovir                                                                                                             Compromised immune system, seasonal pattern                                                                                                                                                                http://www.cdc.gov/adenovirus/hcp/prevention-treatment.html CDC, Centers for Disease Control and Prevention; NCCN, National Comprehensive Cancer Network; HSV, Herpes simplex virus; VZV, Varicella-Zoster virus; CMV, cytomegalovirus; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; RSV, respiratory syncytial virus.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/onco-2016-1-300.PMC4943096.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/d0/41/cp-2016-2-855.PMC4943105.pdf
"GU Ser Gen n. 65, 19/3/2010, available from: http://www.parlamento.it/parlam/ leggi/10038l.htm 14.",Non-OADS,/arxiv_data1/oa_pdf/d0/41/cp-2016-2-855.PMC4943105.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/                             Article,Non-OADS,/arxiv_data1/oa_pdf/d0/41/cp-2016-2-855.PMC4943105.pdf
Available from: http://www.agenzia- farmaco.gov.it/it/content/nota-66 31.,Non-OADS,/arxiv_data1/oa_pdf/d0/41/cp-2016-2-855.PMC4943105.pdf
Available from: http://www.agenziafarma- co.gov.it/sites/default/files/Diclofenac_DH PC_it_rev_AIFA.pdf 32.,OADS,/arxiv_data1/oa_pdf/d0/41/cp-2016-2-855.PMC4943105.pdf
Available from: http://www.apps.who.int/iris/ bitstream/10665/144852/2/9789241564830_eng.,OADS,/arxiv_data1/oa_pdf/c5/e8/JFMPC-5-101.PMC4943114.pdf
Available from: http://www.nvbdcp.gov.in/Doc/ mal_situation_Jan2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/e8/JFMPC-5-101.PMC4943114.pdf
Available  from: http://www.phcfm.org/index.php/phcfm/article/ view/257/279.,OADS,/arxiv_data1/oa_pdf/c5/e8/JFMPC-5-101.PMC4943114.pdf
Available from: http://www.pediatriconcall.,Non-OADS,/arxiv_data1/oa_pdf/3b/5e/JFMPC-5-108.PMC4943115.pdf
"The  Pearson coefficient of  correlation was calculated for evaluating  relations among variables.The protocol of  the study was approved by the Ethics  Committee of  the Shahrekord University of  Medical  Sciences (URL: http://www.skums.ac.ir), (RCT code:  IRCT201512116480n10).",Non-OADS,/arxiv_data1/oa_pdf/35/d7/JFMPC-5-134.PMC4943120.pdf
Available from: http://www.ufrgs.br/psiq/ WHOQOL‑OLD%20Manual%20POrtugues.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/bc/JFMPC-5-139.PMC4943121.pdf
Available from: http://www.who.int/gho/ps/.,Non-OADS,/arxiv_data1/oa_pdf/74/fd/JFMPC-5-154.PMC4943124.pdf
Available from: http://www.diabetes.com.au/pdf/ obesity_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/fd/JFMPC-5-154.PMC4943124.pdf
Available  from: http://www.whoindia.org/LinkFiles/Adolescent_ Health_and_Development_(AHD)_UNFPA_Country_Report.,Non-OADS,/arxiv_data1/oa_pdf/51/98/JFMPC-5-187.PMC4943137.pdf
Available  from: http://www.unicef.org/media/files/Opportunity_in_ Crisis_LoRes_EN_05182011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/51/98/JFMPC-5-187.PMC4943137.pdf
Available from: http://www.unicef.org/india/ hiv_aids_156.htm.,Non-OADS,/arxiv_data1/oa_pdf/51/98/JFMPC-5-187.PMC4943137.pdf
Available from:  http://www.aidsfree‑india.org/youth‑adolescence/ hiv‑aids‑youth‑adolescents‑intro.htm.,Non-OADS,/arxiv_data1/oa_pdf/51/98/JFMPC-5-187.PMC4943137.pdf
Available from: http://www.naco.gov.in/ upload/Policies%20&%20Guidelines/5‑GUILDELINES%20 FOR%20HIV%20TESTING.pdf.,Non-OADS,/arxiv_data1/oa_pdf/51/98/JFMPC-5-187.PMC4943137.pdf
Available from: http://www.unaids.org/en/ dataanalysis/monitoringcountryprogress/ progress‑reports/2010countries/india_2010_country_ progress_report_en.pdf.,OADS,/arxiv_data1/oa_pdf/51/98/JFMPC-5-187.PMC4943137.pdf
Available  from: http://digitalcommons.brockport.edu/bookshelf/36.,Non-OADS,/arxiv_data1/oa_pdf/11/0c/JFMPC-5-190.PMC4943138.pdf
Available from:  https://www.mhealthworkinggroup.org/sites/mhealthwg.,Non-OADS,/arxiv_data1/oa_pdf/98/f1/JFMPC-5-192.PMC4943139.pdf
Letter to EditorJournal of Family Medicine and Primary Care 193 January 2016 : Volume 5 : Issue 1Available from: http://www.gsmamobileeconomyafrica.,Non-OADS,/arxiv_data1/oa_pdf/98/f1/JFMPC-5-192.PMC4943139.pdf
Available from http://currents.plos.,Non-OADS,/arxiv_data1/oa_pdf/98/f1/JFMPC-5-192.PMC4943139.pdf
Available from: http://www.informationweek.com/ healthcare/mobile‑and‑wireless/magpi‑mobile‑data‑tool‑aid s‑ebola‑fight/d/d‑id/1317577.,Non-OADS,/arxiv_data1/oa_pdf/98/f1/JFMPC-5-192.PMC4943139.pdf
Available from: http://www.who.int/features/ factfiles/roadsafety/en/index.html#.,Non-OADS,/arxiv_data1/oa_pdf/e6/d3/JFMPC-5-195.PMC4943141.pdf
Available from: http://www.mciindia.org/ Information desk/For students/List of colleges teaching  MBBS.aspx [Last accessed on 2014 Apr 13].,Non-OADS,/arxiv_data1/oa_pdf/9a/9a/JFMPC-5-20.PMC4943143.pdf
Available  from: http://www.mciindia.org/InformationDesk/ CollegesCoursesSearch.aspx [Last accessed on  2014 Sept 13].,Non-OADS,/arxiv_data1/oa_pdf/9a/9a/JFMPC-5-20.PMC4943143.pdf
Available  from: http://www.natboard.edu.in/pdoof/Indicative%20 Seat%20Matrix%20‑%20DNB%20CET%20Jan%202013.pdf  [Last accessed on 2014 Sept 13].,Non-OADS,/arxiv_data1/oa_pdf/9a/9a/JFMPC-5-20.PMC4943143.pdf
Available from:  http://www.amstat.org/about/ethicalguidelines.cfm.,Non-OADS,/arxiv_data1/oa_pdf/d1/d5/JFMPC-5-24.PMC4943144.pdf
Available  from:  http://www.stat.tugraz.at/AJS/ausg072/072Strasak.,OADS,/arxiv_data1/oa_pdf/d1/d5/JFMPC-5-24.PMC4943144.pdf
Available from: http://www.njcmindia.,Non-OADS,/arxiv_data1/oa_pdf/d1/d5/JFMPC-5-24.PMC4943144.pdf
Available from:  http://www.mciindia.org/Rules‑and‑Regulation/ Postgraduate‑Medical‑Education‑Regulations‑2000.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3f/20/JFMPC-5-3.PMC4943145.pdf
Available from: https://www.theabfm.org/ about/history.aspx.,Non-OADS,/arxiv_data1/oa_pdf/3f/20/JFMPC-5-3.PMC4943145.pdf
Available  from: http://www.indiatoday.intoday.in/story/ family‑physicians‑are‑dying‑a‑silent‑death/1/201164.html.,Non-OADS,/arxiv_data1/oa_pdf/3f/20/JFMPC-5-3.PMC4943145.pdf
Available from: http://www.timesofindia.indiatimes.com/ india/75‑per‑cent‑of‑doctors‑have‑been‑attacked‑at‑work  ‑by‑disgruntled‑attendants‑study‑says/articleshow  /49533759.cms.,Non-OADS,/arxiv_data1/oa_pdf/3f/20/JFMPC-5-3.PMC4943145.pdf
Available from: http://www.planningcommission.gov.,Non-OADS,/arxiv_data1/oa_pdf/3f/20/JFMPC-5-3.PMC4943145.pdf
Available from: http://www.nrmp.org/wp‑content/ uploads/2015/05/Main‑Match‑Results‑and‑Data‑2015_ final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3f/20/JFMPC-5-3.PMC4943145.pdf
Available from: http://www.svr‑gesundheit.de/fileadmin/ user_upload/Gutachten/2014/SVR‑Gutachten_2014_ Langfassung.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/c8/JFMPC-5-34.PMC4943146.pdf
Available from: http://www.pmdc.org.pk/LinkClick.,Non-OADS,/arxiv_data1/oa_pdf/55/2e/JFMPC-5-45.PMC4943148.pdf
Available from: http://www.gmc‑uk.org/education/./ professionalbehaviour.asp.,Non-OADS,/arxiv_data1/oa_pdf/0c/95/JFMPC-5-56.PMC4943150.pdf
Available from: http://www.abimfoundation.,Non-OADS,/arxiv_data1/oa_pdf/0c/95/JFMPC-5-56.PMC4943150.pdf
Available from: http://www.publikasi.,Non-OADS,/arxiv_data1/oa_pdf/0c/95/JFMPC-5-56.PMC4943150.pdf
Available from: http://www.cfpc.ca.,Non-OADS,/arxiv_data1/oa_pdf/0c/95/JFMPC-5-56.PMC4943150.pdf
Available from: http://www.sisbq.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/JFMPC-5-77.PMC4943155.pdf
Available from: http://www.unicef.org/ india/health.html.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/JFMPC-5-77.PMC4943155.pdf
Available from: http://www.mohfw.,Non-OADS,/arxiv_data1/oa_pdf/12/a9/JFMPC-5-82.PMC4943156.pdf
Available  from: http://www.cdc.gov/tobacco/global/gtss/index.,OADS,/arxiv_data1/oa_pdf/12/a9/JFMPC-5-82.PMC4943156.pdf
Available  from: http://www.apps.nccd.cdc.gov/gtssData/Ancillary/ DataReports.aspx?CAID=2.,OADS,/arxiv_data1/oa_pdf/12/a9/JFMPC-5-82.PMC4943156.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/a1/ofw065.PMC4943171.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs164/en/ .,Non-OADS,/arxiv_data1/oa_pdf/5b/a1/ofw065.PMC4943171.pdf
Available at: http://www.who.int/hiv/ pub/hepatitis/hepatitis-c-guidelines/en/ .,Non-OADS,/arxiv_data1/oa_pdf/5b/a1/ofw065.PMC4943171.pdf
Available at: http://www.hepcoalition.,Non-OADS,/arxiv_data1/oa_pdf/5b/a1/ofw065.PMC4943171.pdf
Available at: http://www.gilead.com/~/media/Files/pdfs/ other/HCV%20Generic%20Agreement%20Fast%20Facts%203215.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5b/a1/ofw065.PMC4943171.pdf
Available at:https://www.msfaccess.org/sites/default/ ﬁles/MSF_assets/HepC/Docs/HepC_ brief_OvercomingbarriersToAccess_ENG_2015.pdf .,OADS,/arxiv_data1/oa_pdf/5b/a1/ofw065.PMC4943171.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/4a/evw084.PMC4943174.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/dd/evw099.PMC4943175.pdf
"ImageJ(Rasband, W.S., ImageJ, U. S. National Institutes of Health,Bethesda, MD; http://imagej.nih.gov/ij/ , 1997-2014) was used to convert 8-bit gray scale images to false RGB colorsand for image analysis.",OADS,/arxiv_data1/oa_pdf/a1/dd/evw099.PMC4943175.pdf
Compositional Bias and Codon Usage Calculations of Guanine-Cytosine content of third position 4-fold degenerate sites (GC3s) and the effective number ofcodons were done through the use of custom python scripts (available: https://github.com/maurerax/Basic-Informatics- Katzlab- ).,OADS,/arxiv_data1/oa_pdf/a1/dd/evw099.PMC4943175.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/7b/evw101.PMC4943176.pdf
"MLST data were submitted to the C. botulinum MLST data- base ( http://pubmlst.org/cbotulinum /, last accessed May 10, 2016).",OADS,/arxiv_data1/oa_pdf/04/7b/evw101.PMC4943176.pdf
S1–S10 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/04/7b/evw101.PMC4943176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/98/evw104.PMC4943177.pdf
"2005 ; http://web.wi.mit.edu/young/nucleosome , accessed January 2012), and averaged levels of a given histone modiﬁcationacross the last 500 bp of each gene’s transcript boundaries(Xu et al.",OADS,/arxiv_data1/oa_pdf/77/98/evw104.PMC4943177.pdf
Supplementary Material Supplementary tables S1–S5 andﬁgures S1–S9 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/77/98/evw104.PMC4943177.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/13/evw106.PMC4943178.pdf
"Supplementary Material Supplementary ﬁgures S1, S2 and table S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.",Non-OADS,/arxiv_data1/oa_pdf/e8/13/evw106.PMC4943178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/evw107.PMC4943179.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/52/evw108.PMC4943180.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/77/evw109.PMC4943181.pdf
Supplementary Material Supplementary ﬁgure S1 and table S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/6d/77/evw109.PMC4943181.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/03/evw112.PMC4943183.pdf
"(2012) , using all sequences with an active UniProt entry ( UniProt 2015 ,http://www.uniprot.org ,r e - trieved 2015 Jun 28).",Non-OADS,/arxiv_data1/oa_pdf/ac/03/evw112.PMC4943183.pdf
"2015 ,http://tcoffee.crg.ca t/apps/tcoffee/, last accessed August 2, 2015) under the default conditions.",Non-OADS,/arxiv_data1/oa_pdf/ac/03/evw112.PMC4943183.pdf
"2014 ,http://pfam.xfam.org , last accessed August 12, 2015) with the gathering threshold selected as cutoff.",Non-OADS,/arxiv_data1/oa_pdf/ac/03/evw112.PMC4943183.pdf
"2013 ) Protein Model Portal; http://www.proteinmodelportal.org/ query/up/ P1980 9, last accessed August 10, 2015) where no structural information was available, for the sequence P19809 (EPEC intimin).",OADS,/arxiv_data1/oa_pdf/ac/03/evw112.PMC4943183.pdf
"Accepted: May 1, 2016 Data deposition: This project has been deposited at Zenodo under the accession http://dx.doi.org/10.5281/zenodo.51708 .",OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
"Fifteen algorithms have submitte d their orthology estimates on66 reference proteomes ( http://www.ebi.ac.uk/reference_ proteomes , last accessed 19 May 2016) to QFO’s benchmarking tool ( http://orthology.benchmarkservice.org/cgi-bin/gateway.pl , last accessed 19 May 2016) ( Altenhoff et al.",OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
"lausanne.isb-sib.ch/databases/SwissTree/speciestree.nhx ,l a s t accessed 19 May 2016) and was pruned to match the taxa in the Quest for Orthologs reference proteomes ( http://www.ebi.",OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
"These, and the datasets supporting the con-clusions in this article, are available at geneages.org, and the associated GitHub repository ( https://github.com/marcottelab/ Gene-Ages , last accessed 19 May 2016) with the following commit id: fee8d009d4d5ee 24c3ae3cb0763439c48d4705e6.",OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
Tables are available at https://github.com/marcottelab/Gene-Ages Common name Uniprot ID False-negative analysis Anopheles gambiae (Mosquito) ANOGA No Bos taurus (Cattle) BOVIN No Branchiostoma ﬂoridae (Lancelet) BRAFL NoCaenorhabditis elegans (Worm) CAEEL YesCandida albicans CANAL Yes Canis lupus familiaris (Dog) CANFA No Gallus gallus (Chicken) CHICK YesCiona intestinalis (Tunicate) CIOIN No Cryptococcus neoformans CRYNJ No Danio rerio (Zebraﬁsh) DANRE YesDrosophila melanogaster (Fly) DROME Yes Homo sapiens (Human) HUMAN Yes Ixodes scapularis (Tick) IXOSC NoMacaca mulatta (Rhesus macaque) MACMU NoMonosiga brevicollis (Choanoﬂagellate) MONBE No Monodelphis domestica (Opossum) MONDO No Mus musculus (Mouse) MOUSE YesNematostella vectensis (Sea anemone) NEMVE No Neurospora crassa NEUCR No Ornithorhynchus anatinus (Platypus) ORNAN NoPan troglodytes (Chimp) PANTR No Phaeosphaeria nodorum PHANO No Rattus rattus (Rat) RAT YesSaccaromyces cerevisiae (Budding yeast)YEAST Yes Schistosoma mansoni (Blood ﬂuke) SCHMA No Schizosaccharomyces pombe (Fission yeast)SCHPO Yes Sclerotinia sclerotiorum SCLS1 No Takifugu rubripes (Pufferﬁsh) TAKRU NoUstilago maydis (Corn smut/Huitlacoche USTMA No Xenopus tropicalis (Frog) XENTR No Yarrowia lipolytica YARLI NoLiebeskind et al.,Non-OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
"We cannot, therefore, rule out the possibility that some of the“youngest” proteins may be due to the limited sensitivity of the homology searches (see also supplemental iPython note- book “errorCorrelation_plotting” ( Supplementary Material online) at https://github.com/marcottelab/Gene-Ages/tree/ master/Notebooks ).",Non-OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
"These decisions wereinformed by the underlying distributions of values.Nevertheless, we supply the source data ﬁles, scripts usedfor these analyses, as well as interactive iPython notebooks,and we invite researches to explore and change parameters ifthey desire ( https://github.com/marcottelab/Gene-Ages ).",Non-OADS,/arxiv_data1/oa_pdf/79/00/evw113.PMC4943184.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/66/evw114.PMC4943185.pdf
http://dx.doi.org/10.1038/37052.,Non-OADS,/arxiv_data1/oa_pdf/72/66/evw114.PMC4943185.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/d1/evw115.PMC4943186.pdf
"The corresponding coding sequences for A. thali- anawere downloaded from The Arabidopsis Information Resource database ( https://www.arabidopsis.org , last accessed on May 18, 2016).",OADS,/arxiv_data1/oa_pdf/7d/d1/evw115.PMC4943186.pdf
"Prediction of Transit Peptides The cleavage site of 50-transit peptides for nuclear-encoded plastid-targeted genes (NuCpRP and NuCpOT) was predictedin silico using the TargetP web server ( http://www.cbs.dtu.dk/ services/TargetP/ , last accessed on May 18, 2016; Nielsen et al.",OADS,/arxiv_data1/oa_pdf/7d/d1/evw115.PMC4943186.pdf
"Prediction of Conserved Domains Conserved domains were predicted by uploading the se- quences to the NCBI Conserved Domain Database for com- parison (v3.14 with default options and E-value threshold of0.01; http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi , last accessed on May 18, 2016; Marchler-Bauer et al.",OADS,/arxiv_data1/oa_pdf/7d/d1/evw115.PMC4943186.pdf
"Codon Usage Bias Estimation To estimate the codon usage bias for NuCpRP and NuCyRP, the effective number of codons (Nc) ( Wright 1990 ) was esti- mated using CodonW ( http://codonw.sourceforge.net ,l a s t accessed on May 18, 2016; Peden 1999 ).",OADS,/arxiv_data1/oa_pdf/7d/d1/evw115.PMC4943186.pdf
"2007 ) of the spinach plastid ribosome were downloaded from the Research Collaboratory for StructuralBioinformatics Protei n Data Bank (RCSB PDB, http://www.rcsb.",OADS,/arxiv_data1/oa_pdf/7d/d1/evw115.PMC4943186.pdf
Available from: https://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/7d/d1/evw115.PMC4943186.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/eb/evw116.PMC4943187.pdf
"A fasta ﬁle was then generated using gffread, and total exonic length was determined using the perl script fastaNamesSizes.pl ( http://www.molecularevolution.",OADS,/arxiv_data1/oa_pdf/49/eb/evw116.PMC4943187.pdf
Version R package version 0.8-12. http://mulcyber.toulouse.inra.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/evw116.PMC4943187.pdf
http://pseudobase.biology.duke.edu/ .,Non-OADS,/arxiv_data1/oa_pdf/49/eb/evw116.PMC4943187.pdf
http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/49/eb/evw116.PMC4943187.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/47/evw117.PMC4943188.pdf
"First, screening the sequenced teff genome ( http://www.tef-research.org/genome.html ) for ho- mologous genes to g-prolamin genes in the Panicoideae sub- family found three sequences that could encode teff g-type prolamins.",OADS,/arxiv_data1/oa_pdf/c3/47/evw117.PMC4943188.pdf
The teff Ha-like locus was from Scaffold1023:14107-23158 ( http://www.tef-research.org/genome.html ) and the foxtail millet Ha-like locus was downloaded from NCBI as XM_004963284.,OADS,/arxiv_data1/oa_pdf/c3/47/evw117.PMC4943188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/b0/evw118.PMC4943189.pdf
Materials and Methods Data Sources The NR protein database was downloaded from the NCBI(20th September 2015) ftp://ftp.ncbi.nih.gov/blast/db/FASTA/ nr.gz.,OADS,/arxiv_data1/oa_pdf/aa/b0/evw118.PMC4943189.pdf
Proteins from the ‘Origins of Multicellularity’ project were downloaded from https://www.broadinstitute.org/annota tion/genome/multicellularity_project/MultiHome.html .,OADS,/arxiv_data1/oa_pdf/aa/b0/evw118.PMC4943189.pdf
Predicted proteins from Schizosaccharomyces were down- loaded from https://www.broadinstitute.org/scientiﬁc-com munity/science/projects/fungal-genome-initiative/schizosac- charomyces-genomes-project .,OADS,/arxiv_data1/oa_pdf/aa/b0/evw118.PMC4943189.pdf
Trichoplax adhaerens protein models were taken from: ftp://ftp.ncbi.nih.gov/genomes/refseq/invertebrate/Trichoplax_ adhaerens/ .,OADS,/arxiv_data1/oa_pdf/aa/b0/evw118.PMC4943189.pdf
"cryophilus ), via mutually con- sistent groups of four reciproc al best hits in all against all searches performed with the phmmer program from thehmmer package ( http://hmmer.org/ ).",OADS,/arxiv_data1/oa_pdf/aa/b0/evw118.PMC4943189.pdf
Supplementary Material Supplementary material andﬁgures S1 and S2 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/aa/b0/evw118.PMC4943189.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/evw119.PMC4943190.pdf
"The method, enacted as “OcculterCut” ( https://sourceforge.net/projects/occultercut , last accessed April 30, 2016), identiﬁed species containing distinct AT-rich regions.",Non-OADS,/arxiv_data1/oa_pdf/ef/2d/evw121.PMC4943192.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/2d/evw121.PMC4943192.pdf
"To this end, we present the software OcculterCut (available from https://sourceforge.net/projects/ occultercut , last accessed April 30, 2016) that is capable of replicating the analyses presented herein as well as reporting gene annotations within and near AT-rich regions.",OADS,/arxiv_data1/oa_pdf/ef/2d/evw121.PMC4943192.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/01/evw123.PMC4943194.pdf
Supplementary Material Supplementary ﬁgures S1–S4 andtables S1–S11 are available atGenome Biology and Evolution online http://www.gbe.,OADS,/arxiv_data1/oa_pdf/4e/01/evw123.PMC4943194.pdf
Available from: http://www.r-project.org .,Non-OADS,/arxiv_data1/oa_pdf/4e/01/evw123.PMC4943194.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/5e/evw124.PMC4943195.pdf
"In order to overcome these limitations, we developed a different approach, which we called mtArchitect ( http://www.biologiaevolutiva.org/tmar ques/mtarchitect/ ).",Non-OADS,/arxiv_data1/oa_pdf/6f/5e/evw124.PMC4943195.pdf
"Neighbor joining trees of whole mitochondrial genomes, coding regions and D-loops were constructed usingMAFFT with 1,000 bootstrap repetitions and were edited withFigTree v1.4.0 ( http://tree.bio.ed.ac.uk/software/ﬁgtree/ ).",OADS,/arxiv_data1/oa_pdf/6f/5e/evw124.PMC4943195.pdf
To calculate each model’s posterior probability weused a weighted multinomial logistic regression (LR)(Beaumont 2008 ) using R scripts from https://code.google.,OADS,/arxiv_data1/oa_pdf/6f/5e/evw124.PMC4943195.pdf
Available from: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/6f/5e/evw124.PMC4943195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/c9/evw125.PMC4943196.pdf
A web-based database implementation (Beta version) of the pipeline is available athttp://evodivmet.langebio.cinvestav.mx/EvoMining/index.,OADS,/arxiv_data1/oa_pdf/57/c9/evw125.PMC4943196.pdf
In most of the 23 phylo-genetic reconstructions (provided as online supplementary material athttp://evodivmet.langebio .cinvestav.mx/EvoMining /index.html ) the central metabolic homologs formed clades with topologies that recapitulate speciation events.,OADS,/arxiv_data1/oa_pdf/57/c9/evw125.PMC4943196.pdf
Supplementary Material Supplementary ﬁgures 1 and 2 and tables 1–9 are available at Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/57/c9/evw125.PMC4943196.pdf
"Accepted: May 24, 2016 Data deposition: The willow pseudomolecule data reported in this article have been deposited at the Willow Resource under the accession web http://bio.njfu.edu.cn/willow_chromosome .",OADS,/arxiv_data1/oa_pdf/55/80/evw127.PMC4943198.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/80/evw127.PMC4943198.pdf
Chromosomeidentities of willow were designated based on sequencehomology to chromosome sequences of P. trichocarpa (http://genome.jgi.do e.gov/pages/dynamicOrganismDownload.,OADS,/arxiv_data1/oa_pdf/55/80/evw127.PMC4943198.pdf
"The corresponding infor- mation for P. trichocarpa was retrieved from the Joint Genome Institute, United States Department of Energy website (http://genome.jgi.doe.gov/pages/dynamicOrganismDownload.",OADS,/arxiv_data1/oa_pdf/55/80/evw127.PMC4943198.pdf
"Collinearity charts were drawn using the software package VGSC (a web-based Vector Graph toolkit for displaying g enome Synteny and Collinearity; available at http://bio.njfu.edu.cn/vgsc-web/ , last accessed June 8, 2016) ( Xu et al.",OADS,/arxiv_data1/oa_pdf/55/80/evw127.PMC4943198.pdf
"Results Integration of Sequence Scaffolds of S. suchowensis Integration analysis enabled a t otal of 1,025 sequence scaffolds to be anchored on the 19 chromosomes (Assembly ver2.0;http://bio.njfu.edu.cn/willow_chromosome , last accessed June 8, 2016).",OADS,/arxiv_data1/oa_pdf/55/80/evw127.PMC4943198.pdf
2016. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/80/evw127.PMC4943198.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/7a/evw129.PMC4943200.pdf
Available from: http://data.kew.org/cvalues/ .,OADS,/arxiv_data1/oa_pdf/92/7a/evw129.PMC4943200.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/f9/evw130.PMC4943201.pdf
Supplementary Material Supplementary ﬁgures S1 and S2 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour- nals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/f9/evw130.PMC4943201.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/c7/evw135.PMC4943203.pdf
"Genomes were aligned with the open-sourceMAUVE aligner version 2.3.1 using the progressive algorithm.The alignments were generated using the default settings (http://darlinglab.org /mauve/mauve.html , last accessed June 8, 2016).",OADS,/arxiv_data1/oa_pdf/e3/c7/evw135.PMC4943203.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/7d/evw137.PMC4943204.pdf
"ClinVar data were downloaded from theClinVar catalogue FTP server ( ftp://ftp.ncbi.nlm.nih.gov/pub/ clinvar/tab_delimited/ , last accessed June 14, 2016) (Landrum et al.",OADS,/arxiv_data1/oa_pdf/db/7d/evw137.PMC4943204.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/89/evw140.PMC4943205.pdf
"Results are publicly available via a web interface at the following URL http://genopole.pas- teur.fr/SynTView/ﬂash/Leishmania/SynWeb.html (last accessed June 18, 2016) for four Leishmania genomes: L. major strain Friedlin (NC_001905, NC_004916, NC_007244-73, NC_007284-87; Ivens et al.",OADS,/arxiv_data1/oa_pdf/a9/89/evw140.PMC4943205.pdf
"These ﬁve se- quences made up a strongly s upported clade (i.e., 84Table 1 The L. major HSP70 protein family Gene ID MW AA GeneDB annotation NameaDomains ( E-value) LmjF.28.2770 71.7 658 HSP70, putative LmjF_HSPA1A cd10233 , 6-384 (0); cl17037, 6-384 (0); PTZ00009 , 1-616 (0); pfam00012, 6-615 (0) LmjF.28.2780 71.7 658 HSP70, putative LmjF_HSPA1B cd10233 , 6-384 (0); cl17037, 6-384 (0); PTZ00009 , 1-616 (0); pfam00012, 6-615 (0) LmjF.26.1240 70.6 641 HSP70.4 LmjF_HSPA2 cd10233 , 6-382 (0); cl17037, 6-382 (0); PTZ00009 , 1-641 (0); pfam00012, 6-613 (0) LmjF.28.1200 71.9 658 BiP LmjF_HSPA5 cd10233 , 36-408 (0); cl17037, 36-408 (0); PTZ00009 , 34-649 (0); pfam00012, 38-642 (0); pfam01968, 208-250 (9e-05); cl00668, 208-250 (9e-05); pfam01968, 208-250 (9.0e-05); cl00668 208-250 (9.0e-05); pfam13057 , 568-642 (4.6e-3); cl16063, 568-642 (4.6e-3) LmjF.30.2460 68.9 635 HSP70-related protein 1 LmjF_HSPA9A cd11733 , 26-402 (0); cl17037, 26-402 (0); PTZ00186 , 1-633 (0); pfam00012, 29-625 (0) LmjF.30.2470 71.9 662 HSP70-related protein 1 LmjF_HSPA9B cd11733 , 26-402 (0); cl17037, 26-402 (0); PTZ00186 , 1-662 (0); pfam00012, 29-625 (0) LmjF.30.2480 71.9 662 HSP70-related protein 1 LmjF_HSPA9C cd11733 , 26-402 (0); cl17037, 26-402 (0); PTZ00186 , 1-662 (0); pfam00012, 29-625 (0) LmjF.30.2490 71.6 660 HSP70-related protein 1 LmjF_HSPA9D cd11733 , 26-402 (0); cl17037, 26-402 (0); PTZ00186 , 1-660 (0); pfam00012, 29-625 (0) LmjF.30.2550 70.6 652 HSP70-related protein 1 LmjF_HSPA9E cd11733 , 26-402 (0); cl17037, 26-402 (0); PTZ00186 , 1-652 (0); pfam00012, 29-625 (0) LmjF.28.2820 72.3 662 HSP70, putative LmjF_HSPA3 cd10233 , 10-395 (1.6e-172); cl17037, 10-395 (1.6e-172); pfam00012 , 10-628 (0); PTZ00009, 6-555 (0) LmjF.18.1370 91.8 823 HSP110, putative LmjF_HSPH1 cd10228, 2-390 (0); cl17037, 2-390 (0); pfam02782, 286-388 (4.4e-06); cl17173 , 618-689 (8.5e-3) LmjF.26.0900 104.1 944 HSP70-like protein LmjF_HRP1 cd10170 , 94-538 (3.5e-92); cl17037, 94-538 (3.5e-92); pfam00012 , 93-545 (5.7e-69); PTZ00400, 84-547 (1.8e-52) LmjF.35.4710 78.8 723 Hypothetical protein LmjF_HRP2 cd10230 , 28-407 (1.7e-138); cl17037, 28-407 (1.7e-138); pfam00012 , 27-436 (3.2e-43); PTZ00186, 5-407 (2.7e-28) LmjF.01.0640 117.5 1112 HSP70-like protein LmjF_HRP3 cd10230 , 99-690 (3.1e-74); cl17037, 99-690 (3.1e-74); pfam00012 , 335-689 (1.6e-19); PTZ00186, 399-689 (4.2e-13); LmjF.29.1240 78.9 722 Hypothetical protein LmjF_HRP4 cd10170 , 8-384 (1.2e-29); cl17037, 8-384 (1.2e-29); pfam00012 , 8-386 (3.2e-14); PTZ00186, 8-386 (10e-06); pfam00515, 659-692 (2e-4); cl22897, 659-692 (2e-4); pfam13424 , 625-691 (3.4e-4) LmjF.32.0190 81.5 768 Hypothetical protein LmjF_HRP5 cd10170 , 23-498 (2.2e-06); cl17037, 23-498 (2.2e-06); pfam00012 , 23-73 (2.6e-4); PTZ00186, 20-73 (3.6e-4) aProposed name following the nomenclature assigned by the HUGO Gene Nomenclature Committee ( http://www.genenames.org/genefamilies/HSP , last accessed June 18, 2016) and used in the NCBI Entrez Gene database for human HSPs.",Non-OADS,/arxiv_data1/oa_pdf/a9/89/evw140.PMC4943205.pdf
"4E , data accessible via URL http://genopole.pasteur.",OADS,/arxiv_data1/oa_pdf/a9/89/evw140.PMC4943205.pdf
"Our analysis documents synteny across all species and all HSP70 family members (data not shown but accessible via URL http://genopole.pasteur.fr/ SynTView/ﬂash/Leishmania/ SynWeb.html , last accessed June 18, 2016), but revealed substantial gene copy number variations for the HSPA1 and HSPA9 gene arrays across the different Leishmania species(ﬁg.",OADS,/arxiv_data1/oa_pdf/a9/89/evw140.PMC4943205.pdf
Supplementary Material Supplementary tables S1–S4 andﬁgures S1–S12 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/a9/89/evw140.PMC4943205.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/34/evw141.PMC4943206.pdf
"Databases of Illumina reads as well as assembled contigs speciﬁc to different types of repetitive DNA elements identi-ﬁ e dd en o v oi nt h es e q u e n c i n gd a t aw e r ee s t a b l i s h e da n da r epublicly available ( http://olomouc.ueb.cas.cz/projects/Ludisia_ discolor , last accessed June 14, 2016) and raw data were FIG.1 .—Histogram of relative ﬂuorescence intensity obtained afte r the analysis of propidium iodide-stained nuclei.",OADS,/arxiv_data1/oa_pdf/23/34/evw141.PMC4943206.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/5/2/ e002757.,Non-OADS,/arxiv_data1/oa_pdf/a0/33/JAH3-5-e002022.PMC4943232.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/9c/51/JAH3-5-e002197.PMC4943233.pdf
"An accompanying Data S1 is available at http://jaha.ahajournals.org/content/5/3/e002197/suppl/DC1*The ROCKET AF Steering Committee & Investigators are listed in the Appendix.Correspondence to: Sean D. Pokorney, MD, MBA, Division of Cardiology, Duke University Medical Center, 2301 Erwin Rd, DUMC 3845, Durham, NC 27710.",Non-OADS,/arxiv_data1/oa_pdf/9c/51/JAH3-5-e002197.PMC4943233.pdf
Accompanying Tables S1 and S2 are available at http://jaha.ahajournals.org/content/5/3/e002284/suppl/DC1.,Non-OADS,/arxiv_data1/oa_pdf/86/f3/JAH3-5-e002284.PMC4943234.pdf
Available at: https://www.jacksonheartstudy.org/ jhsinfo/ForResearchers/FormsManuals/Exam1Manuals/tabid/111/Defaul-t.aspx.,Non-OADS,/arxiv_data1/oa_pdf/86/f3/JAH3-5-e002284.PMC4943234.pdf
Available at: https://www.jacksonheartstudy.org/jhsinfo/Portals/0/pdf/manuals1/Blood_pressure_manual4_02-18-2001(1).pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/f3/JAH3-5-e002284.PMC4943234.pdf
"Accompanying Tables S1 through S5 are available at http://jaha.ahajournals.org/content/5/3/e002377/suppl/DC1Correspondence to: Jos/C19e R. Romero, MD, Department of Neurology, Boston University School of Medicine, 715 Albany Street, B-608, Boston, MA 02118-2526.",Non-OADS,/arxiv_data1/oa_pdf/0e/df/JAH3-5-e002377.PMC4943235.pdf
"An accompanying Figure S1 is available at http://jaha.ahajournals.org/con- tent/5/3/e002545/suppl/DC1 Correspondence to: Caroline S. Fox, MD, MPH, Framingham Heart Study, National Heart, Lung, and Blood Institute, 73 Mount Wayte Ave, Suite 2,Framingham, MA 01702.",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/JAH3-5-e002545.PMC4943240.pdf
An accompanying Data S1 is available at http://jaha.ahajournals.org/con- tent/5/3/e002562/suppl/DC1 *Dr X.-Q.,OADS,/arxiv_data1/oa_pdf/f8/8a/JAH3-5-e002562.PMC4943241.pdf
"Accompanying Tables S1, S2, and Appendix S1 (which lists the members of the EUROPA/PERGENE Investigators) are available at http://jaha.ahajour- nals.org/content/5/3/e002688/suppl/DC1 Correspondence to: Eric Boersma, PhD, MSc, Thoraxcenter, Department of Cardiology, Erasmus MC, BD-041, ‘s-Gravendijkwal 230, 3015CE Rotterdam, The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/64/14/JAH3-5-e002688.PMC4943245.pdf
"CMR Analysis All image analyses were performed using the software, Segment (http://segment.heiberg.se).25 All image analysis was performed by Imacor AB as a core lab service in both trials.",OADS,/arxiv_data1/oa_pdf/d1/37/JAH3-5-e002708.PMC4943247.pdf
"*ClinCalc.com (http://clincalc.com/Stats/SampleSize.aspx), which uses analytical formulas as opposed to Monte Carlo simulations.",Non-OADS,/arxiv_data1/oa_pdf/d1/37/JAH3-5-e002708.PMC4943247.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/content/5/3/e002712/suppl/DC1*Dr Rhee and Dr Gerszten contributed equally to this work.Correspondence to: Robert E. Gerszten, MD, Cardiovascular Research Center, Massachusetts General Hospital, Simches Research Building, 185 Cambridge St, 3208, Boston, MA 02114.",Non-OADS,/arxiv_data1/oa_pdf/7c/09/JAH3-5-e002712.PMC4943248.pdf
"Accompanying Data S1, Table S1, and Figures S1, S2 are available at http://jaha.ahajournals.org/content/5/3/e002737/suppl/DC1 Correspondence to: M. G. Myriam Hunink, MD, PhD, Department of Radiology and Department of Epidemiology, Na 2818, P.O.",OADS,/arxiv_data1/oa_pdf/9b/2c/JAH3-5-e002737.PMC4943251.pdf
Densitomet- ric analysis of Western blots was done using ImageJ software (from NIH at: http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/48/be/JAH3-5-e002777.PMC4943253.pdf
"The registry collects detailed patient and procedure characteristics, as well as in-hospital treatments and outcomes, using common data standards and deﬁnitions described online at https://www.ncdr.com/web- ncdr/action/home/datacollection.",OADS,/arxiv_data1/oa_pdf/96/39/JAH3-5-e002784.PMC4943255.pdf
"An accompanying Appendix S1 is available at http://jaha.ahajournals.org/ content/5/3/e002798/suppl/DC1 Correspondence to: Nigel Gupta, MD, Department of Electrophysiology, Southern CA Permanente Medical Group, 4867 Sunset Blvd, Los Angeles, CA90027.",Non-OADS,/arxiv_data1/oa_pdf/87/c0/JAH3-5-e002798.PMC4943256.pdf
Available at: http://www.Gao.Gov/ products/gao-11-468.,Non-OADS,/arxiv_data1/oa_pdf/87/c0/JAH3-5-e002798.PMC4943256.pdf
Available at: https://www.Ncdr.Com/webncdr/home/about-the-ncdr.,Non-OADS,/arxiv_data1/oa_pdf/87/c0/JAH3-5-e002798.PMC4943256.pdf
Clinical Trial Registration- —URL: https://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/28/bb/JAH3-5-e002828.PMC4943260.pdf
"Clinical assessment was performed to classify dyspnea based on the New York Heart Association functional classi- ﬁcation.12Comprehensive resting standard echocardiography was performed with a Vivid 7 or E9 (GE Ving Med Ultrasound) according to guideline standards.13,14The perioperative risk scores were calculated with use of the STS v2.73 calculator(http://riskcalc.sts.org/).",Non-OADS,/arxiv_data1/oa_pdf/28/bb/JAH3-5-e002828.PMC4943260.pdf
"Accompanying Data S1 and Figures S1 through S5 are available at http://jaha.ahajournals.org/content/5/3/e002836/suppl/DC1 Correspondence to: Richard J. Gilbert, MD, Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Ave, Boston, MA02115-5005.",OADS,/arxiv_data1/oa_pdf/84/3d/JAH3-5-e002836.PMC4943261.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/ content/5/3/e002877/suppl/DC1 Correspondence to: Brett W. Sperry, MD, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195.",Non-OADS,/arxiv_data1/oa_pdf/68/3d/JAH3-5-e002877.PMC4943263.pdf
"*An accompanying Appendix S1, which list the members of the DCCT/EDIC Research Group, is available at http://jaha.ahajournals.org/content/5/3/e002882/suppl/DC1 Correspondence to: Elsayed Z. Soliman MD, MSc, MS, FAHA, FACC, Epidemiological Cardiology Research Center (EPICARE), Wake Forest School of Medicine, Medical Center Blvd, Winston Salem, NC 27157.",Non-OADS,/arxiv_data1/oa_pdf/41/35/JAH3-5-e002882.PMC4943265.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/5b/ce/JAH3-5-e002919.PMC4943266.pdf
"Accompanying Tables S1 and S2 and Figure S1 are available at http://jaha.ahajournals.org/content/5/3/e002924/suppl/DC1 Correspondence to: Paul S. Chan, MD, MSc, Mid America Heart Institute, 5th Floor, 4401 Wornall Rd, Kansas City, MO 64111.E-mail: pchan@saint-lukes.org Received November 16, 2015; accepted February 3, 2016.ª2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/06/c6/JAH3-5-e002924.PMC4943267.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/06/c6/JAH3-5-e002924.PMC4943267.pdf
Available at: https://www.heart.org/HEARTORG/General/Heart-and-Stroke- Association-Statistics_UCM_319064_SubHomePage.jsp.,Non-OADS,/arxiv_data1/oa_pdf/32/1a/JAH3-5-e002944.PMC4943268.pdf
"An accompanying Data S1 is available at http://jaha.ahajournals.org/con- tent/5/3/e002975/suppl/DC1 Correspondence to: Oh Young Bang, MD, PhD, Department of Neurology, Samsung Medical Center, Sungkyunkwan University, 81, Irwon-Ro, Gangnam-gu, Seoul 135 –710, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/fc/56/JAH3-5-e002975.PMC4943271.pdf
"*An accompanying Appendix S1, which lists the members of the HOMED-BP Study Investigators is available at http://jaha.ahajournals.org/content/5 /3/ e002995/suppl/DC1 Part of the work was presented at the 2013 Scienti ﬁc Meeting of the Belgian Hypertension Committee held on October 5, 2013 in Gent, Belgium.",Non-OADS,/arxiv_data1/oa_pdf/65/ff/JAH3-5-e002995.PMC4943272.pdf
Available at: http://www.whocc.no/atc_ddd_index/.,OADS,/arxiv_data1/oa_pdf/65/ff/JAH3-5-e002995.PMC4943272.pdf
"The 1727 controls in the GWAS were randomly selected from the Taiwan Han Chinese Cell and Genome Bank in Taiwan, as reported previously.14The single-nucleotide polymorphism (SNP) genotyping results of another independent group of 1802 controls in the replication study were randomly selected from the publically available summary frequency of the Taiwan Biobank Website (https://taiwanview.twbiobank.org.tw/tai- wanview/twbchipinfo.do).",Non-OADS,/arxiv_data1/oa_pdf/c0/34/JAH3-5-e003003.PMC4943273.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/3/e003010/suppl/DC1 Correspondence to: S. Marlene Grenon, MDCM, MMSc, FRCSC, Department of Surgery, University of California, San Francisco, Surgical Services, Veterans Affairs Medical Center, Mail Code 112G, 4150 Clement St, San Francisco, CA94121.",Non-OADS,/arxiv_data1/oa_pdf/d7/dd/JAH3-5-e003010.PMC4943274.pdf
Available at: http://report.nih.gov/nihfactsheets/ ViewFactSheet.aspx?csid=58.,OADS,/arxiv_data1/oa_pdf/d7/dd/JAH3-5-e003010.PMC4943274.pdf
Available at: http://www.ptsd.va.- gov/professional/pages/assessments/assessment-pdf/PCL-handout.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/dd/JAH3-5-e003010.PMC4943274.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/bf/2c/JAH3-5-e003038.PMC4943275.pdf
"*An accompanying Appendix S1, which lists the CHANCE Investigators, is available at http://jaha.ahajournals.org/content/5/3/e003038/suppl/D C1 Correspondence to: Yongjun Wang, MD, Vascular Neurology, Department of Neurology, Beijing TianTan Hospital, Capital Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/bf/2c/JAH3-5-e003038.PMC4943275.pdf
"Accompanying Figures S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/3/e003062/suppl/DC1 *Dr Yuichiro Takei is currently located at the Department of Calci ﬁed Tissue Biology, Hiroshima University Institute of Biomedical & Health Sciences, 1-2-3Kasumi Minami-ku, Hiroshima 734-8553, Japan.",OADS,/arxiv_data1/oa_pdf/8e/e5/JAH3-5-e003062.PMC4943277.pdf
"December 18, 2015; Available at: http://dx.doi.org/10.1016/j.jdiacomp.",OADS,/arxiv_data1/oa_pdf/8e/e5/JAH3-5-e003062.PMC4943277.pdf
Accompanying Data S1 and Table S1 are available at http://jaha.ahajour- nals.org/content/5/3/e003102/suppl/DC1 *Dr Zhou and Dr Li contributed equally to this work.,OADS,/arxiv_data1/oa_pdf/14/f3/JAH3-5-e003102.PMC4943279.pdf
Available at: http://qualityindicators.ahrq.gov/downloads/modules/iqi/v31/ iqi_guide_v31.pdf.,OADS,/arxiv_data1/oa_pdf/14/f3/JAH3-5-e003102.PMC4943279.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/e4/39/JAH3-5-e003137.PMC4943281.pdf
"Accompanying Figures S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/3/e003155/suppl/DC1 Correspondence to: Akio Chikata, MD, Department of Disease Control and Homeostasis, Graduate School of Medical Science, Kanazawa University, 13-1Takara-machi, Kanazawa 920-8641, Japan.",Non-OADS,/arxiv_data1/oa_pdf/e3/33/JAH3-5-e003155.PMC4943282.pdf
"Accompanying Figures S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/3/e003208/suppl/DC1 *Dr Hashimoto, Dr Sivakumaran, and Dr Carnicer contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/38/8e/JAH3-5-e003208.PMC4943286.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/70/22/JAH3-5-e003255.PMC4943287.pdf
Accompanying Tables S1 and S2 are available at http://jaha.ahajournals.org/content/5/3/e003255/suppl/DC1*Dr Zbinden and Dr Piccolo contributed equally to this study.,Non-OADS,/arxiv_data1/oa_pdf/70/22/JAH3-5-e003255.PMC4943287.pdf
Data from http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics and with guidelines published by CPIC (www.PharmGKB.or g).,OADS,/arxiv_data1/oa_pdf/9a/5c/JAH3-5-e003440.PMC4943290.pdf
"Moreover, the lack of readily available genetic test results may no longer be an issue since many institutions and laboratories (http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/9a/5c/JAH3-5-e003440.PMC4943290.pdf
Available at: http://www.fda.gov/% 20drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm.,Non-OADS,/arxiv_data1/oa_pdf/9a/5c/JAH3-5-e003440.PMC4943290.pdf
"   Case Rep Dermatol 2016;8:151 –155  DOI: 10.1159/000446470   Published online: June 6, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/5e/77/cde-0008-0151.PMC4943297.pdf
"   Case Rep Ophthalmol 2016;7:341 –345  DOI: 10.1159/000446602   Published online: June 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f3/f6/cop-0007-0341.PMC4943299.pdf
"   Case Rep Ophthalmol 2016;7:333 –340  DOI: 10.1159/000446638   Published online: June 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/8e/76/cop-0007-0333.PMC4943300.pdf
"   Case Rep Dermatol 2016;8:136 –141  DOI: 10.1159/000446342   Published online: June 6, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAcces sLicense).",Non-OADS,/arxiv_data1/oa_pdf/69/d7/cde-0008-0136.PMC4943301.pdf
"   Case Rep Dermatol 2016;8:107 –111  Published online: May 23, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/O penAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/78/a7/cde-0008-0107.PMC4943302.pdf
"   Case Rep Ophthalmol 2016;7:309 –314  DOI: 10.1159/000446512   Published online: June 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/32/f5/cop-0007-0309.PMC4943303.pdf
"   Case Rep Dermatol 2016;8:164 –170  DOI: 10.1159/000446528   Published online: June 6, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ac/bd/cde-0008-0164.PMC4943304.pdf
"   Case Rep Dermatol 2016;8:118 –123  Published online: May 24, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com /Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c3/58/cde-0008-0118.PMC4943305.pdf
"   Case Rep Dermatol 2016;8:112 –117  Published online: May 23, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  Internation al License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d0/c2/cde-0008-0112.PMC4943306.pdf
"   Case Rep Ophthalmol 2016;7:296–302  DOI: 10.1159/000446151  Published online: June 2, 2016  © 2016 The Author(s)  Published by S. Karger AG, Basel   www.karger.com/cop  This article is licensed under the Creative Commons Attribution-NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/3d/55/cop-0007-0296.PMC4943307.pdf
"   Case Rep Ophthalmol 2016;7:328 –332  DOI: 10.1159/000446423   Published online: June 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This ar ticle is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/0e/de/cop-0007-0328.PMC4943308.pdf
"   Case Rep Ophthalmol 2016;7:290–295  DOI: 10.1159/000446208  Published online: June 2, 2016  © 2016 The Author(s)  Published by S. Karger AG, Basel   www.karger.com/cop  This article is licensed under the Creative Commons Attribution-NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ea/1a/cop-0007-0290.PMC4943309.pdf
"   Case Rep Ophthalmol 2016;7:303–308  DOI: 10.1159/000446391  Published online: June 2, 2016  © 2016 The Author(s)  Published by S. Karger AG, Basel   www.karger.com/cop  This article is licensed under the Creative Commons Attribution-NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/75/00/cop-0007-0303.PMC4943310.pdf
"   Case Rep Dermatol 2016;8:130 –135  DOI: 10.1159/000445992   Published online: June 6, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed unde r the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1b/29/cde-0008-0130.PMC4943311.pdf
DOI:  http://dx.doi.org/10.1016/j.dsi.2016.02.001.,OADS,/arxiv_data1/oa_pdf/1b/29/cde-0008-0130.PMC4943311.pdf
"   Case Rep Dermatol 2016;8:124 –129  DOI: 10.1159/000446469   Published online: June 2, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attributi on-NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ba/b6/cde-0008-0124.PMC4943312.pdf
"   Case Rep Ophthalmol 2016;7:315 –320  DOI: 10.1159/000446603   Published online: June 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/7d/fe/cop-0007-0315.PMC4943313.pdf
"   Case Rep Dermatol 2016;8:156 –163  DOI: 10.1159/000446343   Published online: June 6, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/48/cf/cde-0008-0156.PMC4943314.pdf
"   Case Rep Ophthalmol 2016;7:279 –284  DOI: 10.1159/000446103   Published online: June 2, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/23/9c/cop-0007-0279.PMC4943315.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © A Miyanohara et al.",Non-OADS,/arxiv_data1/oa_pdf/05/10/mtm201646.PMC4943453.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm),Non-OADS,/arxiv_data1/oa_pdf/05/10/mtm201646.PMC4943453.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part C Volume 22, Number 7, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tec.2015.0557 621",Non-OADS,/arxiv_data1/oa_pdf/fe/74/ten.tec.2015.0557.PMC4943469.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/71/ofw106.PMC4943527.pdf
mycobank.org/ http://www.indexfungorum.org ).,Non-OADS,/arxiv_data1/oa_pdf/18/71/ofw106.PMC4943527.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/db/ofw101.PMC4943531.pdf
"Swiss HIV Cohort Study data are gathered by the 5 Swiss University Hospitals, 2 Cantonal Hospitals, 15 af ﬁl- iated hospitals, and 36 private physicians (listed in http://www.shcs.ch/180- health-care-providers ).",OADS,/arxiv_data1/oa_pdf/7c/db/ofw101.PMC4943531.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/ba/ofw103.PMC4943532.pdf
Available at: http://www.theguardian.com/w orld/2016/mar/03/zika-virus- carried-more-common-mosquito-scientists-say .,Non-OADS,/arxiv_data1/oa_pdf/d1/ba/ofw103.PMC4943532.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/fd/ofw097.PMC4943534.pdf
Availableat:http://circ.ahajournals.org/content/132/Suppl_3/A17992.short .A c c e s s e d2 2 December 2015.,Non-OADS,/arxiv_data1/oa_pdf/f8/fd/ofw097.PMC4943534.pdf
Avail- able at: http://www.hiv-druginteractions.org/ .,Non-OADS,/arxiv_data1/oa_pdf/f8/fd/ofw097.PMC4943534.pdf
Available at: http://aidsinfo.nih.gov/guidelines .,Non-OADS,/arxiv_data1/oa_pdf/f8/fd/ofw097.PMC4943534.pdf
Available at: http://www.uspreventiveservicestaskforce.,Non-OADS,/arxiv_data1/oa_pdf/f8/fd/ofw097.PMC4943534.pdf
Available at: http://www.iom.edu/r eports/2010/dietary- reference-intakes-for-calcium-and-vitamin-d.aspx .,Non-OADS,/arxiv_data1/oa_pdf/f8/fd/ofw097.PMC4943534.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/ce/ofw100.PMC4943535.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/67/ofw093.PMC4943537.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/a4/ofw109.PMC4943538.pdf
"The 1917 HIV/AIDS Clinic Cohort ( http://www.uab.edu/ medicine/1917cliniccohort/ ) is a prospective cohort capturing clinical, sociodemographic, and behavioral information.",Non-OADS,/arxiv_data1/oa_pdf/ac/a4/ofw109.PMC4943538.pdf
Available at: https://aidsinfo.nih.gov/content ﬁles/lvguidelines/AA_Tables.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ac/a4/ofw109.PMC4943538.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/9a/ofw074.PMC4943539.pdf
Available at: http://www.drugbank.ca/drugs/DB00254 .,Non-OADS,/arxiv_data1/oa_pdf/24/9a/ofw074.PMC4943539.pdf
Available at: http://www.drugbank.ca/drugs/DB00207 .,Non-OADS,/arxiv_data1/oa_pdf/24/9a/ofw074.PMC4943539.pdf
Available at: http://www.drugbank.ca/drugs/DB00440 .,Non-OADS,/arxiv_data1/oa_pdf/24/9a/ofw074.PMC4943539.pdf
Available at: http://www.drugbank.ca/drugs/ DB01015 .,Non-OADS,/arxiv_data1/oa_pdf/24/9a/ofw074.PMC4943539.pdf
Available at: https://www.ebi.ac.uk/ena/data/view/PRJEB7708 .,Non-OADS,/arxiv_data1/oa_pdf/24/9a/ofw074.PMC4943539.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/d9/ofw088.PMC4943540.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/94/ofw095.PMC4943541.pdf
Available at: http://www.microbiologyresearch.,Non-OADS,/arxiv_data1/oa_pdf/03/94/ofw095.PMC4943541.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/94/ofw099.PMC4943542.pdf
Available at: http://www.cdc.gov/hepatitis/statistics/ 2013surveillance/commentary.htm#hepatitisC .,Non-OADS,/arxiv_data1/oa_pdf/f8/94/ofw099.PMC4943542.pdf
Available at: http://www.mass.gov/eohhs/ researcher/community-health/masschip/health-status-indicators.html .A c c e s s e d 2 April 2016.,Non-OADS,/arxiv_data1/oa_pdf/f8/94/ofw099.PMC4943542.pdf
Available at: http://bphc.hrsa.gov/uds/ datacenter.aspx?q=d&bid=011460&state=MA&year=2014 .,OADS,/arxiv_data1/oa_pdf/f8/94/ofw099.PMC4943542.pdf
"Recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.",Non-OADS,/arxiv_data1/oa_pdf/f8/94/ofw099.PMC4943542.pdf
Available at: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/f8/94/ofw099.PMC4943542.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/2d/ofw105.PMC4943543.pdf
Available at: http://www.unaids.org/sites/default/ ﬁles/media_asset/ UNAIDS_Global_Report_2013_en_1.pdf .,OADS,/arxiv_data1/oa_pdf/36/2d/ofw105.PMC4943543.pdf
"HCV Guidance: Recommendations for testing, managing, and treat- ing hepatitis C. Available at: http://www.hcvguidelines.org .",Non-OADS,/arxiv_data1/oa_pdf/36/2d/ofw105.PMC4943543.pdf
Available at: http://aidsinfo.nih.gov/ guidelines .,Non-OADS,/arxiv_data1/oa_pdf/36/2d/ofw105.PMC4943543.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/ef/ofw104.PMC4943544.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/7e/ofw096.PMC4943545.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/ofw094.PMC4943546.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/b1/ofw108.PMC4943547.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/03/ofw107.PMC4943548.pdf
Available at: http://applications.emro.who.int/ docs/who_em_pol_387_e_en.pdf?ua=1 .,OADS,/arxiv_data1/oa_pdf/20/55/ofw111.PMC4943549.pdf
Available at: http://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html .,Non-OADS,/arxiv_data1/oa_pdf/20/55/ofw111.PMC4943549.pdf
Available at:http://applications.emro.who.int/docs/EM_RC57_inf_doc_1_en.pdf?ua=1 .,OADS,/arxiv_data1/oa_pdf/20/55/ofw111.PMC4943549.pdf
"Polio Laboratory Network Quarterly Updates, 2008 ; Available at: http://archives.who.int/vaccines/en/poliolab/1996/21.pdf .",Non-OADS,/arxiv_data1/oa_pdf/20/55/ofw111.PMC4943549.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/c2/ofw062.PMC4943550.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/6c/ofw080.PMC4943551.pdf
http://www.cdc.gov/ tularemia/resources/whotularemiamanual.pdf .,Non-OADS,/arxiv_data1/oa_pdf/92/6c/ofw080.PMC4943551.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/e0/ofw081.PMC4943552.pdf
"Respiratory Syncytial Virus (RSV) activity: Wisconsin State Laboratory of Hy- giene, 2013 ; Available at: http://www.slh.wisc.edu/labupdates/reports/rsv.dot .",Non-OADS,/arxiv_data1/oa_pdf/4c/e0/ofw081.PMC4943552.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/f1/ofw083.PMC4943553.pdf
Available at: http://www.nrmp.org/wp-content/uploads/2015/09/Applicant- Survey-Report-2015.pdf .,OADS,/arxiv_data1/oa_pdf/5e/f1/ofw083.PMC4943553.pdf
Available at: http://www.census.gov/people/ io/publications/table_packages.html .,OADS,/arxiv_data1/oa_pdf/5e/f1/ofw083.PMC4943553.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/2d/ofw076.PMC4943554.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/fa/ofw060.PMC4943555.pdf
"As ofApril 2016, the Centers for Disease Con-trol and Prevention reported 168 isolates of NDM-type and VIM-type MBL-pro- ducing Enterobacteriaceae in 27 states, and the majority (151) were NDM-type (http://www.cdc.gov/hai/organisms/cre/ TrackingCRE.html#CREmapNDM ).",OADS,/arxiv_data1/oa_pdf/a1/42/ofw090.PMC4943557.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/42/ofw090.PMC4943557.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/36/ofw084.PMC4943558.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/20/ofw098.PMC4943560.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/1c/ofw078.PMC4943562.pdf
Available at: http://apps.who.int//iris/handle/10665/85321 .,OADS,/arxiv_data1/oa_pdf/f1/b5/ofv158.PMC4943563.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/53/ofw067.PMC4943564.pdf
Available at:http://www.bls.gov/cpi/cpid1501.pdf .,Non-OADS,/arxiv_data1/oa_pdf/df/53/ofw067.PMC4943564.pdf
Available at:http://www.sdcms.org/Portals/18/Assets/pdf/germ/02-24-2015%5B1%5D.pdf .,OADS,/arxiv_data1/oa_pdf/a9/ab/ofw079.PMC4943565.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/89/ofw085.PMC4943566.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/ab/ofw089.PMC4943568.pdf
Available at: http://www.bhiva.org/documents/Guidelines/Treatment/2015/2015-treatment-guidelines.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ed/ab/ofw089.PMC4943568.pdf
Available at: http://apps.who.int/iris/bitstream/10665/198064/1/ 9789241509893_eng.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/ed/ab/ofw089.PMC4943568.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/40/ofw077.PMC4943569.pdf
"Epub 2015 Aug 11; PMID: 26265008; http://dx.doi.org/10.15252/embr.201540974 © Richard L. Carpenedo, Paul A. Cassar, and William L. Stanford.",Non-OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
"3, 303 –304 http://dx.doi.org/10.1080/15384101.2015.1124698",Non-OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
18555785; PMID:18555785; http://dx.doi.org/10.1016/j.cell.2008.04.043 2.,OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
21503874; PMID:21503874; http://dx.doi.org/10.1002/jcp.22787 3.,Non-OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
26265008; PMID:26265008; http://dx.doi.org/10.15252/embr.201540974 4.,OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
18371337; PMID:18371337; http://dx.doi.org/10.1016/j.stem.2007.04.002 5.,OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
20144788; PMID:20144788; http://dx.doi.org/10.1016/j.stem.2009.12.014 7.,OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
20621047; PMID:20621047; http://dx.doi.org/10.1016/j.stem.2010.06.011 Figure 1.,OADS,/arxiv_data1/oa_pdf/36/83/kccy-15-03-1124698.PMC4943698.pdf
"   Case Rep Oncol 2016;9:273 –279  DOI: 10.1159/000446315   Published online: May 23, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Ser vices/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a4/94/cro-0009-0273.PMC4943741.pdf
"   Case Rep Ophthalmol 2016;7:274 –278  DOI: 10.1159/000446152   Published online: May 10, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karg er.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/86/c4/cop-0007-0274.PMC4943765.pdf
"   Case Rep Ophthalmol 2016;7:237 –242  10.1159/000446104   Published online: May 2, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663 -2699/16/0071 –0237$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a1/91/cop-0007-0237.PMC4943766.pdf
"   Case Rep Ophthalmol 2016;7:268 –273  DOI: 10.1159/000446102   Published online: May 10, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/be/5b/cop-0007-0268.PMC4943767.pdf
"   Case Rep Ophthalmol 2016;7:230 –236  10.1159/000446016   Published online: April 29, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663 -2699/16/0071 –0230$39.50/0   www.karger.com/cop   This article is licensed under the C reative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a0/31/cop-0007-0230.PMC4943768.pdf
"   Case Rep Ophthalmol 2016;7:262 –267  DOI: 10.1159/000445974   Published online: May 10, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e1/69/cop-0007-0262.PMC4943769.pdf
"   Case Rep Ophthalmol 2016;7:253 –261  DOI: 10.1159/000445937   Published online: May 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is  licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d2/d2/cop-0007-0253.PMC4943770.pdf
"   Case Rep Ophthalmol 2016;7:249 –252  DOI: 10.1159/000445880   Published online: May 9, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonComme rcial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f2/8f/cop-0007-0249.PMC4943771.pdf
"   Case Rep Ophthalmol 2016;7:243 –248  DOI: 10.1159/000445824   Published online: May 10, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLic ense).",Non-OADS,/arxiv_data1/oa_pdf/4e/e7/cop-0007-0243.PMC4943772.pdf
"   Case Rep Ophthalmol 2016;7:202 –207  10.1159/000445796   Published online: April 29, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663 -2699/16/0071 –0202$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4 .0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/17/00/cop-0007-0202.PMC4943773.pdf
"   Case Rep Ophthalmol 2016;7:223 –229  10.1159/000445795   Published online: April 29, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663 -2699/16/0071 –0223$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  Internationa l License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f2/a3/cop-0007-0223.PMC4943774.pdf
"   Case Rep Ophthalmol   DOI: 10.1159/000445497    © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e1/70/cop-0007-0184.PMC4943775.pdf
"   Case Rep Ophthalmol 2016;7:216 –222  10.1159/000445496   Published online: April 29, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663 -2699/16/0071 –0216$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/5b/e3/cop-0007-0216.PMC4943776.pdf
Available from: http://www.unicef.pt/ docs/Progress_on_Child_and_Maternal_Nutrition_EN_110309.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/c2/2a/1679-4508-eins-13-3-0435.PMC4943793.pdf
Disponível em: http://bvsms.saude.gov.br/bvs/periodicos/boletim_eletronico_epi_ano04_n01.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/13/1679-4508-eins-13-2-0177.PMC4943806.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs204/en/,Non-OADS,/arxiv_data1/oa_pdf/a1/fd/1679-4508-eins-13-2-0189.PMC4943808.pdf
Disponível em:  http://www.aids.gov.br/sites/default/files/anexos/publicacao/2011/50073/boletim_hepatites2011_pdf_64874.pdf  3.,Non-OADS,/arxiv_data1/oa_pdf/a1/fd/1679-4508-eins-13-2-0189.PMC4943808.pdf
Available from: http://www.cdc.gov/chronicdisease/ resources/publications/AAG/pdf/chronic.pdf 2.,OADS,/arxiv_data1/oa_pdf/07/6e/1679-4508-eins-13-2-0196.PMC4943809.pdf
(7) Randomization was performed by the GraphPad  software website (http://www.graphpad.com/quickcalcs/ index.cfm).,OADS,/arxiv_data1/oa_pdf/39/00/1679-4508-eins-13-2-0249.PMC4943818.pdf
Disponível em: http://tabnet.datasus.gov.,OADS,/arxiv_data1/oa_pdf/76/ec/1679-4508-eins-13-2-0283.PMC4943825.pdf
Disponível em: http://portal.cfm.org.br/index.php?option=com_conte nt&view=article&id=24374:saude-da-mulher-e-da-crianca-cfm-recomenda- o-uso-de-acido-folico-para-gestantes&catid=3) 5.,Non-OADS,/arxiv_data1/oa_pdf/76/ec/1679-4508-eins-13-2-0283.PMC4943825.pdf
Available from: http://www.cebm.net/ index.aspx?o=1025 10.,Non-OADS,/arxiv_data1/oa_pdf/5f/df/1679-4508-eins-13-2-0290.PMC4943826.pdf
Disponível em: http://www.abto.org.br/abtov03/default.aspx?mn=457&c=900&s=0  6.,Non-OADS,/arxiv_data1/oa_pdf/59/cf/1679-4508-eins-13-2-0297.PMC4943827.pdf
Disponível em: http://www.saude.sp.gov.br/transplante .,Non-OADS,/arxiv_data1/oa_pdf/59/cf/1679-4508-eins-13-2-0297.PMC4943827.pdf
Disponível em: http://www.abto.org.br  4.,Non-OADS,/arxiv_data1/oa_pdf/0e/59/1679-4508-eins-13-2-0310.PMC4943829.pdf
Available: http://www.omim.org 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/e3/1679-4508-eins-13-2-0336.PMC4943834.pdf
"In effect, the mutant is less compact than the WT, easier  to unfold upon heating and upon the addition of chemical  denaturants, and tends to generate light-scattering aggregates  more readily.Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> Received 23 April 2016 | Accepted 12 July 2016 | Published 14 July 2016© 2016 Molecular Vision 771Structural study of the G57W mutant of human gamma-S- crystallin, associated with congenital cataract Ismail Khan,1 Sushil Chandani,2 Dorairajan Balasubramanian1 1Prof.",Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  772METHODS The study adhered to the tenets of the Declaration of Helsinki  and the ARVO statement on human subjects.,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  773of ammonium sulfate and eluted using a gradient of 0–30%  of ammonium sulfate in 50 mM Tris-Cl buffer (pH 7.3).,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  774(constant pressure) setting for 100 ps each.,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  775 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  776 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  777 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
"Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  778Figure 3B shows that the wild-type molecule displays a  sharp transition from the native to the denatured state, with a  midpoint at 2.15 M GdnCl, while the mutant G57W displays  a more gradual transition.",OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  779that there is a salt bridge between residues E51 and R52 in  the WT molecule; this salt bridge is disrupted in the G57W  mutant due to a shift in the position of R52 to facilitate the  cation–π interaction described.,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
"Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  780laboratory-made C-terminal mutant of CrygS, and comparing  its packing and stability features with those of the wild-type  molecule, would be interesting.",Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  781REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
"Molecular Vision  2016; 22:771-782 <http://www.molvis.org/molvis/v 22/771> © 2016 Molecular Vision  782Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/b5/f7/mv-v22-771.PMC4943855.pdf
"GLUT1 is one of the 12 GLUT isoforms described [ 20],  composed of a glycoprotein with 12 transmembrane domains Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> Received 25 January 2016 | Accepted 12 July 2016 | Published 14 July 2016© 2016 Molecular Vision 761GLUT1 activity contributes to the impairment of PEDF secretion  by the RPE Sofia M. Calado,1,2 Liliana S. Alves,2,3 Sónia Simão,2,4 Gabriela A. Silva2 1PhD Program in Biomedical Sciences, Department of Biomedical Sciences and Medicine, University of Algarve, Campus  Gambelas, Faro, Portugal; 2CEDOC, NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa,  Campo Mártires da Pátria, Lisboa, Portugal; 3ProRegeM PhD Program, NOVA Medical School/Faculdade de Ciências  Médicas, Universidade Nova de Lisboa, Campo Mártires da Pátria, Lisboa, Portugal; 4Centre for Biomedical Research (CBMR),  University of Algarve, Campus Gambelas, Faro, Portugal Purpose:  In this study, we aimed to understand whether glucose transporter 1 (GLUT1) activity affects the secretion  capacity of antiangiogenic factor pigment epithelium-derived factor (PEDF) by the RPE cells, thus explaining the reduc - tion in PEDF levels observed in patients with diabetic retinopathy (DR).",Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  762and a single N-glycosylation site.,Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  763six-well flat-bottom tissue culture plates and maintained for  72 h in culture medium containing 25 mM of D-glucose.,Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  764 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
"Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  765membrane of the RPE cells subjected to hypoxia, it was  necessary to determine if this translates into increased  glucose uptake by RPE cells.",Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
"Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  766GLUT1 and PEDF expression is altered in the RPE of  diabetic mice:  To confirm the validity of our in vitro find - ings, we analyzed the expression of GLUT1 and PEDF in the  RPE of wild-type and Ins2Akita diabetic mice (Figure 6).",Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  767(Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
"Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  768that the secretory function of RPE might be impaired  [29,30,39].",Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  76911.,Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
Molecular Vision  2016; 22:761-770 <http://www.molvis.org/molvis/v 22/761> © 2016 Molecular Vision  77037.,Non-OADS,/arxiv_data1/oa_pdf/87/87/mv-v22-761.PMC4943856.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Correspondence to: William R Schwan, MD, Department of Microbiology, University of Wisconsin-La Crosse, 1725 State St, La  Crosse, WI 54601, United States.",Non-OADS,/arxiv_data1/oa_pdf/26/4f/nihms800331.PMC4943863.pdf
"Address for correspondence: Kwang-Ha Yoo, M.D., Ph.D. Department of Internal Medicine, Konkuk University Hospital, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 05030, Korea Phone: 82-2-2030-7522, Fax: 82-2-2030-7748, E-mail: khyou@kuh.ac.krAddress for co-correspondence: Kwan Hyung Kim, M.D., Ph.D.Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 271 Cheonbo-ro, Uijeongbu 11765, KoreaPhone: 82-31-820-3000, Fax: 82-31-847-2719, E-mail: kwan-kim@catholic.ac.kr*The members of the group are listed at the end of this article.Received: Dec. 1, 2015, Revised: Dec. 20, 2015, Accepted: Dec. 21, 2015 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.3.111ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:111-120",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
"After search - ing three databases (The National Guideline Clearinghouse, http://www.guideline.gov/; the Guideline International Net - work, http://www.g-i-n.net/library/international-guidelines-library; and the Trip database, https://www.tripdatabase.com), guidelines satisfying the following criteria were selected for adaptation: (1) guidelines developed in a country similar to Korea in terms of climate and region; (2) international guidelines or guidelines developed by international groups; (3) guidelines developed or updated since 2011; (4) guidelines for adults; and (5) guidelines containing general information on the diagnosis, treatment, and management of asthma.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
"Finally, four guidelines from GINA, NAEPP , SIGN, and Can- ada were selected after using the AGREE II method (http://www.agreetrust.org/agree-ii/) 9.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
"Systematic review involved searching databases including Medline (http://www.ncbi.nlm.nih.gov/pubmed), EMBASE (https://www.embase.com), and the Cochrane library (http://www.cochranelibrary.com/).",OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
"Korean asthma guideline http://dx.doi.org/10.4046/trd.2016.79.3.111  113 www.e-trd.org have conflicts of interest: the Korean Asthma and Allergy So- ciety, the Korean Medical Association, the Korean Physicians’ Association, the Korean Academy of Family Medicine, the Ko-rean General Physician Association, the Korean Association of Internal Medicine, the Korean Nurse Association, the Health Insurance Review and Assessment Service, the National Health Insurance Service, the Ministry of Health and Welfare, and the Korean Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
Korean asthma guideline http://dx.doi.org/10.4046/trd.2016.79.3.111  115 www.e-trd.org tests are not available and clinical diagnosis via therapeutic  trials with ICS and SABA is needed.,Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
"Korean asthma guideline http://dx.doi.org/10.4046/trd.2016.79.3.111  117 www.e-trd.org asthma in perioperative periods, pregnancy, and the presence  of comorbid diseases.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
"Korean asthma guideline http://dx.doi.org/10.4046/trd.2016.79.3.111  119 www.e-trd.org Medical Center, University of Ulsan, Seoul, Korea), Seong Yong  Lim (Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea), Sung Chul Lim (Chonnam National University Hospital, Gwangju, Korea), Ki-Suck Jung (Hallym University Sacred Heart Hospital, Anyang, Korea), Hye Sook Choi (Dong-guk University Gyeongju Hospital, Gyeongju, Korea) The Scientific Committee of Asthma Study Group in KATRD Hyeon-K young Koo (Inje University Ilsan Paik Hospital,  Goyang, Korea), Ki Uk Kim (Pusan National University Hos - pital, Busan, Korea), Deog K yeom Kim (SMG-SNU Boramae  Medical Center, Seoul National University College of Medi-cine, Seoul, Korea), Sang-Ha Kim (Wonju Severance Christian Hospital, Yonsei University, Wonju, Korea), Sei Won Kim (Yeouido St. Mary’s Hospital, The Catholic University of Ko-rea, Seoul, Korea), So Ri Kim (Chonbuk National University Hospital, Jeonju, Korea), Young Sam Kim (Yonsei University Severance Hospital, Seoul, Korea), Eun K yung Kim (CHA Bundang Medical Center, CHA University, Seongnam, Korea), Yee Hyung Kim (K yung Hee University Hospital at Gang-dong, Seoul, Korea), Jung Hyun Kim (CHA Bundang Medical Center, CHA University, Seongnam, Korea), Tae-Hyung Kim (Hanyang University Guri Hospital, Guri, Korea), Hui Jung Kim (Wonkwang University Sanbon Hospital, Gunpo, Korea), Hee K yoo Kim (Kosin University Gospel Hospital, Busan, Ko-rea), Seung Won Ra (Ulsan University Hospital, Ulsan, Korea), Yon Ju Ryu (Ewha Womans University Mokdong Hospital, Seoul, Korea), Won- Yeon Lee (Wonju Severance Christian Hospital, Yonsei University, Wonju, Korea), Ji-yong Moon (Hanyang University Guri Hospital, Guri, Korea), K yung Hoon Min (Korea University Guro Hospital, Seoul, Korea), So Young Park (Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea), Seung Yong Park (Chonbuk National University Hospital, Jeonju, Korea), Jin K yeong Park (Samsung Medical Center, Sungkyunkwan University, Seoul, Korea), Hye K yeong Park (Inje University Ilsan Paik Hospital, Goyang, Korea), Hye Yun Park (Samsung Medical Center, Sungkyunkwan Univer - sity, Seoul, Korea), Min Kwang Byun (Gangnam Severance Hospital, Yonsei University, Seoul, Korea), K yeong Cheol Shin (Yeungnam University Medical Center, Daegu, Korea), Seung Soo Shin (Ajou University Hospital, Suwon, Korea), Yun Su Sim (Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea), Soo Jung Um (Dong-A University Hospital, Busan, Korea), Young Soon Yoon (Dongguk University Ilsan Hospital, Goyang, Korea), Hyoung K yu Yoon (Yeouido St. Mary’s Hospital, The Catholic University of Korea, Seoul, Ko-rea), Ho Il Yoon (Seoul National University Bundang Hospital, Seongnam, Korea), Sang Yeub Lee (Korea University Anam Hospital, Seoul, Korea), Sei Won Lee (Asan Medical Center, University of Ulsan, Seoul, Korea), Young Seok Lee (Gang-nam Severance Hospital, Yonsei University, Seoul, Korea), Jae Hyung Lee (Eulji University Hospital, Seoul, Korea), Ji-Hyun Lee (CHA Bundang Medical Center, CHA University, Seong-nam, Korea), Chin Kook Rhee (Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea), Chang Hoon Lee (Seoul National University Hospital, Seoul, Korea), Seong Yong Lim (Kangbuk Samsung Hospital, Sungkyunkwan Uni-versity, Seoul, Korea), Ji Ye Jung (Yonsei University Severance Hospital, Seoul, Korea), Eun Jung Jo (Pusan National Uni-versity Hospital, Busan, Korea), Eun Young Choi (Yeungnam University Medical Center, Daegu, Korea), Hye Sook Choi (Dongguk University Gyeongju Hospital, Gyeongju, Korea), Eun Young Heo (SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea), Yong Il Hwang (Hallym University Sacred Heart Hospital, Anyang, Korea) References 1.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
Available from: http://www.who.int/ gard/publications/GARD_Manual/en/.,Non-OADS,/arxiv_data1/oa_pdf/e3/d7/trd-79-111.PMC4943894.pdf
"Address for correspondence: Kwang Ha Yoo, M.D., Ph.D. Division of Pulmonary and Critical Care Medicine, Department  of Internal Medicine, Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, KoreaPhone: 82-2-2030-7522, Fax: 82-2-2030-7748E-mail: khyou@kuh.ac.krReceived: Dec. 9, 2015Revised: Dec. 24, 2015Accepted: Jan. 6, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.3.121ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:121-126",Non-OADS,/arxiv_data1/oa_pdf/91/03/trd-79-121.PMC4943895.pdf
Early chronic obstructive lung disease http://dx.doi.org/10.4046/trd.2016.79.3.121  123 www.e-trd.org ison with no treatment.,Non-OADS,/arxiv_data1/oa_pdf/91/03/trd-79-121.PMC4943895.pdf
Early chronic obstructive lung disease http://dx.doi.org/10.4046/trd.2016.79.3.121  125 www.e-trd.org 2.,Non-OADS,/arxiv_data1/oa_pdf/91/03/trd-79-121.PMC4943895.pdf
"Department of Internal Medicine, Pusan National University Hospital,  179 Gudeok-ro, Seo-gu, Busan 49241, KoreaPhone: 82-51-240-8756, Fax: 82-51-254-3127E-mail: mokgamokga@gmail.comReceived: Dec. 8, 2015Revised: Jan. 12, 2016Accepted: Jan. 19, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.3.127ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:127-133",Non-OADS,/arxiv_data1/oa_pdf/74/67/trd-79-127.PMC4943896.pdf
"Latent tuberculosis infection in healthcare workers http://dx.doi.org/10.4046/trd.2016.79.3.127  129 www.e-trd.org guidelines recommend that routine follow-up is not necessary  for low-risk hospital settings; that HCWs should receive annu-al screening for L TBI in settings classified as medium risk; and that if the setting is classified as one where there is a potential for ongoing transmission (i.e., evidence of person-to-person transmission of  M. tuberculosis : e.g., unrecognized TB in pa- tients or HCWs), testing for L TBI might need to be performed as frequently as every 8–10 weeks.",Non-OADS,/arxiv_data1/oa_pdf/74/67/trd-79-127.PMC4943896.pdf
Latent tuberculosis infection in healthcare workers http://dx.doi.org/10.4046/trd.2016.79.3.127  131 www.e-trd.org 4) Which examinations should be performed as part of  the contact investigation?,Non-OADS,/arxiv_data1/oa_pdf/74/67/trd-79-127.PMC4943896.pdf
Available from: https://www.nice.org.uk/guid - ance/cg117/chapter/1-Guidance.,Non-OADS,/arxiv_data1/oa_pdf/74/67/trd-79-127.PMC4943896.pdf
Available from: http://www.health.wa.gov.au/circularsnew.,Non-OADS,/arxiv_data1/oa_pdf/74/67/trd-79-127.PMC4943896.pdf
Latent tuberculosis infection in healthcare workers http://dx.doi.org/10.4046/trd.2016.79.3.127  133 www.e-trd.org 2005;54:1-47.,Non-OADS,/arxiv_data1/oa_pdf/74/67/trd-79-127.PMC4943896.pdf
Available  from: http://westhertshospitals.nhs.uk/infection_control/documents/policies/TB_Policy_Feb_2013_v7.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/67/trd-79-127.PMC4943896.pdf
"Address for correspondence: Hossein Samadi Kafil, Ph.D. Drug Applied Research Center, Tabriz University of Medical Sciences,  Tabriz 5166614711, IranPhone: 98-9127184735, Fax: 98-4113364661E-mail: Kafilhs@tbzmed.ac.irReceived: Sep. 13, 2015Revised: Nov. 1, 2015Accepted: Jan. 19, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).REVIEW http://dx.doi.org/10.4046/trd.2016.79.3.134ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:134-142",Non-OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
http://dx.doi.org/10.4046/trd.2016.79.3.134  135 www.e-trd.org Fluorescence microscopy with fluorochrome staining and  light emitting diode technology improves the sensitivity of TB detection by nearly 10% compared with the conventional staining 7.,Non-OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
"http://dx.doi.org/10.4046/trd.2016.79.3.134  137 www.e-trd.org to both RIF and isoniazid (INH), thus can detect MDR-TB.",Non-OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
"http://dx.doi.org/10.4046/trd.2016.79.3.134  139 www.e-trd.org ample, a test with 85% sensitivity and 97% specificity in the  identification of those with TB could prevent 392,000 deaths per year (22% of global TB deaths) 69.",Non-OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
Available from: http://apps.who.int/iris/bitstream/10665/44241/1/9789241598866_eng.pdf.,OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
Available from:  http://www.who.int/iris/handle/10665/44586#sthash.Cdd- BEYMy.dpuf.,OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
Avail-able from: http://www.who.int/tb/publications/ISTC_3rdEd.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
Available from: http://apps.who.int/iris/ bitstream/10665/112469/1/9789241506700_eng.pdf.,OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
http://dx.doi.org/10.4046/trd.2016.79.3.134  141 www.e-trd.org Mycobacterium tuberculosis : a systematic review and meta- analysis.,Non-OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
Available from: http://www.clearview.com/tb_elisa.aspx.,Non-OADS,/arxiv_data1/oa_pdf/48/c7/trd-79-134.PMC4943897.pdf
"Address for correspondence: Sung Woo Park, M.D., Ph.D. Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi- gu, Bucheon 14584, KoreaPhone: 82-32-621-5145, Fax: 82-32-621-5018, E-mail: swpark@schmc.ac.kr*This paper has already been published as the master's thesis of first author, Ae Rin Baek in Soonchunhyang University Graduate School.Received: Dec. 19, 2015, Revised: Feb. 2, 2016, Accepted: May 3, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.3.143ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:143-152",Non-OADS,/arxiv_data1/oa_pdf/c6/e2/trd-79-143.PMC4943898.pdf
"Apolipoprotein-A1 suppress epithelial-to-mesenchymal transition in lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.3.143  145 www.e-trd.org maintained in Ham’s F12K medium with 10% fetal bovine  serum, 100 U/mL penicillin, and 100 mg/mL streptomycin.",Non-OADS,/arxiv_data1/oa_pdf/c6/e2/trd-79-143.PMC4943898.pdf
Apolipoprotein-A1 suppress epithelial-to-mesenchymal transition in lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.3.143  147 www.e-trd.org densitometry data were normalized to β-actin.,Non-OADS,/arxiv_data1/oa_pdf/c6/e2/trd-79-143.PMC4943898.pdf
Apolipoprotein-A1 suppress epithelial-to-mesenchymal transition in lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.3.143  149 www.e-trd.org 3.,Non-OADS,/arxiv_data1/oa_pdf/c6/e2/trd-79-143.PMC4943898.pdf
Apolipoprotein-A1 suppress epithelial-to-mesenchymal transition in lung fibrosis http://dx.doi.org/10.4046/trd.2016.79.3.143  151 www.e-trd.org distribution of ApoA1 in the alveolar epithelium and perma- nent chronic lung fibrosis are essential for EMT experiments  in vivo .,Non-OADS,/arxiv_data1/oa_pdf/c6/e2/trd-79-143.PMC4943898.pdf
"Department of Biochemistry, Jawaharlal Institute of Postgraduate  Medical Education and Research (JIPMER), Pondicherry 605006, IndiaPhone: 91-9442262333, Fax: 91-4132272735E-mail: sridhar_biochem@yahoo.co.inReceived: Nov. 18, 2015Revised: Dec. 16, 2015Accepted: May 4, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.3.153ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:153-157",Non-OADS,/arxiv_data1/oa_pdf/b1/05/trd-79-153.PMC4943899.pdf
"Vitamin D levels negatively associated with pulmonary tuberculosis http://dx.doi.org/10.4046/trd.2016.79.3.153  155 www.e-trd.org levels of sputum AFB positivity (r=–0.34, p=0.005) (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/b1/05/trd-79-153.PMC4943899.pdf
"Vitamin D levels negatively associated with pulmonary tuberculosis http://dx.doi.org/10.4046/trd.2016.79.3.153  157 www.e-trd.org ment of India, Central Tuberculosis; 2005 [cited 2016 Mar 1].",Non-OADS,/arxiv_data1/oa_pdf/b1/05/trd-79-153.PMC4943899.pdf
Available from: http://www.tbcindia.nic.in/pdfs/RNTCP%20Lab%20Network%20Guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/05/trd-79-153.PMC4943899.pdf
Keywords: Tuberculosis; Respiratory Insufficiency; Critical CareORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.3.158 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:158-164 Copyright © 2016The Korean Academy of Tuberculosis and Respiratory Diseases.,Non-OADS,/arxiv_data1/oa_pdf/8f/ed/trd-79-158.PMC4943900.pdf
"6, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8f/ed/trd-79-158.PMC4943900.pdf
Tuberculosis in the ICU http://dx.doi.org/10.4046/trd.2016.79.3.158  159 www.e-trd.org Introduction Tuberculosis (TB) maintains its international prominence  as a serious health problem and remains one of the most fatal  contagious diseases.,Non-OADS,/arxiv_data1/oa_pdf/8f/ed/trd-79-158.PMC4943900.pdf
Tuberculosis in the ICU http://dx.doi.org/10.4046/trd.2016.79.3.158  161 www.e-trd.org survived (n=15) over a period of 30 days were compared  (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/8f/ed/trd-79-158.PMC4943900.pdf
"Tuberculosis in the ICU http://dx.doi.org/10.4046/trd.2016.79.3.158  163 www.e-trd.org the majority of patients at admission to the ICU or during anti- TB treatment planning; therefore, ineffective treatments were administered.",Non-OADS,/arxiv_data1/oa_pdf/8f/ed/trd-79-158.PMC4943900.pdf
"11, 2016, Accepted: May 10, 2016 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2016.79.3.165ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:165-178",Non-OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
"Use of T-RFLP in asthma http://dx.doi.org/10.4046/trd.2016.79.3.165  167 www.e-trd.org 9700 system (Applied Biosystems, Foster City, CA, USA) was  used; a 50- μL reaction mixture was prepared for each sample  using 5 μL Taq buffer (20 mM MgCl2 is contained), 0.5 μM for - ward primer, 0.6 μM reverse primer, 0.2 mM dNTP , 0.7 mg/mL  bovine serum albumin (New England Biolabs, Beverly, MA, USA), 2 U ExTaq HS (TaKaRa, Tokyo, Japan), 100 ng template DNA, and sterile distilled water.",Non-OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
"Briefly, four  restriction enzymes (ApoI, HhaI, NlaIV , and Hpy166II), suit - able for the analysis of respiratory bacterial pathogens, and the  Restriction Enzyme Picker (REPK) Online version 1.3 (http://rocaplab.ocean.washington.edu/tools/repk) were used for the profiling.",OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
"An operational taxonomic unit (OTU) was deter - mined using T-REX software (http://trex.biohpc.org/, Cornell University), and the relative amounts of each OTUs were mea-sured.",OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
The representative bacterial species or taxonomically related groups in the sputum were predicted using the T-RF size information from the T-RFLP database (http://mededu.cau.ac.kr/micro/FRETS.asp) created in this study.,OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
"Use of T-RFLP in asthma http://dx.doi.org/10.4046/trd.2016.79.3.165  169 www.e-trd.org Lachnospiraceae, Alteromonadaceae, Methylococcaceae,  Moraxellaceae , and Pseudomonadaceae .",Non-OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
Use of T-RFLP in asthma http://dx.doi.org/10.4046/trd.2016.79.3.165  171 www.e-trd.org asthma patients.,Non-OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
Use of T-RFLP in asthma http://dx.doi.org/10.4046/trd.2016.79.3.165  173 www.e-trd.org the investigation of the microbiome in whole sputum samples  of asthma patients using T-RFLP in a relatively larger sample size and the microbial composition in airway could not be clearly divided according to the presence of asthma.,Non-OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
Use of T-RFLP in asthma http://dx.doi.org/10.4046/trd.2016.79.3.165  175 www.e-trd.org Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
Use of T-RFLP in asthma http://dx.doi.org/10.4046/trd.2016.79.3.165  177 www.e-trd.org Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/91/5c/trd-79-165.PMC4943901.pdf
"Department of Internal Medicine, Seoul National University College  of Medicine and Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaPhone: 82-2-2072-4915, Fax: 82-2-762-9662E-mail: sunmich81@gmail.comReceived: Aug. 27, 2015Revised: Sep. 11, 2015Accepted: Sep. 15, 2015 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).CASE REPORThttp://dx.doi.org/10.4046/trd.2016.79.3.179ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:179-183",Non-OADS,/arxiv_data1/oa_pdf/c6/cf/trd-79-179.PMC4943902.pdf
Decreased huge necrotic hepatocellular carcinoma after massive expectoration of sputum http://dx.doi.org/10.4046/trd.2016.79.3.179  181 www.e-trd.org line (12.8 g/dL).,Non-OADS,/arxiv_data1/oa_pdf/c6/cf/trd-79-179.PMC4943902.pdf
Decreased huge necrotic hepatocellular carcinoma after massive expectoration of sputum http://dx.doi.org/10.4046/trd.2016.79.3.179  183 www.e-trd.org Conflicts of Interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/c6/cf/trd-79-179.PMC4943902.pdf
"Division of Pulmonary Medicine, Department of Internal Medicine, Eulji  University Hospital, 95 Dunsanseo-ro, Seo-gu, Daejeon 35233, KoreaPhone: 82-42-611-3154, Fax: 82-42-259-1162E-mail: casimirus@naver.comReceived: Aug. 10, 2015Revised: Sep. 15, 2015Accepted: Sep. 24, 2015 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).CASE REPORThttp://dx.doi.org/10.4046/trd.2016.79.3.184ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:184-187",Non-OADS,/arxiv_data1/oa_pdf/bf/e5/trd-79-184.PMC4943903.pdf
"The case of IgG4-related lung disease http://dx.doi.org/10.4046/trd.2016.79.3.184  185 www.e-trd.org lobe, which was not found in the past film.",Non-OADS,/arxiv_data1/oa_pdf/bf/e5/trd-79-184.PMC4943903.pdf
The case of IgG4-related lung disease http://dx.doi.org/10.4046/trd.2016.79.3.184  187 www.e-trd.org 8.,Non-OADS,/arxiv_data1/oa_pdf/bf/e5/trd-79-184.PMC4943903.pdf
"24, 2015Accepted: Sep. 19, 2015 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/).CASE REPORThttp://dx.doi.org/10.4046/trd.2016.79.3.188ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:188-192",Non-OADS,/arxiv_data1/oa_pdf/1d/a8/trd-79-188.PMC4943904.pdf
ARDS and antisynthetase syndrome http://dx.doi.org/10.4046/trd.2016.79.3.188  189 www.e-trd.org she developed a fever and headache.,Non-OADS,/arxiv_data1/oa_pdf/1d/a8/trd-79-188.PMC4943904.pdf
ARDS and antisynthetase syndrome http://dx.doi.org/10.4046/trd.2016.79.3.188  191 www.e-trd.org cally documented ILD10.,Non-OADS,/arxiv_data1/oa_pdf/1d/a8/trd-79-188.PMC4943904.pdf
"193Outcome of Inhaler Withdrawal in Patients  Receiving Triple Therapy for COPD Tuberc Respir Dis 2016;79:22-30, http://dx.doi.org/10.4046/trd.2016.79.1.22 In this article, the institutional affiliation of the author was published incorrectly.",Non-OADS,/arxiv_data1/oa_pdf/dd/a6/trd-79-193.PMC4943905.pdf
"Sae Ahm Kim, M.D.1, Ji-Hyun Lee, M.D., Ph.D.2, Eun-Kyung Kim, M.D., Ph.D.2, Tae-Hyung Kim,  M.D., Ph.D.3, Woo Jin Kim, M.D., Ph.D.4, Jin Hwa Lee, M.D., Ph.D.5, Ho Il Yoon, M.D., Ph.D.6,  Seunghee Baek, Ph.D.7, Jae Seung Lee, M.D., Ph.D.8, Yeon-Mok Oh, M.D., Ph.D.8 and Sang-Do Lee,  M.D., Ph.D.8 1Department of Internal Medicine and 2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine,  CHA Bundang Medical Center, CHA University, Seongnam, 3Division of Pulmonology, Department of Internal Medicine,  Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, 4Department of Internal Medicine, Kangwon  National University College of Medicine, Chuncheon, 5Department of Internal Medicine, Ewha Womans University Mokdong  Hospital, Ewha Womans University School of Medicine, Seoul, 6Seoul National University Bundang Hospital, Seoul National  University College of Medicine, Seongnam, 7Department of Clinical Epidemiology and Biostatistics, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, 8Department of Pulmonary and Critical Care Medicine, Asthma Center, and  Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaERRATUMhttp://dx.doi.org/10.4046/trd.2016.79.3.193ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2016;79:193 Copyright © 2016The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/dd/a6/trd-79-193.PMC4943905.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6b/b1/10620_2016_Article_4156.PMC4943968.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a7/dd/10620_2016_Article_4144.PMC4943970.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/52/99/10620_2016_Article_4147.PMC4943977.pdf
"Original Article J Gastric Cancer 2016;16(2):105-110  http://dx.doi.org/10.5230/jgc.2016.16.2.105 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Although surgical resection with regional lymph node (LN)  dissection is the only curative treatment for patients with gastric cancer (GC), a significant proportion of patients undergoing cu- rative surgery experience disease recurrence that results in poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/89/99/jgc-16-105.PMC4943998.pdf
"Case Report J Gastric Cancer 2016;16(2):111-114  http://dx.doi.org/10.5230/jgc.2016.16.2.111 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Tuberculosis (TB) is one of the leading infectious diseases,  with a high morbidity and mortality worldwide; approximately  8.6 million new cases and 1.3 million deaths are reported annu- ally.1 The incidence of TB in South Korea was 97 per 100,000  persons in 2010.1 The age-standardized incidence rate of gastric  cancer is 59.3 persons and 23.5 persons per 100,000 male and  female individuals, respectively.2 The co-existence of TB and  cancer causes a diagnostic dilemma, as similarities in their pre- sentations may lead to a delay in the appropriate therapy.3 In  the current patient, a diagnosis of gastric cancer was established.",Non-OADS,/arxiv_data1/oa_pdf/78/42/jgc-16-111.PMC4943999.pdf
Available from: http://www.who.int/tb/publica- tions/global_report/en/index.html.,OADS,/arxiv_data1/oa_pdf/78/42/jgc-16-111.PMC4943999.pdf
"Case Report J Gastric Cancer 2016;16(2):115-119  http://dx.doi.org/10.5230/jgc.2016.16.2.115 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastric cancer is the fifth most commonly diagnosed cancer  and the third leading cause of cancer-related death worldwide.1  Surgery is the main treatment strategy for gastric cancer; only  R0 resection anticipates a potential cure.",Non-OADS,/arxiv_data1/oa_pdf/67/b8/jgc-16-115.PMC4944000.pdf
"Case Report J Gastric Cancer 2016;16(2):120-124  http://dx.doi.org/10.5230/jgc.2016.16.2.120 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Primary squamous cell carcinoma (SCC) of the stomach is  a rare type of gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/05/d9/jgc-16-120.PMC4944001.pdf
"Letter to the Editor J Gastric Cancer 2016;16(2):125-127  http://dx.doi.org/10.5230/jgc.2016.16.2.125 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dear Editor: We read with interest an article titled, “Short-Term Out- comes of Laparoscopic Total Gastrectomy Performed by a Single Surgeon Experienced in Open Gastrectomy: Review of Initial Experience ” in your journal, published in September 2015  (doi: http://dx.doi.org/10.5230/jgc.2015.15.3.159), by Song et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/37/jgc-16-125.PMC4944002.pdf
"Letter to the Editor J Gastric Cancer 2016;16(2):128-129  http://dx.doi.org/10.5230/jgc.2016.16.2.128 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.To the Editor:  We appreciate the interest and comments from Kong et al.",Non-OADS,/arxiv_data1/oa_pdf/30/2a/jgc-16-128.PMC4944003.pdf
"on  our recent manuscript, “Short-Term Outcomes of Laparoscopic  Total Gastrectomy Performed by a Single Surgeon Experienced in Open Gastrectomy: Review of Initial Experience ” (doi:  http://dx.doi.org/10.5230/jgc.2015.15.3.159).",Non-OADS,/arxiv_data1/oa_pdf/30/2a/jgc-16-128.PMC4944003.pdf
Available from: http://www.acgme.org/acgmeweb/Por - tals/0/GSNatData1112.pdf.,OADS,/arxiv_data1/oa_pdf/30/2a/jgc-16-128.PMC4944003.pdf
"Review Article J Gastric Cancer 2016;16(2):63-71  http://dx.doi.org/10.5230/jgc.2016.16.2.63 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Due to the initiation of health screening programs in East  Asian countries, including Korea and Japan, the proportion of  early gastric cancer (EGC) has been increasing.1 With the excel- lent outcomes obtained after early treatment of gastric cancer, surgeons are now recognizing postoperative quality of life (QOL)  to be as important to consider as survival for these patients.",Non-OADS,/arxiv_data1/oa_pdf/c9/9c/jgc-16-63.PMC4944004.pdf
"Original Article J Gastric Cancer 2016;16(2):72-77  http://dx.doi.org/10.5230/jgc.2016.16.2.72 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Anatomic variation in the hepatic artery has been reported  to occur in approximately 30% of the population.1-3 The most  common variant is an aberrant left hepatic artery (ALHA) aris- ing from the left gastric artery (LGA).",Non-OADS,/arxiv_data1/oa_pdf/9d/f1/jgc-16-72.PMC4944005.pdf
"Original Article J Gastric Cancer 2016;16(2):78-84  http://dx.doi.org/10.5230/jgc.2016.16.2.78 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastric cancer (GC) is one of the most common cancers in  the word.",Non-OADS,/arxiv_data1/oa_pdf/c3/23/jgc-16-78.PMC4944006.pdf
Available from: https://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/c3/23/jgc-16-78.PMC4944006.pdf
"Original Article J Gastric Cancer 2016;16(2):85-92  http://dx.doi.org/10.5230/jgc.2016.16.2.85 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastric cancer is the fifth most common malignant tumor  and the third leading cause of cancer-related death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ae/87/jgc-16-85.PMC4944007.pdf
"Original Article J Gastric Cancer 2016;16(2):93-97  http://dx.doi.org/10.5230/jgc.2016.16.2.93 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction The proportion of patients with early gastric cancer is more  than 50% of the total incidences in Japan.1 Since the first lap- aroscopy-assisted distal gastrectomy (LADG) for early gastric  cancer was reported in 1994,2 the number of LADGs has rapidly  increased because of better cosmetic outcomes, more rapid re-covery of bowel function, less pain, and a shorter hospital stay  than that for open distal gastrectomy (ODG).",Non-OADS,/arxiv_data1/oa_pdf/07/55/jgc-16-93.PMC4944008.pdf
Available from: http://evs.nci.nih.gov/ftp1/CTCAE/About.,OADS,/arxiv_data1/oa_pdf/07/55/jgc-16-93.PMC4944008.pdf
"Original Article J Gastric Cancer 2016;16(2):98-104  http://dx.doi.org/10.5230/jgc.2016.16.2.98 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction With the improvement of surgical techniques and postopera- tive comprehensive treatments, the survival time of patients with  gastric cancer has extended after surgery; therefore, more atten- tion has been paid to postoperative quality of life.",Non-OADS,/arxiv_data1/oa_pdf/cb/67/jgc-16-98.PMC4944009.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁgshare.hgv.842.,OADS,/arxiv_data1/oa_pdf/21/df/hgv201622.PMC4944010.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016Maturity-onset diabetes of the young N Iwasaki et al 4 Human Genome Variation (2016) 16022 Of ﬁcial journal of the Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/21/df/hgv201622.PMC4944010.pdf
"1/9 http://ejgo.orgABSTRACT Objective: Evaluate the impact of radiotherapy on cause specific survival (CSS) and overall  survival (OS) for stage (I–III) clear cell, mucinous, and endometriod ovarian cancer.Methods: We analyzed incidence, survival, and treatments from the Surveillance, Epidemiology, and End Results (SEER) Program from 2004 to 2011 for clear cell, mucinous, and endometriod histologies of the ovary for stages (I–III).",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"2016 Sep;27(5):e45 http://doi.org/10.3802/jgo.2016.27.e45pISSN 2005-0380·eISSN 2005-0399 Original Article Received: Mar 12, 2016 Revised: Apr 27, 2016Accepted: Apr 27, 2016 Correspondence to Sagar C. PatelDepartment of Radiation Oncology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA.",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"ORCID Sagar C. Patelhttp://orcid.org/0000-0002-2675-616XJonathan Frandsenhttp://orcid.org/0000-0001-8406-3380 This paper was presented at Poster  Presentation at American Society for Therapeutic Radiology and Oncology, October 2015.",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"2/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"12.0.6 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2014).",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"3/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"For stage I patients, OS was higher and statistically significant in individuals who did not receive RT at 5 years (85% vs. 57%) and 10 years (77% vs. 73%,  4/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer Fig.",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"5/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer Fig.",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"6/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer Fig.",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"Similarly, our SEER  7/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"8/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"PUBMED | CROSSREF 9/9 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e45RT, clear cell, mucinous, endometriod ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/26/cf/jgo-27-e45.PMC4944012.pdf
"1/10 http://ejgo.orgABSTRACT Objective: The aim of this study was to compare survival outcomes in two groups of patients with  recurrent epithelial ovarian cancer (EOC) with initial recurrence detection by cancer antigen 125 (CA-125) elevation or imaging, and underwent secondary cytoreductive surgery (SCS).Methods: A retrospective review of the medical records was performed on 99 recurrent EOC patients who underwent SCS at the Samsung Medical Center between January 2002 and December 2013.",Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
"2016 Sep;27(5):e46 http://doi.org/10.3802/jgo.2016.27.e46pISSN 2005-0380·eISSN 2005-0399 Original Article Received: Feb 14, 2016 Revised: Apr 14, 2016Accepted: Apr 28, 2016 Correspondence to Tae-Joong KimDepartment of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea.E-mail: tj28.kim@gmail.com Copyright © 2016.",Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
"ORCID E Sun Paikhttp://orcid.org/0000-0002-6172-5860Tae-Joong Kimhttp://orcid.org/0000-0002-9693-9164Yoo-Young Leehttp://orcid.org/0000-0002-6951-4558Chel Hun Choihttp://orcid.org/0000-0002-0199-6669Jeong-Won Leehttp://orcid.org/0000-0002-6945-0398Byoung-Gie Kimhttp://orcid.org/0000-0002-0572-8450Duk-Soo Baehttp://orcid.org/0000-0003-0016-1704 Conflict of Interest No potential conflict of interest relevant to this article was reported.E Sun Paik, Tae-Joong Kim, Yoo-Young Lee, Chel Hun Choi, Jeong-Won Lee,  Byoung-Gie Kim, Duk-Soo Bae Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of  Medicine, Seoul, KoreaComparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer",Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
2/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection,Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
If recurrence was suspected with  3/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection Fig.,OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
4/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection,Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
5/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection Table 1.,OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
"Although it was not clearly demonstrated in our data, these differences may  6/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection Table 2.",OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
"In contrast, imaging studies in EOC patients are known to be useful in the detection of late recurrence, especially in patients who  7/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection Fig.",Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
8/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection Table 3.,OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
PUBMED | CROSSREF 9/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection,Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
PUBMED | CROSSREF 10/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e46Comparison by different recurrence detection,Non-OADS,/arxiv_data1/oa_pdf/3a/72/jgo-27-e46.PMC4944013.pdf
"1/10 http://ejgo.orgABSTRACT Objective: Bevacizumab was recently approved by the US Food and Drug Administration for  use in recurrent platinum resistant epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) when no more than two prior cytotoxic regimens have been used; due to concerns for gastrointestinal perforation.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"2016 Sep;27(5):e47 http://doi.org/10.3802/jgo.2016.27.e47pISSN 2005-0380·eISSN 2005-0399 Original Article Received: Jan 9, 2016 Revised: Mar 31, 2016Accepted: May 2, 2016 Correspondence to Jovana Y. MartinDivision of Gynecologic Oncology, University of Washington Medical Center, Box 356460, Seattle, WA 98195, USA.E-mail: jymartin@uw.edu Copyright © 2016.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"ORCID Jovana Y. Martinhttp://orcid.org/0000-0002-6564-3790Renata R. Urbanhttp://orcid.org/0000-0001-8967-3794John B. Liaohttp://orcid.org/0000-0002-3018-7879 Previously presented as a poster presentation  at the Western Association of Gynecologic Oncologists Annual Meeting, June 2015, Santa Rosa, CA, USA.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"The regimen that contained bevacizumab was the last  2/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"Six patients  3/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC Table 1.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"One 74-year- 4/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC Table 2.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"5/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC Table 4.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"We found  6/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC Fig.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"7/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC Table 5.",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"While currently, bevacizumab  8/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"PUBMED | CROSSREF 9/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm  19 .,Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"PUBMED | CROSSREF 10/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e47Bevacizumab toxicity in recurrent EOC, FTC, and PPC",Non-OADS,/arxiv_data1/oa_pdf/2f/7d/jgo-27-e47.PMC4944014.pdf
"1/10 http://ejgo.orgABSTRACT Objective: To evaluate the recurrence rates and patterns of failure in patients with stage I  endometrial carcinoma after surgical staging without adjuvant therapy.Methods: Medical records of 229 patients with stage I endometrial carcinoma, treated with surgery alone between 2002 and 2010 at Siriraj Hospital were retrospectively reviewed.",Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
"2016 Sep;27(5):e48 http://doi.org/10.3802/jgo.2016.27.e48pISSN 2005-0380·eISSN 2005-0399 Original Article Received: Jan 12, 2016 Revised: Apr 20, 2016Accepted: May 8, 2016 Correspondence to Atthapon JaishuenDepartment of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Rd., Bangkoknoi, Bangkok 10700, Thailand.E-mail: ajaishuen@hotmail.com Copyright © 2016.",Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
"ORCID Suwanit Therasakvichyahttp://orcid.org/0000-0002-0115-594XSompop Kuljarusnonthttp://orcid.org/0000-0002-1892-0839Janjira Petsuksirihttp://orcid.org/0000-0002-2334-4899Pattama Chaopotonghttp://orcid.org/0000-0001-7118-3340Vuthinun Achariyapotahttp://orcid.org/0000-0002-6635-9871Pisutt Srichaikulhttp://orcid.org/0000-0002-6541-7304Atthapon Jaishuenhttp://orcid.org/0000-0001-7618-4609Suwanit Therasakvichya,1 Sompop Kuljarusnont,1 Janjira Petsuksiri,2   Pattama Chaopotong,1 Vuthinun Achariyapota,1 Pisutt Srichaikul,1   Atthapon Jaishuen1 1Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University,  Bangkok, Thailand 2Division of Radiation Oncology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandClinical outcomes of stage I  endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences",Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
2/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone Funding This study was supported by the Siriraj Research development Fund.,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
3/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
The former studies reported no benefit of  4/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
Four cases that underwent para-aortic lymph  5/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
6/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
7/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
PUBMED | CROSSREF 8/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp  22.,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
PUBMED | CROSSREF 9/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
PUBMED | CROSSREF 10/10 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e48Stage I endometrial cancer with surgery alone,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/jgo-27-e48.PMC4944015.pdf
"1/11 http://ejgo.orgABSTRACT Objective: This study aimed to examine the meaning and usefulness of sexually transmitted  infection (STI) test when caring for patients who have abnormal cervical cytology and/or positive high-risk human papillomavirus (HPV) DNA test results.Methods: Among patients who underwent liquid-based cervical cytology and HPV DNA tests at the Obstetrics and Gynecology outpatient clinic, 800 patients who showed abnormal cervical cytology were compared with 200 patients in the control group.",Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
"2016 Sep;27(5):e49 http://doi.org/10.3802/jgo.2016.27.e49pISSN 2005-0380·eISSN 2005-0399 Original Article Received: Mar 3, 2016 Revised: Apr 26, 2016Accepted: May 9, 2016 Correspondence to Sung Ran HongDepartment of Pathology, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu, Seoul 04619, Korea.E-mail: srh7661@naver.com Copyright © 2016.",Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
"ORCID Hye-Sun Kimhttp://orcid.org/0000-0002-7201-3957In-Ho Leehttp://orcid.org/0000-0001-8856-3243 Conflict of Interest No potential conflict of interest relevant to this article was reported.Hye-Sun Kim,1 Tae Jin Kim,2 In-Ho Lee,2 Sung Ran Hong1 1Department of Pathology, Cheil General Hospital & Women's Healthcare Center, Dankook University  College of Medicine, Seoul, Korea 2Department of Obstetrics and Gynecology, Cheil General Hospital & Women's Healthcare Center, Dankook  University College of Medicine, Seoul, KoreaAssociations between sexually  transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients",Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
Study population The study population consisted of women who had undergone a cervical cytology test using a liquid-based cytology technique and an HPV DNA test at the Obstetrics and  2/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
3/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
4/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
5/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear Table 1.,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
A number of previous studies showed that specific  6/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear Table 2.,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
7/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear Table 4.,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
8/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear Table 6.,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
9/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
PUBMED | CROSSREF 10/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
PUBMED | CROSSREF 11/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e49Role of STI test in managing abnormal Pap smear,Non-OADS,/arxiv_data1/oa_pdf/df/41/jgo-27-e49.PMC4944016.pdf
"1/7 http://ejgo.orgApril 22nd to 25th, 1986–Chengdu, China, is one of the important dates for Gynecologic  Oncology in China.",Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
"2016 Sep;27(5):e50 http://doi.org/10.3802/jgo.2016.27.e50pISSN 2005-0380·eISSN 2005-0399 Meeting Report Correspondence to Jihong LiuDepartment of Gynecologic Oncology, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou 510060, China.E-mail: liujih@mail.sysu.edu.cn Copyright © 2016.",Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
2/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e50The 15th meeting of Chinese Society of Gynecologic Oncology  Fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
3/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e50The 15th meeting of Chinese Society of Gynecologic Oncology Fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
4/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e50The 15th meeting of Chinese Society of Gynecologic Oncology Fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
5/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e50The 15th meeting of Chinese Society of Gynecologic Oncology Fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
6/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e50The 15th meeting of Chinese Society of Gynecologic Oncology,Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
7/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e50The 15th meeting of Chinese Society of Gynecologic Oncology Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/3b/jgo-27-e50.PMC4944017.pdf
1/17 http://ejgo.orgABSTRACT Cervical cancer is the fourth most lethal women’s cancer worldwide.,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
"2016 Sep;27(5):e51 http://doi.org/10.3802/jgo.2016.27.e51pISSN 2005-0380·eISSN 2005-0399 Review Article Received: May 6, 2016 Accepted: May 23, 2016 Correspondence to Chien-Fu HungDepartment of Pathology, The Johns Hopkins School of Medicine, Cancer Research Building II, Room 307, 1550 Orleans Street, Baltimore, MD 21231, USA.E-mail: Chung2@jhmi.edu Copyright © 2016.",Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
"ORCID Sung-Jong Leehttp://orcid.org/0000-0002-6077-2649Andrew Yanghttp://orcid.org/0000-0003-0200-9140T.-C. Wuhttp://orcid.org/0000-0003-1623-4584Chien-Fu Hunghttp://orcid.org/0000-0001-9170-7797Sung-Jong Lee,1 Andrew Yang,2 T.-C. Wu,2,3,4,5 Chien-Fu Hung2,4 1Department of Obstetrics and Gynecology, St. Vincent's Hospital, College of Medicine, The Catholic  University of Korea, Suwon, Korea 2Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA 3Department of Obstetrics and Gynecology, Johns Hopkins Medical Institutions, Baltimore, MD, USA 4Department of Oncology, Johns Hopkins Medical Institutions, Baltimore, MD, USA 5Department of Molecular Microbiology and Immunology, Johns Hopkins Medical Institutions, Baltimore,  MD, USAImmunotherapy for human  papillomavirus-associated disease and cervical cancer: review of clinical and translational research",Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
"2/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases Funding This work was funded by the United States National Institutes of Health (NIH) Cervical Cancer Specialized Program of Research Excellence (SPORE) P50 CA098252 grant, R01 CA114425 grant, 1 R21 CA194896 grant, and 5 R21 AI109259 grant.",Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
One potential treatment method involves  3/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
4/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
"Thus, Lm can utilize both MHC class I and II pathways: The Listeria peptide in the cytoplasm processed by proteasome is displayed on MHC class I on the host cell and triggers  5/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases Fig.",Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
"In addition,  6/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases",Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
7/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
Thirty percent of patients (eight of 27) who received all vaccinations showed clinical regression to CIN I. Intralesional  8/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
9/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
Ipilimumab will be intravenously administered  10/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
11/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
PUBMED | CROSSREF 12/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
PUBMED | CROSSREF 13/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
PUBMED 14/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
PUBMED | CROSSREF 15/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
PUBMED | CROSSREF 16/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
PUBMED | CROSSREF 17/17 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e51Update review for treatment against HPV diseases,Non-OADS,/arxiv_data1/oa_pdf/93/b7/jgo-27-e51.PMC4944018.pdf
"1/11 http://ejgo.orgABSTRACT Objective : We aimed to assess the efficacy of neoadjuvant chemotherapy followed by surgery  (NACT+S), and compared the clinical outcome with that of concurrent chemoradiotherapy  (CCRT) in patients with International Federation of Gynecology and Obstetrics (FIGO) IB–IIB  cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
"2016 Sep;27(5):e52 http://doi.org/10.3802/jgo.2016.27.e52 pISSN 2005-0380·eISSN 2005-0399 Original Article Received:  Feb 2, 2016 Revised:  Apr 28, 2016 Accepted:  May 30, 2016 Correspondence to Yong Bae Kim Department of Radiation Oncology, Yonsei  Cancer Center, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu,  Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
"ORCID Jeongshim Lee http://orcid.org/0000-0002-7280-5401 Tae Hyung Kim http://orcid.org/0000-0002-5205-3775 Ki Chang Keum http://orcid.org/0000-0003-4123-7998 Yong Bae Kim http://orcid.org/0000-0003-4884-2330 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Jeongshim Lee,1 Tae Hyung Kim,1 Gwi Eon Kim,1,2 Ki Chang Keum,1 Yong Bae Kim1,3 1Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul,  Korea 2Department of Radiation Oncology, Jeju National University School of Medicine, Jeju, Korea 3Yonsei Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, KoreaNeoadjuvant chemotherapy followed  by surgery has no therapeutic  advantages over concurrent  chemoradiotherapy in International  Federation of Gynecology and  Obstetrics stage IB-IIB cervical cancer",Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
2/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
"Patient survival was defined as follows: (1) LRC was defined as the interval period from  the end of treatment to the date of locoregional failure; (2) PFS was defined as the interval  period from the end of treatment to the date of disease progression or recurrence, last follow- 3/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer",Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
4/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
Multivariate analysis revealed that histopathologic type  5/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
"Additionally, uneven distribution of baseline characteristics was likely to  6/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer Fig.",Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
7/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer Fig.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
8/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
"However, no remarkable  9/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer Fig.",Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
PUBMED  | CROSSREF 10/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
PUBMED 11/11 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e52NACT+S in FIGO stage IB-IIB cervical cancer,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/jgo-27-e52.PMC4944019.pdf
"1/7 http://ejgo.orgABSTRACT Objective: To identify key factors for predicting positive cone margin and appropriate cone  length.Methods: We retrospectively reviewed the margin status of patients who received conization with high grade cervical intraepithelial neoplasia, along with other factors such as patient age, parity, preoperative cytology, size of disease, type of transformation zone, and cone  length from patient records.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
"2016 Sep;27(5):e54 http://doi.org/10.3802/jgo.2016.27.e54pISSN 2005-0380·eISSN 2005-0399 Original Article Received: Mar 1, 2016 Revised: May 31, 2016Accepted: Jun 12, 2016 Correspondence to Kouichiro KawanoDepartment of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.E-mail: kawano_kouichirou@kurume-u.ac.jp Copyright © 2016.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
"Asian Society of  Gynecologic Oncology, Korean Society of  Gynecologic OncologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
"ORCID Kouichiro Kawanohttp://orcid.org/0000-0003-4354-4975Koji Yonemotohttp://orcid.org/0000-0002-9712-1057Kazuto Tasakihttp://orcid.org/0000-0003-0987-7960Rurika Tasakihttp://orcid.org/0000-0002-5899-3856 Funding This study was supported in part by the Supporting Fund of Obstetrics and Gynecology, Kurume University, Kurume, Japan.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
Not only  2/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e54Appropriate cone length for the treatment of CIN,Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
3/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e54Appropriate cone length for the treatment of CIN Fig.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
The estimated linear function by logistic  4/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e54Appropriate cone length for the treatment of CIN Table 1.,OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
This  5/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e54Appropriate cone length for the treatment of CIN Table 3.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
PUBMED | CROSSREF 6/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e54Appropriate cone length for the treatment of CIN,Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
PUBMED | CROSSREF 7/7 http://ejgo.org http://doi.org/10.3802/jgo.2016.27.e54Appropriate cone length for the treatment of CIN,Non-OADS,/arxiv_data1/oa_pdf/75/bd/jgo-27-e54.PMC4944020.pdf
"Geneva, Switzerland: World Health  Organization; 2008. http://www.who.int/diabetes/publications/ Diabetes_final_13_6.pdf.",Non-OADS,/arxiv_data1/oa_pdf/a2/36/10.1177_0145721716644673.PMC4944180.pdf
Peers  for Progress; 2014. http://peersforprogress.org/wp-content/ uploads/2014/09/140922-global-evidence-for-peer-support- humanizing-health-care.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a2/36/10.1177_0145721716644673.PMC4944180.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a2/36/10.1177_0145721716644673.PMC4944180.pdf
"Medical Department - Cardiology, Klinikum rechts der Isar – Technische Universita ¨tM u¨nchen, DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 81675 Munich, Germany 5Co-senior author *Correspondence: ar.hansen@uke.de http://dx.doi.org/10.1016/j.stemcr.2016.04.011 SUMMARY Analyzing contractile force, the most important and best understood function of cardiomyocytes in vivo is not established in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM).",Non-OADS,/arxiv_data1/oa_pdf/a3/b8/main.PMC4944531.pdf
"7 j29–42 jJuly 12, 2016 jª2016 The Author(s) 29 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a3/b8/main.PMC4944531.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, two tables, and ﬁve movies and can befound with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/a3/b8/main.PMC4944531.pdf
"A phase 1 clinical trial of BAY1187982, an anti-FGFR2 antibody, in subjects with advanced solid tumors known to express FGFR2  has  been  conducted  (http://ClinicalTrials.gov, NCT02368951).",Non-OADS,/arxiv_data1/oa_pdf/3e/31/CBM-13-2-260.PMC4944539.pdf
"BGJ398 will be tested in phase 2 clinical trials in patients with advanced cholangiocarcinoma with FGFR2 gene fusions or other FGFR genetic alterations (http://ClinicalTrials.gov,  NCT02150967).",Non-OADS,/arxiv_data1/oa_pdf/3e/31/CBM-13-2-260.PMC4944539.pdf
"Lenvatinib, another example, will be tested in phase 1/2 clinical trials in children and adolescents with refractory or relapsed solid malignancies (http://ClinicalTrials.gov, NCT02432274).",Non-OADS,/arxiv_data1/oa_pdf/3e/31/CBM-13-2-260.PMC4944539.pdf
"Other tyrosine kinase inhibitors such as BIBF1120, TKI258, nintedanib and ponatinib are also in phase 1 and/or 2 clinical trials (http://ClinicalTrials.gov)84-87.",Non-OADS,/arxiv_data1/oa_pdf/3e/31/CBM-13-2-260.PMC4944539.pdf
"Similarly, another anti PD-1 agent pembrolizumab has been granted accelerated US FDA approval  for  the  treatment  of  patients  with  advanced (metastatic) NSCLC whose disease has progressed after other treatments  and  with  tumors  that  express  PD-L1 (http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce ments/ucm465444.htm).",Non-OADS,/arxiv_data1/oa_pdf/33/85/CBM-13-2-157.PMC4944542.pdf
are warranted (http://www.aacr.,Non-OADS,/arxiv_data1/oa_pdf/33/85/CBM-13-2-157.PMC4944542.pdf
References http://www.cancer.gov/dictionary?cdrid=561717.,Non-OADS,/arxiv_data1/oa_pdf/56/31/CBM-13-2-226.PMC4944544.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01953926.51.,Non-OADS,/arxiv_data1/oa_pdf/56/31/CBM-13-2-226.PMC4944544.pdf
Harmonization  of  assay  protocols  and reporting through the use of standard operating procedures have the potential to reduce inter-laboratory variability (http://miataproject.org/)  and  increase  the  odds  of identifying previously unidentified predictors of response.,Non-OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
Available from: https://clinicaltrials.gov/ct2/results?term=radiotherapy+pd- 1&amp;Search=Search58.,Non-OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
Available from: https://clinicaltrials.gov/ct2/results?term=brentuximab+nivoluma b&amp;Search=Search77.,OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
Available from: https://clinicaltrials.gov/show/NCT02243371.85.,Non-OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
Available from: https://clinicaltrials.gov/ct2/results?term=MEDI6469&amp;Search =Search.112.,OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02472977.129.,Non-OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
https://clinicaltrials.gov/ct2/show/NCT02476123?term=Study+of +combination+therapy+with+mogamulizumab+%28kw- 0761%29+and+nivolumab+%28ono-4538%2Fbms- 936558%29+in+subjects+with+advanced+solid+tumors&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02301130?term=Study+of +mogamulizumab+%2B+medi4736+and+mogamulizumab+%2 B+tremelimumab+in+subjects+w%2F+advanced+solid+tumors &rank=1133.,Non-OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02546531?term=Defactinib +combined+with+pembrolizumab+and+gemcitabine+in+patient s+with+advanced+cancer&rank=1.135.,Non-OADS,/arxiv_data1/oa_pdf/77/69/CBM-13-2-171.PMC4944548.pdf
"http://dx.doi.org/10.1016/j.stemcr.2016.05.012 SUMMARY Metabolism is remodeled when somatic cells are reprogrammed into induced pluripotent stem cells (iPSCs), but the majority of iPSCs are not fully reprogrammed.",Non-OADS,/arxiv_data1/oa_pdf/37/88/main.PMC4944586.pdf
1 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/88/main.PMC4944586.pdf
with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.,OADS,/arxiv_data1/oa_pdf/37/88/main.PMC4944586.pdf
"Chan School of Public Health, Boston, MA 02115, USA 8Harvard Stem Cell Institute, Cambridge, MA 02138, USA 9Division of Human Genetics 10Division of Developmental Biology 11Division of Pathology Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA 12Computational Biology Program, Oregon Health & Science University, Portland, OR 97239, USA 13Shefﬁeld Institute for Translational Neuroscience, University of Shefﬁeld, Shefﬁeld S10 2HQ, UK 14Division of Cardiovascular Medicine, Departments of Medicine and Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232, USA 15Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH 45229, USA 16Co-ﬁrst author 17Co-senior author *Correspondence: carolyn.lutzko@cchmc.org http://dx.doi.org/10.1016/j.stemcr.2016.05.006 SUMMARY The rigorous characterization of distinct induced pluripotent stem cells (iPSC) derived from multiple reprogramming technologies, somatic sources, and donors is required to understand potential sources of variability and downstream potential.",Non-OADS,/arxiv_data1/oa_pdf/9f/4c/main.PMC4944587.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/4c/main.PMC4944587.pdf
EXPERIMENTAL PROCEDURES Methods and Data Availability All data and methods described herein are available at https:// www.synapse.org/PCBC (http://dx.doi.org/10.7303/syn1773109 ) and/or Supplemental Experimental Procedures .,OADS,/arxiv_data1/oa_pdf/9f/4c/main.PMC4944587.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, Supplemental Results, six ﬁgures, and nine tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.05.006 .",OADS,/arxiv_data1/oa_pdf/9f/4c/main.PMC4944587.pdf
"Retrieved  from http://iehn.org/resolutions.shareholder.php Jiang, R. J., & Bansal, P. (2003).",OADS,/arxiv_data1/oa_pdf/49/62/10.1177_0007650314536393.PMC4944588.pdf
"(Available at http://ec.europa.eu/enter-prise/sectors/chemicals/reach/index_en.htm) Ring, P. S., & Van de Ven, A.",OADS,/arxiv_data1/oa_pdf/49/62/10.1177_0007650314536393.PMC4944588.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
"Thomas Zgonis, DPMPodiatry Professor of Orthopedics, Division of Podiatric Medicine and SurgeryUniversity of Texas Health Science Center at San Antonio (San Antonio,Texas)Surgical consensus for diabetic forefoot osteomyelitis Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
"hallux valgus and hammer toe deformities) when these pose risk of reulcerationor new (‘transfer’) ulcers.7.14 DFO, diabetic foot osteomyelitis.Surgical consensus for diabetic forefoot osteomyelitis Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK65149/ [cited 16 July 2015].,Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
"Clin Infect Dis Off Publ Infect Dis Soc Am 2008; 47: 528 /C130.Surgical consensus for diabetic forefoot osteomyelitis Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
"8 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 30079 - http://dx.doi.org/10.3402/dfa.v7.30079",Non-OADS,/arxiv_data1/oa_pdf/11/98/DFA-7-30079.PMC4944594.pdf
Available from: http://www.waterintakecalculator.com/Index.html.,OADS,/arxiv_data1/oa_pdf/a2/99/JEHP-4-72.PMC4944599.pdf
Retrieved from Available from:  http://www.unfpa.org/adolescents and youth/.2008.,Non-OADS,/arxiv_data1/oa_pdf/c7/74/JEHP-4-78.PMC4944604.pdf
Available from: http://www.who.int/.,Non-OADS,/arxiv_data1/oa_pdf/c7/74/JEHP-4-78.PMC4944604.pdf
Available from: http://journal.bums.ac.ir/browse.,Non-OADS,/arxiv_data1/oa_pdf/7d/3c/JEHP-4-74.PMC4944606.pdf
Available from:  http://www.nhs.uk/Change4Life/Pages/exercise‑activity‑ideas.aspx.,Non-OADS,/arxiv_data1/oa_pdf/54/10/JEHP-4-77.PMC4944608.pdf
Available from: http://www.hej.sagepub.com/ cgi/doi/10.1177/001789699405300310.,Non-OADS,/arxiv_data1/oa_pdf/54/10/JEHP-4-77.PMC4944608.pdf
Available from: http://www.do‑groove.com/tv‑ads/commercials.,Non-OADS,/arxiv_data1/oa_pdf/54/10/JEHP-4-77.PMC4944608.pdf
4 | December 2015http://www.people.umass.edu/aizen/pdf/tpb.measurement.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/10/JEHP-4-77.PMC4944608.pdf
Available from: http://www.linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/54/10/JEHP-4-77.PMC4944608.pdf
Available from: http://www.tandfprod.,Non-OADS,/arxiv_data1/oa_pdf/54/10/JEHP-4-77.PMC4944608.pdf
Available from: http://www.ala.org/ala/acrl/acrlstandards/standards.,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/JEHP-4-76.PMC4944610.pdf
Available from: http://edu.bojnourdiau.ac.ir/ page/download‑KlHHI1tGP_A.artdl.,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/JEHP-4-76.PMC4944610.pdf
Available from: http://www.sid.ir/Fa/ViewPaperFa.,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/JEHP-4-76.PMC4944610.pdf
Available from: http://www.jil.lbore.ac.uk/ojc.,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/JEHP-4-76.PMC4944610.pdf
Available from: http://www.idv.sagepub.com/ content/24/2.,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/JEHP-4-76.PMC4944610.pdf
Available from:  http://www.apps.webofknowledge.com/summary.do?,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/JEHP-4-76.PMC4944610.pdf
Available  from: http://www.apps.webofknowledge.com/full_record.,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/JEHP-4-76.PMC4944610.pdf
Available from: http:// www.http://prc.coh.org/QOL‑CS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/d8/JEHP-4-70.PMC4944611.pdf
Available from: http://www.cdc.gov/nchs/ products/pubs/pubd/hestats/physicalactivity/physicalactivity.htm.,OADS,/arxiv_data1/oa_pdf/2f/50/JEHP-4-81.PMC4944613.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/72/c1/UA-8-270.PMC4944617.pdf
Available  from: http://uroweb.org/wp‑content/uploads/22‑Urolithiasis_LR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/0e/UA-8-286.PMC4944620.pdf
Available from: http://globocan.iarc.,Non-OADS,/arxiv_data1/oa_pdf/4c/70/UA-8-333.PMC4944627.pdf
Available from: http://www.bjui.org.,Non-OADS,/arxiv_data1/oa_pdf/50/0b/UA-8-357.PMC4944632.pdf
Available from: http://www.atlasgeneticsoncology.org/Tumors/ MyofibroID5073.html.,Non-OADS,/arxiv_data1/oa_pdf/11/49/UA-8-366.PMC4944635.pdf
Available from: http://www.pathologyoutlines.com/topic/bladderIMT.html.,Non-OADS,/arxiv_data1/oa_pdf/11/49/UA-8-366.PMC4944635.pdf
Available From:  http://www.nccn.org/ professionals/physician_gls/pdf/sarcoma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/02/UA-8-372.PMC4944637.pdf
Available from:  http://www.uptodate.com/contents/ systemic‑treatment‑of‑metastatic‑soft‑tissue‑sarcoma.,Non-OADS,/arxiv_data1/oa_pdf/e0/02/UA-8-372.PMC4944637.pdf
T HIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.o rg/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.04.002,Non-OADS,/arxiv_data1/oa_pdf/84/6f/main.PMC4944656.pdf
This is an openaccess article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/6f/main.PMC4944656.pdf
"Stem Cell Reports Article Dopamine D2 Receptor-Mediated Regulation of Pancreatic bCell Mass Daisuke Sakano,1Sungik Choi,2Masateru Kataoka,2Nobuaki Shiraki,1Motonari Uesugi,3Kazuhiko Kume,4 and Shoen Kume1,* 1Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259-B-25 Nagatsuta, Midori-ku, Yokohama, Kanagawa 226-8501, Japan 2Division of Stem Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Honjo 2-2-1, Kumamoto 860-0811, Japan 3Department of Chemical Biology, Institute for Chemical Research, Institute for Integrated Cell-Material Sciences, Kyoto University, Uji, Kyoto 6 11-0011, Japan 4Department of Neuropharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe Street, Mizuho, Nagoya 467-8603 , Japan *Correspondence: skume@bio.titech.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.05.015 SUMMARY Understanding the molecular mechanisms that regulate bcell mass and proliferation is important for the treatment of diabetes.",OADS,/arxiv_data1/oa_pdf/d5/1d/main.PMC4944721.pdf
95 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/1d/main.PMC4944721.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and one table andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.05.015 .,Non-OADS,/arxiv_data1/oa_pdf/d5/1d/main.PMC4944721.pdf
"Stem Cell Reports Article Retinoic Acid Is Sufﬁcient for the In Vitro Induction of Mouse Spermatocytes Si Wang,1,2Xiuxia Wang,1Longfei Ma,1,3Xiwen Lin,1Daoqin Zhang,1,3Zhen Li,1,3Yujian Wu,1 Chunwei Zheng,1,3Xue Feng,1,4Shangying Liao,1Yanmin Feng,1,3Jian Chen,1,3Xiangjing Hu,1,3 Min Wang,1,5and Chunsheng Han1,* 1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China 2National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China 3University of Chinese Academy of Sciences, Beijing 100049, China 4Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China 5Center for Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China *Correspondence: hancs@ioz.ac.cn http://dx.doi.org/10.1016/j.stemcr.2016.05.013 SUMMARY Meiosis is the key step in gametogenesis.",Non-OADS,/arxiv_data1/oa_pdf/95/4c/main.PMC4944723.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/4c/main.PMC4944723.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, and seven tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/95/4c/main.PMC4944723.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.06.005 SUMMARY The molecular mechanisms regulating neural progenitor (NP) proliferation are fundamental in establishing the cytoarchitecture of the mammalian neocortex.,OADS,/arxiv_data1/oa_pdf/74/0e/main.PMC4944761.pdf
69 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/0e/main.PMC4944761.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and ﬁve ﬁgures and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2016.06.005 .,Non-OADS,/arxiv_data1/oa_pdf/74/0e/main.PMC4944761.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/83/ott-9-4181.PMC4944908.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4181–4186OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4181Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10824 2 Clinical efficacy of first-generation EGFR-TKIs in  patients with advanced non-small-cell lung cancer  harboring EGFR exon 20 mutations Dan chen1 Zhengbo song2 guoping cheng3 1Department of cardiothoracic  surgery, The First affiliated hospital  of chongqing Medical University,   chongqing, 2Department of  chemotherapy, 3Department of  Pathology, Zhejiang cancer hospital,   hangzhou, People’s republic of chinaPurpose:  Subsets of non-small-cell lung cancer patients with epidermal growth factor receptor  (EGFR) mutations carry uncommon subtypes.",Non-OADS,/arxiv_data1/oa_pdf/3b/83/ott-9-4181.PMC4944908.pdf
"The  published data demonstrate moderate sensitivity of these two mutations to EGFR-TKI  treatment, resulting in a median progression-free survival (PFS) of ~6 months.13–15 correspondence: guoping cheng Department of Pathology, Zhejiang  cancer hospital, 38 guangji road,  310022 hangzhou, People’s republic  of china Tel/fax +86 571 8812 2082 email zjzlyy11@163.co m  Zhengbo song Department of chemotherapy, Zhejiang  cancer hospital, 38 guangji road,  310022 hangzhou, People’s republic  of china Tel/fax +86 571 8812 2080 email songzhengbo83@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: Efficacy of first-generation EGFR-TKIs in NSCLC patients DOI: http://dx.doi.org/10.2147/OTT.S108242",Non-OADS,/arxiv_data1/oa_pdf/3b/83/ott-9-4181.PMC4944908.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3b/83/ott-9-4181.PMC4944908.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/83/ott-9-4181.PMC4944908.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/45/dddt-10-2203.PMC4944909.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2203–2209Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2203Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10411 1 acyl lipidation of a peptide: effects on activity  and epidermal permeability in vitro Daniel rocco1,2 James ross1,2 Paul e Murray1 rima caccetta1,2 1school of Pharmacy, 2curtin health  innovation research institute, curtin  University, Perth, W a, australiaAbstract:  Short-chain lipid conjugates can increase permeability of a small peptide across  human epidermis; however, the emerging lipoaminoacid (LAA) conjugation technique is costly  and can deliver mixed synthetic products of varied biological potential.",Non-OADS,/arxiv_data1/oa_pdf/0a/45/dddt-10-2203.PMC4944909.pdf
"Much research is concentrated on skin permeation  enhancement, and in recent years, lipidation of peptides, which increases the lipophi - licity of such molecules, has emerged as a promising option.2–5 The tetrapeptide L-Ala-L-Ala-L-Pro-L-Val (L-AAPV; 356  Da) is an inhibitor of  the enzyme human neutrophil elastase (HNE), which plays a part in host defense and  cellular remodeling following injury.2 HNE levels are normally tightly controlled by its correspondence: rima caccetta school of Pharmacy, curtin University,  gPO Box U1987, Perth, Wa 6845,  australia Tel +61 8 9266 2885 Fax +61 8 9266 2769 email r.caccetta@curtin.edu.a u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Rocco et al Running head recto: Acyl lipidation of a peptide DOI: http://dx.doi.org/10.2147/DDDT.S104111 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/0a/45/dddt-10-2203.PMC4944909.pdf
Or use: http://youtu.be/b7lzR6eUoM MVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/0a/45/dddt-10-2203.PMC4944909.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0a/45/dddt-10-2203.PMC4944909.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/45/dddt-10-2203.PMC4944909.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/50/ott-9-4113.PMC4944910.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4113–4120OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4113Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10414 0 Observational cohort study focused on treatment  continuity of patients administered XelOX plus  bevacizumab for previously untreated metastatic  colorectal cancer Masahito Kotaka1 Fusao ikeda2 Masaki Tsujie3 shinichi Y oshioka4 Y oshihiko nakamoto5 Takaaki ishii6 Takahisa Kyogoku7 Takeshi Kato8 akihito Tsuji9 Michiya Kobayashi10 1gastrointestinal cancer center, sano  hospital, Kobe, hyogo, 2Department  of surgery, Kohka Public hospital,  Koka, shiga, 3Department of colorectal  surgery, sakai city Medical center,  sakai, Osaka, 4Department of surgery,  hyogo Prefectural nishinomiya  hospital, nishinomiya, hyogo,  5Department of surgery, seikei-kai  chiba Medical center, chiba, chiba,  6Department of surgery, Kobe-ekisaikai  hospital, Kobe, hyogo, 7Department  of surgery, nishikobe Medical  center, Kobe, hyogo, 8Department  of colorectal surgery, Kansai rosai  hospital, amagasaki, hyogo, 9Kagawa  University hospital cancer center,  Kita-gun, Kagawa, 10Department of  human health and Medical sciences,  Kochi Medical school, Kochi University,  nangoku, Kochi, JapanBackground:  There has been remarkable progress in systemic chemotherapy for metastatic  colorectal cancer due to the widespread use of irinotecan, oxaliplatin, anti-vascular endothelial  growth factor antibody, and anti-epidermal growth factor receptor antibody.",Non-OADS,/arxiv_data1/oa_pdf/98/50/ott-9-4113.PMC4944910.pdf
"correspondence: Masahito Kotaka gastrointestinal cancer center, sano  hospital, 2-5-1 shimizugaoka, Tarumi-ku,  Kobe, hyogo 655-0031, Japan Tel +81 78 785 1000 Fax +81 78 785 0077 email tomomakotaka6410@yahoo.co.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kotaka et al Running head recto: XELOX plus bevacizumab treatment for metastatic colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S104140",Non-OADS,/arxiv_data1/oa_pdf/98/50/ott-9-4113.PMC4944910.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/98/50/ott-9-4113.PMC4944910.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/50/ott-9-4113.PMC4944910.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a4/98/opth-10-1257.PMC4944911.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1257–1264Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1257CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10538 5 Efficacy and safety of sustained-delivery fluocinolone  acetonide intravitreal implant in patients with  chronic diabetic macular edema insufficiently  responsive to available therapies: a real-life study pascale Massin ali erginay Bénédicte Dupas aude Couturier ramin Tadayoni Ophthalmology Department,   lariboisière Hospital, paris, FrancePurpose:  To evaluate the efficacy and safety of sustained-delivery fluocinolone acetonide  (FAc) intravitreal implant for diabetic macular edema (DME).",Non-OADS,/arxiv_data1/oa_pdf/a4/98/opth-10-1257.PMC4944911.pdf
"Keywords:  diabetic macular edema, intravitreal corticosteroid, corticosteroid intravitreal  implant, fluocinolone acetonide Introduction Diabetic macular edema (DME) is the primary cause of vision loss in diabetic  retinopathy, which is the leading cause of blindness in individuals aged 20–70 years  in developed countries.1,2 The global prevalence of diabetic retinopathy among dia - betics is ~35% and DME is reported in 6.8% of diabetics.3 A bilateral disease was  reported in 33%–41.5% of patients with DME.4,5 According to the Early Treatment  Diabetic Retinopathy Study, between 25% to 33% of eyes with clinically significant  macular edema experience a visual loss of 15 letters or more within 3 years if left  untreated.6 The pathophysiology of DME is a complex process initiated by hyperglycemia and  leading to dilated capillaries and retinal microaneurysms.7 Angiogenesis, inflamma - tion, and oxidative stress contribute to the pathogenesis of DME.8–10 The consequences  are an impairment of the blood–retinal barrier, an increase of vascular permeability,  and finally an accumulation of fluid in retinal tissue.8,10,11 At early stages, vascular  endothelial growth factor (VEGF) is the major driver of retinal changes, whereas in  chronic DME, sustained inflammatory processes are primarily responsible.12 Indeed, Correspondence: pascale Massin Service d’Ophtalmologie, Hôpital  lariboisière, 2 rue ambroise paré,  75010 paris, France Tel +33 (1) 49 95 24 74 email pascale.massin1@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2016 Volume: 10 Running head verso: Massin et al Running head recto: Fluocinolone acetonide intravitreal implants in chronic DME DOI: http://dx.doi.org/10.2147/OPTH.S105385",Non-OADS,/arxiv_data1/oa_pdf/a4/98/opth-10-1257.PMC4944911.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a4/98/opth-10-1257.PMC4944911.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/98/opth-10-1257.PMC4944911.pdf
Available from:  https://www.medicines.org.uk/emc/medicine/2763 6.,Non-OADS,/arxiv_data1/oa_pdf/a4/98/opth-10-1257.PMC4944911.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7f/2b/idr-9-161.PMC4944912.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7f/2b/idr-9-161.PMC4944912.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 161–169Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 161 RevIew open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S96163Strategies for prevention of ultrasound-guided  prostate biopsy infections Diane D Lu Jay D Raman Division of Urology, Penn State Milton  S. Hershey Medical Center, Hershey,  PA, USAAbstract:  Prostate cancer is the most common cancer in male patients and the second lead- ing cause of cancer-related mortality in males.",Non-OADS,/arxiv_data1/oa_pdf/7f/2b/idr-9-161.PMC4944912.pdf
"9  Thus, while infectious complications occur in a minority of those undergoing biopsy, the clinical significance can be life-threatening, and judicious selection of patients for biopsy is strongly advised.Correspondence: Jay D Raman Division of Urology, Penn State Milton S. Hershey Medical Center, 500 University Drive, Mail Code H055, Hershey, PA 17033-0850, USATel +1 717 531 6979Fax +1 717 531 4475email jraman@hmc.psu.eduJournal name: Infection and Drug Resistance  Article Designation: ReviewY ear: 2016V olume: 9Running head verso: Lu and RamanRunning head recto: Prevention of prostate biopsy infectionsDOI: http://dx.doi.org/10.2147/IDR.S96163 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/7f/2b/idr-9-161.PMC4944912.pdf
Or use: http://youtu.be/yMGC3TjvYdE,Non-OADS,/arxiv_data1/oa_pdf/7f/2b/idr-9-161.PMC4944912.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/7f/2b/idr-9-161.PMC4944912.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 169 Prevention of prostate biopsy infections 55.,Non-OADS,/arxiv_data1/oa_pdf/7f/2b/idr-9-161.PMC4944912.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/ab/ott-9-4173.PMC4944913.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4173–4180OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4173Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10313 0 intravenous pamidronate versus oral and  intravenous clodronate in bone metastatic breast  cancer: a randomized, open-label, non-inferiority  Phase iii trial alexandra von au1 eva Milloth1 ingo Diel2 stefan stefanovic1 andre hennigs1 Markus Wallwiener1 Joerg heil1 Michael golatta1 Joachim rom1 christof sohn1 andreas schneeweiss1 Florian schuetz1 christoph Domschke1 1Breast Unit, Department of  gynecology and Obstetrics,   heidelberg University hospital,   heidelberg, 2cgg  clinic – centrum  für ganzheitliche gynäkologie  Mannheim, Mannheim, germanyPurpose:  Patients with metastasized breast cancer often suffer from discomfort caused by  metastatic bone disease.",Non-OADS,/arxiv_data1/oa_pdf/fd/ab/ott-9-4173.PMC4944913.pdf
"Approximately  10%–15% of all breast cancer patients develop early metastatic disease within 3 years correspondence: christoph Domschke Breast Unit, Department of gynecology  and Obstetrics, heidelberg University  hospital, im neuenheimer Feld 440,  69120 heidelberg, germany Tel +49 6221 56 7901 Fax +49 6221 56 4328 email christoph.domschke@med.uni- heidelberg.d e Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: von Au et al Running head recto: Bisphosphonates in metastatic breast cancer DOI: http://dx.doi.org/10.2147/OTT.S103130",Non-OADS,/arxiv_data1/oa_pdf/fd/ab/ott-9-4173.PMC4944913.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fd/ab/ott-9-4173.PMC4944913.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/ab/ott-9-4173.PMC4944913.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/62/idr-9-171.PMC4944914.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/62/idr-9-171.PMC4944914.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 171–179Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 171 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S106181Early detection of neonatal group B streptococcus  sepsis and the possible diagnostic utility of IL-6,  IL-8, and CD11b in a human umbilical cord blood  in vitro model Britt Nakstad1,2  T onje Sonerud1,3  Anne Lee Solevåg1 1Department of Pediatric and  Adolescent Medicine, Akershus  University Hospital, Lørenskog,   2Institute of Clinical Medicine,   University of Oslo, Lørenskog,   3Section of Clinical Molecular Biology  (EpiGen), Division of Medicine,  Akershus University Hospital,  Lørenskog, NorwayBackground: Group B streptococcus (GBS) infection remains a major cause of neonatal  morbidity and mortality, and GBS III is the predominant strain in early-onset GBS neonatal  sepsis.",Non-OADS,/arxiv_data1/oa_pdf/95/62/idr-9-171.PMC4944914.pdf
"Keywords:  TLR4, TLR6, CD64, GBS serotypes, flow cytometry Background Early-onset group B streptococcus (GBS) sepsis occurs in the first week of life and is com - monly caused by GBS serotypes Ia, II, III, and V .1–4 Even though intrapartum antibiotic  prophylaxis has reduced the incidence of early-onset neonatal sepsis (EONS) caused by  GBS dramatically,5 GBS remains a major cause of neonatal sepsis with a high morbid- ity and mortality rate.6 Recent population-based surveillance studies in the US revealed  GBS as the etiological agent of EONS in 38%–43% of all cases, with the incidence of Correspondence: Britt Nakstad   Department of Pediatric and Adolescent  Medicine, Akershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway   Tel +47 9340 4858 Email britt.nakstad@medisin.uio.noJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Nakstad et alRunning head recto: Early biomarkers of group B streptococcus neonatal sepsisDOI: http://dx.doi.org/10.2147/IDR.S106181",Non-OADS,/arxiv_data1/oa_pdf/95/62/idr-9-171.PMC4944914.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/95/62/idr-9-171.PMC4944914.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 179 Early biomarkers of group B streptococcus neonatal sepsis  13.,Non-OADS,/arxiv_data1/oa_pdf/95/62/idr-9-171.PMC4944914.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/b5/ijwh-8-265.PMC4944915.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 265–272International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  265RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S9015 7 Systemic lupus erythematosus: strategies to  improve pregnancy outcomes Yuriko Yamamoto Shigeru Aoki Perinatal Center for Maternity and  Neonate, Y okohama City University  Medical Center, Y okohama, Kanagawa  Prefecture, JapanAbstract:  Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease  with a high prevalence in females of childbearing age.",Non-OADS,/arxiv_data1/oa_pdf/fe/b5/ijwh-8-265.PMC4944915.pdf
"Preconception Although SLE patients can theoretically develop ovarian failure due to autoimmune  ovarian injury, altered hypothalamic–pituitary–ovarian axis, and diminished ovarian  reserve,3 current evidence suggests that they are as fertile as the general population.4 Correspondence: Shigeru Aoki Perinatal Center for Maternity and  Neonate, Yokohama City University  Medical Center, 4-57 Urafunecho,  Minami-ku, Yokohama, Kanagawa  Prefecture 232-0024, Japan Tel +81 45 261 5656 Fax +81 45 253 5784 email smyyaoki@yahoo.co.j p Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Y amamoto and Aoki Running head recto: Pregnancy in systemic lupus erythematosus DOI: http://dx.doi.org/10.2147/IJWH.S90157",Non-OADS,/arxiv_data1/oa_pdf/fe/b5/ijwh-8-265.PMC4944915.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/fe/b5/ijwh-8-265.PMC4944915.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/b5/ijwh-8-265.PMC4944915.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/88/7a/nss-8-215.PMC4944919.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/88/7a/nss-8-215.PMC4944919.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 215–219Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  215 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S96450Which oropharyngeal factors are significant risk  factors for obstructive sleep apnea?",Non-OADS,/arxiv_data1/oa_pdf/88/7a/nss-8-215.PMC4944919.pdf
"Other risk factors are oral abnormalities such as  macroglossia and a narrow  pharynx.5 Early detection and treatment of OSA have been shown to reduce the risk of Correspondence:  Kittisak Sawanyawisuth Department of Medicine, Faculty of  Medicine, Khon Kaen University, 123 Mitraparp Road, Khon Kaen 40002, ThailandTel +66 43 363 664Fax +66 43 348 399Email kittisak@kku.ac.thJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Ruangsri et alRunning head recto: Oropharyngeal factors and OSADOI: http://dx.doi.org/10.2147/NSS.S96450",Non-OADS,/arxiv_data1/oa_pdf/88/7a/nss-8-215.PMC4944919.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/88/7a/nss-8-215.PMC4944919.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a7/c3/dddt-10-2227.PMC4944921.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2227–2237Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2227Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11024 7 Puerarin transport across a calu-3 cell monolayer –  an in vitro model of nasal mucosa permeability and  the influence of paeoniflorin and menthol lin Zhang shou-Ying Du Yang lu chang liu Zhi-hao Tian chang Yang hui-chao Wu Zhen Wang school of chinese Materia Medica,   Beijing University of chinese  Medicine, chaoyang District, Beijing,   People’s republic of chinaAbstract:  Nasal administration is a high-potential delivery system, particularly because it can  provide a pathway from the nose to the brain.",Non-OADS,/arxiv_data1/oa_pdf/a7/c3/dddt-10-2227.PMC4944921.pdf
"Of these methods, in vitro   cell culture models that accurately simulate the physiological properties of transport  and permeation through nasal epithelial cells at the cellular level have become widely  recognized.7,8 These cell culture models are divided into two types: real nasal mucosa  models based on primary cultures of nasal epithelial cells from various species and  surrogate nasal mucosa models, which generally use Calu-3 cells, RPMI2650 cells, correspondence: shou-Ying Du; Yang lu school of chinese Materia Medica,  Beijing University of chinese Medicine,  no 6, Zhonghuan south road, Wangjing,  chaoyang District, Beijing 100102,  People’s republic of china Tel +86 10 8473 8615 Fax +86 10 10 8473 8611 email dushouying607816@163.co m;  landocean28@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhang et al Running head recto: Puerarin transport across a Calu-3 cell monolayer  DOI: http://dx.doi.org/10.2147/DDDT.S110247",Non-OADS,/arxiv_data1/oa_pdf/a7/c3/dddt-10-2227.PMC4944921.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a7/c3/dddt-10-2227.PMC4944921.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/c3/dddt-10-2227.PMC4944921.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/c6/jir-9-141.PMC4944924.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2016:9 141–145Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  141ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S8072 2significance of mast cell distribution in placental  tissue and membranes in spontaneous preterm  birth Kate needham1 Mitali Fadia2,3 Jane e Dahlstrom2,3 Kirsti harrington2,3 Bruce shadbolt4 stephen J Robson1,3,5 1Department of Obstetrics and  gynaecology, centenary hospital  for Women and children, canberra  hospital, garran, acT, australia;   2Department of anatomical Pathology,   acT Pathology, canberra hospital,   garran, acT, australia; 3anU Medical  school, australian national University,   canberra, acT, australia; 4Department  of epidemiology and Population  health, canberra hospital, garran,   acT, australia; 5John James Medical  centre, Deakin, acT, australia correspondence: stephen J Robson   suite 2, John James Medical centre,   175 strickland crescent, Deakin,   acT 2600, australia   Tel +61 2 6282 3033   Fax +61 2 6281 2899   email s tephen.robson@anu.edu.a uBackground:  Preterm birth is a common cause of adverse neonatal and childhood outcomes,  in both the short and long term.",Non-OADS,/arxiv_data1/oa_pdf/bf/c6/jir-9-141.PMC4944924.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal­of­inflammation­research­journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/bf/c6/jir-9-141.PMC4944924.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/c6/jir-9-141.PMC4944924.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/dd/dddt-10-2211.PMC4944925.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2211–2225Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2211Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10337 0Pharmacogenetic analysis of cinacalcet response  in secondary hyperparathyroidism patients sohyun Jeong1 in-Wha Kim1 Kook-hwan Oh2 nayoung han1 Kwon Wook Joo2 hyo Jin Kim2 Jung Mi Oh1 1college of Pharmacy, research  institute of Pharmaceutical sciences,   seoul national University,   2Department of internal Medicine,   Division of nephrology, seoul  national University hospital,   seoul,  KoreaBackground:  Secondary hyperparathyroidism (SHPT) is one of the major risk factors of  morbidity and mortality in end-stage renal disease.",Non-OADS,/arxiv_data1/oa_pdf/d0/dd/dddt-10-2211.PMC4944925.pdf
"However, because of the complicated problems of  lowering PTH with simultaneously controlling imbalanced serum levels of calcium  and phosphate, traditional therapies of phosphate binders and vitamin D analogues for  managing SHPT have all too often led to clinical problems, including hypercalcemia, correspondence: Jung Mi Oh college of Pharmacy, research institute  of Pharmaceutical sciences, seoul  national University, 1 gwanakro,  gwanak-gu, seoul 08826, Korea Tel +82 2 880 7736 Fax +82 2 882 9560 email jmoh@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Jeong et al Running head recto: Genetic polymorphisms of CASR and cinacalcet response DOI: http://dx.doi.org/10.2147/DDDT.S103370",Non-OADS,/arxiv_data1/oa_pdf/d0/dd/dddt-10-2211.PMC4944925.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d0/dd/dddt-10-2211.PMC4944925.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/dddt-10-2211.PMC4944925.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a5/8e/clep-8-261.PMC4944926.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a5/8e/clep-8-261.PMC4944926.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 261–266Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 261 STUDY PROTOCOL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S103098 Reporting quality of stepped wedge design  randomized trials: a systematic review protocol Alex Thabane1,2 Brittany B Dennis3,4 Olga Gajic-Veljanoski3,9,10 James Paul2,3 Lehana Thabane2,3,5–8 1Life Sciences Program, Queen’s  University, Kingston, ON, Canada;   2Department of Anesthesia,   McMaster University Hamilton ON,   3Department of Clinical Epidemiology  and Biostatistics, McMaster University,   Hamilton ON, Canada; 4St.",Non-OADS,/arxiv_data1/oa_pdf/a5/8e/clep-8-261.PMC4944926.pdf
"2 Furthermore, many clinicians in developing countries may not have full Correspondence:  Lehana Thabane Centre for Evaluation of Medicine, St  Joseph’s Healthcare, 3rd floor, Martha Wing, Room H-325, 50 Charlton Avenue East, Hamilton, ON L8N 4A6, CanadaTel +1 905 522 1155 (Extension 33720)Email thabanl@mcmaster.caJournal name: Clinical Epidemiology Article Designation: STUDY PROTOCOLY ear: 2016V olume: 8Running head verso: Thabane et alRunning head recto: Quality of reporting in stepped wedge design clinical trialsDOI: http://dx.doi.org/10.2147/CLEP .S103098",Non-OADS,/arxiv_data1/oa_pdf/a5/8e/clep-8-261.PMC4944926.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/a5/8e/clep-8-261.PMC4944926.pdf
"To determine which functional categories of genes were significantly affected by Tpm3.1, we performed func- tional annotation of the differentially expressed genes (>1.5-fold change) using Ingenuity Pathway Analy- sis (http://www.ingenuity.com).",OADS,/arxiv_data1/oa_pdf/40/4d/TRA-16-691.PMC4945106.pdf
Ingenuity Pathway Analysis (http://www.ingenuity.com) was performed on genes with positivefoldchangesbetweenTgandWTtissueofgreaterthan1.5(1283transcripts).,OADS,/arxiv_data1/oa_pdf/40/4d/TRA-16-691.PMC4945106.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:328 –339; http://dx.doi.org/10.1016/j.jcmgh.2015.12.008 ) Keywords: Myenteric Neurons; Palmitate; Gut Microbiota; LPS; TLR4; Colon Transit.,OADS,/arxiv_data1/oa_pdf/b4/cf/main.PMC4945127.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/cf/main.PMC4945127.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.12.008,OADS,/arxiv_data1/oa_pdf/b4/cf/main.PMC4945127.pdf
Hoboken: John Wiley & Sons; 2002.  http://dx.doi.org/10.1002/9781119013563 2.,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1161/ CIRCOUTCOMES.109.875658 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1076/edre.7.4.353.8937 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1146/annurev.psych.,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1002/sim.3944 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1207/ S15328007SEM0801_7 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1093/bioinformatics/btg287 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1002/nur.10015 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
2006; 76:1049– 64. http://dx.doi.org/10.1080/10629360600810434 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1002/ sim.2619 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/ 10.1037/1082-989X.7.2.147 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/ 10.1198/000313007X172556 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1093/aje/kwp425 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/ 10.1186/1742-7622-9-3 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/ 10.1093/aje/kwp026 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1177/0962280208101273 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1198/016214505000001375 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1016/ j.tmrv.2014.11.003 .,OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/ 10.1080/01621459.1993.10476366 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/ 10.1177/0962280206074463 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
http://dx.doi.org/10.1186/1471-2288-12-73 .,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/nihms795806.PMC4945131.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c1/75/2145.PMC4945134.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/96/05/2149.PMC4945135.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/fc/2161.PMC4945136.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/36/95/2172.PMC4945137.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f6/ee/2186.PMC4945138.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1a/db/2198.PMC4945139.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/72/69/2213.PMC4945140.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c0/b7/2234.PMC4945141.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ac/6b/2245.PMC4945142.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/87/55/2259.PMC4945143.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ee/79/2272.PMC4945144.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/36/42/2286.PMC4945145.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e8/ec/2301.PMC4945146.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6a/db/2317.PMC4945147.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/47/d1/2331.PMC4945148.pdf
"However, in most cases the biologic Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> Received 20 August 2015 | Accepted 12 July 2016 | Published 14 July 2016© 2016 Molecular Vision 783Variation in PTCHD2 , CRISP3 , NAP1L4 , FSCB , and AP3B2   associated with spherical equivalent Fei Chen,1 Priya Duggal,1 Barbara E.K.",Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  784basis of these associations have yet to be experimentally  validated [ 36].,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  785We defined individuals with spherical equivalent < −1 D in  either eye and < −0.5 D in the opposite eye as myopic and  those with spherical equivalent > +1 D in either eye and >  + 0.5 D in the opposite eye as hyperopic.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  786damaging” (PolyPhen [ 50]) indicating this variant is likely to  have a functional impact.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
"Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  787We identified four additional gene regions with signifi - cant association with spherical equivalent: the AP3B2  gene  (OMIM 602166 ) on chromosome 15q25.2 (p = 1.6 × 10−7), the  PTCHD2  gene (OMIM 611251 ) on chromosome 1p36.22 (p =  3.6 × 10−7), the NAP1L4  gene (OMIM 601651 ) on chromosome  11p15.5 (p = 3.6 × 10−6), and the CRISP3  gene on chromosome  6p12.3 (p = 4.3 × 10−6).",Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  788Table  3. a ssocia Tion resul Ts for gene Tic varian Ts in publishe D gWas loci for spherical  equivalen T or myopia .,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
"Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  789600975 ), suggesting its potential role in the development  of several ocular conditions.",Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
"Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  790and severe hyperopia due to reduced axial length [ 89,90].",Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  791equivalent (p = 1.7 × 10-3).,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  792ocular biometric traits: the Genes in Myopia (GEM) family  study.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  793and refractive error identifies a susceptibility locus at 15q25.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  79455.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  79578.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
"Molecular Vision  2016; 22:783-796 <http://www.molvis.org/molvis/v 22/783> © 2016 Molecular Vision  796Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/6a/94/mv-v22-783.PMC4945165.pdf
"Stem Cell Reports Report Tissue-Engineered Vascular Rings from Human iPSC-Derived Smooth Muscle Cells Biraja C. Dash,1,2,3Karen Levi,4Jonas Schwan,5Jiesi Luo,1,2Oscar Bartulos,1,2Hongwei Wu,1,2,6 Caihong Qiu,2Ting Yi,1,2Yongming Ren,1,2Stuart Campbell,5Marsha W. Rolle,4and Yibing Qyang1,2,7,8,* 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center, Yale School of Medicine, New Haven, CT 06511, USA 2Yale Stem Cell Center, Yale University, New Haven, CT 06510, USA 3Department of Surgery (Plastic), Yale University, New Haven, CT 06520, USA 4Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA 01609, USA 5Department of Biomedical Engineering, Yale University, New Haven, CT 06510, USA 6Department of Orthopedics, Hunan Cancer Hospital and The Afﬁliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410011, China 7Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06510, USA 8Department of Pathology, Yale University, New Haven, CT 06510, USA *Correspondence: yibing.qyang@yale.edu http://dx.doi.org/10.1016/j.stemcr.2016.05.004 SUMMARY There is an urgent need for an efﬁcient approach to obtain a large-scale and renewable source of functional human vascular smooth mus- cle cells (VSMCs) to establish robust, patient-speciﬁc tissue model systems for studying the pathogenesis of vascular disease, and for devel-oping novel therapeutic interventions.",Non-OADS,/arxiv_data1/oa_pdf/0a/c5/main.PMC4945325.pdf
"7 j19–28 jJuly 12, 2016 jª2016 19 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0a/c5/main.PMC4945325.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/0a/c5/main.PMC4945325.pdf
"Soft-ware packages like GIFT (http://icatb.sourceforget.net) orFSL-MELODIC (http://www.fMRIb.ox.ac.uk/fsl/) applydata reduction twice prior to ICA: ﬁrst to each subject, andthen to the concatenated (already reduced) group data[Erhardt et al., 2011].",OADS,/arxiv_data1/oa_pdf/20/cb/HBM-37-2717.PMC4945432.pdf
Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016019 84.,Non-OADS,/arxiv_data1/oa_pdf/bc/89/ANIE-55-8561.PMC4945455.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.199Intest Res 2016;14(3):199-201EDITORIAL Received May 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/bd/54/ir-14-199.PMC4945522.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.199 • Intest Res 2016;14(3):199-201 201 www.irjournal.org that 7 of the 11 performance measures were executed well  by more than 70% of physicians in Asian countries.,Non-OADS,/arxiv_data1/oa_pdf/bd/54/ir-14-199.PMC4945522.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.202Intest Res 2016;14(3):202-210SYSTEMATIC REVIEW Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review Ruben J. Colman1,2, David T. Rubin1 1Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, IL, 2St.",Non-OADS,/arxiv_data1/oa_pdf/36/b9/ir-14-202.PMC4945523.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.202 • Intest Res 2016;14(3):202-210 203 www.irjournal.org colorectal neoplasia.1 Over the last two decades, multiple studies from the Unit - ed States and Europe have demonstrated similar patterns of  elevated risk among patients who present with more severe histologic inflammation relative to their respective UC popu-lations.",Non-OADS,/arxiv_data1/oa_pdf/36/b9/ir-14-202.PMC4945523.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.202 • Intest Res 2016;14(3):202-210 205 www.irjournal.org Table 2.,OADS,/arxiv_data1/oa_pdf/36/b9/ir-14-202.PMC4945523.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.202 • Intest Res 2016;14(3):202-210 207 www.irjournal.org regression models (e.g., conditional logistic regression, strati- fied logistic regression and cox regression), and observa-tional study design.",OADS,/arxiv_data1/oa_pdf/36/b9/ir-14-202.PMC4945523.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.202 • Intest Res 2016;14(3):202-210 209 www.irjournal.org (for the case-control studies,1,4) or with proportional hazard  modeling (Cox regression) (for the cohort study).3 Neoplas - tic outcomes were conceptualized differently across studies  – some utilized an outcome of dysplasia in contrast to can-cer, while others utilized development of advanced neopla-sia (high-grade dysplasia and cancer) or any neoplasia as the primary outcome variable.",Non-OADS,/arxiv_data1/oa_pdf/36/b9/ir-14-202.PMC4945523.pdf
"Ontario, Canada: Ottawa Hospital Research Institute; 2010. http://www.ohri.ca/programs/clinical_epidemi-ology/oxford.asp.",Non-OADS,/arxiv_data1/oa_pdf/36/b9/ir-14-202.PMC4945523.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.211Intest Res 2016;14(3):211-217REVIEW The role of small bowel endoscopy in small bowel Crohn’s disease: when and how?",Non-OADS,/arxiv_data1/oa_pdf/68/b1/ir-14-211.PMC4945524.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.211 • Intest Res 2016;14(3):211-217 213 www.irjournal.org SB cross-sectional imaging such as CTE or MRE is usually  recommended before CE to identify strictures and assess the transmural and extraintestinal lesions of CD.,Non-OADS,/arxiv_data1/oa_pdf/68/b1/ir-14-211.PMC4945524.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.211 • Intest Res 2016;14(3):211-217 215 www.irjournal.org stasis, balloon dilation, or retrieval of retained capsule in  patients with suspected or known CD with bleeding, symp-tomatic strictures.",Non-OADS,/arxiv_data1/oa_pdf/68/b1/ir-14-211.PMC4945524.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.211 • Intest Res 2016;14(3):211-217 217 www.irjournal.org 26.,OADS,/arxiv_data1/oa_pdf/68/b1/ir-14-211.PMC4945524.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.218Intest Res 2016;14(3):218-223ORIGINAL ARTICLE Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries Shu Chen Wei Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan Background/Aims: The cost of caring for patients with inflammatory bowel disease (IBD) is high.",Non-OADS,/arxiv_data1/oa_pdf/23/37/ir-14-218.PMC4945525.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.218 • Intest Res 2016;14(3):218-223 219 www.irjournal.org both CD and UC patients.6 There is an apparent shift in cost  profile from surgery and hospitalization toward anti-TNF  treatment; however, the relatively consistent overall costs suggest that the high costs of these drugs are partly compen-sated for by a reduction in surgery and hospitalization rates.",Non-OADS,/arxiv_data1/oa_pdf/23/37/ir-14-218.PMC4945525.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.218 • Intest Res 2016;14(3):218-223 221 www.irjournal.org public health insurance in Taiwan, Japan, China, and Hong  Kong; in Korea, a 10% copayment system is established.",Non-OADS,/arxiv_data1/oa_pdf/23/37/ir-14-218.PMC4945525.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.218 • Intest Res 2016;14(3):218-223 223 www.irjournal.org REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/23/37/ir-14-218.PMC4945525.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.224Intest Res 2016;14(3):224-230ORIGINAL ARTICLE Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2 nd  Asian Organization for Crohn’s and Colitis (AOCC) meeting in Seoul Eun Soo Kim1, Minhu Chen2, Jun Lee3, Chang-K yun Lee4, You Sun Kim5 1Department of Internal Medicine, K yungpook National University School of Medicine, Daegu, Korea, 2The First Affiliated Hospital of San Yat- Sen University, Guangzhou, China, 3Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea, 4Department  of Internal Medicine, K yung Hee University College of Medicine, Seoul, Korea, 5Department of Internal Medicine, Seoul Paik Hospital, Inje  University College of Medicine, Seoul, Korea Background/Aims: As the number of Asian patients with inflammatory bowel disease (IBD) has increased recently, there is a growing need to improve IBD care in this region.",Non-OADS,/arxiv_data1/oa_pdf/d0/24/ir-14-224.PMC4945526.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.224 • Intest Res 2016;14(3):224-230 225 www.irjournal.org across different countries may induce the variation in the  practice pattern of different health-care systems, resulting in considerable divergence in patient outcomes.",Non-OADS,/arxiv_data1/oa_pdf/d0/24/ir-14-224.PMC4945526.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.224 • Intest Res 2016;14(3):224-230 227 www.irjournal.org Nouse  Other CT SBFT USG MRE CTE BAE CE CDAI HBI PCDAI OtherIOIBDCD 02 04 06 08 0 100China (114) Japan (88) Korea (116) Other (35) 02 04 06 08 0 100China (114) Japan (88) Korea (116) Other (35)UC 92 612 CD 02 04 06 08 0 100China (114) Japan (88) Korea (116) Other (35) 02 04 06 08 0 100China (114) Japan (88) Korea (116) Other (35)UCTruelove- Wittsindex Mayo score Seoindex Pediatric UCDAISt.Mark's index Nouse UC 02 04 06 08 0 100China (114) Japan (88) Korea (116) Other (35) 02 04 06 08 0 100China (114) Japan (88) Korea (116) Other (35)Nouse69 75 5 110(94.8%) 21 47 7 68 32 18 48 1212 12 102(88%) 10 18 95(83.3%) 16 50 27 9 81 28 6 28 6100 12 64 22 100(86%) 12 31 4 57 37 16 60(68%) 22 5 60 45 10 8 11 10 3 11 85 88 19 9 42 96 25 29 20 61(52.5%) 1 11 67 54SometimesAlways Usually Never Rarely SometimesAlways Usually Never Rarely SometimesAlways Usually Never Rarely(%) (%)(%) (%) (%) (%)A B C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/d0/24/ir-14-224.PMC4945526.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.224 • Intest Res 2016;14(3):224-230 229 www.irjournal.org ing.14,15 This issue is well reflected by the result that respon- dents seldom use an endoscopic scoring system such as the  Mayo score or UCEIS, whereas they answered to always per - form an endoscopic examination for UC diagnosis, indicat - ing the impracticability of the endoscopic scoring system.",Non-OADS,/arxiv_data1/oa_pdf/d0/24/ir-14-224.PMC4945526.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.231Intest Res 2016;14(3):231-239ORIGINAL ARTICLE Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2 nd  Asian Organization of Crohn’s and Colitis (AOCC) meeting in Seoul Hiroshi Nakase1*, Bora Keum2*, Byoung Duk Ye3, Soo Jung Park4, Hoon Sup Koo5, Chang Soo Eun6 1Department of Gastroenterology and Hepatology, Sapporo Medical University, School of Medicine, Sapporo, Japan, 2Department of Internal  Medicine, Korea University College of Medicine, Seoul, Korea, 3Department of Gastroenterology, Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, 5Department of  Internal Medicine, Konyang University College of Medicine, Daejeon, Korea, 6Department of Internal Medicine, Hanyang University Guri  Hosptial, Guri, Korea Background/Aims: Inflammatory bowel disease (IBD) management guidelines have been released from Western countries, but no adequate data on the application of these guidelines in Asian countries and no surveys on the treatment of IBD in real practice exist.",Non-OADS,/arxiv_data1/oa_pdf/ef/56/ir-14-231.PMC4945527.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.231 • Intest Res 2016;14(3):231-239 233 www.irjournal.org Japanese physicians selected apheresis therapies (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ef/56/ir-14-231.PMC4945527.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.231 • Intest Res 2016;14(3):231-239 235 www.irjournal.org 5) Monitoring To monitor CD patients during treatments, most physi- cians used clinical activity, blood tests, and colonoscopy for disease monitoring.",OADS,/arxiv_data1/oa_pdf/ef/56/ir-14-231.PMC4945527.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.231 • Intest Res 2016;14(3):231-239 237 www.irjournal.org infection in Asia.,Non-OADS,/arxiv_data1/oa_pdf/ef/56/ir-14-231.PMC4945527.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.231 • Intest Res 2016;14(3):231-239 239 www.irjournal.org 14.,OADS,/arxiv_data1/oa_pdf/ef/56/ir-14-231.PMC4945527.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.240Intest Res 2016;14(3):240-247ORIGINAL ARTICLE Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2 nd Asian Organization of Crohn’s and Colitis (AOCC)  meeting in Seoul Hye K yung Song1, Kang-Moon Lee2, Sung-Ae Jung1, Sung Noh Hong3, Dong Soo Han4, Suk-K yun Yang5; IBD  study group of Korean Association for the Study of Intestinal Diseases (KASID) Department of Internal Medicine, 1Ewha University College of Medicine, Seoul, 2St.",Non-OADS,/arxiv_data1/oa_pdf/57/cc/ir-14-240.PMC4945528.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.240 • Intest Res 2016;14(3):240-247 241 www.irjournal.org ological Association (AGA) developed “ An adult inflammato- ry bowel disease physician performance measures set” that comprised 10 specific measures.,Non-OADS,/arxiv_data1/oa_pdf/57/cc/ir-14-240.PMC4945528.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.240 • Intest Res 2016;14(3):240-247 243 www.irjournal.org awareness among performance measures with higher ranks.,OADS,/arxiv_data1/oa_pdf/57/cc/ir-14-240.PMC4945528.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.240 • Intest Res 2016;14(3):240-247 245 www.irjournal.org compliance of documentation of IBD was 70%, and ranked  fourth.",OADS,/arxiv_data1/oa_pdf/57/cc/ir-14-240.PMC4945528.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.240 • Intest Res 2016;14(3):240-247 247 www.irjournal.org 19.,OADS,/arxiv_data1/oa_pdf/57/cc/ir-14-240.PMC4945528.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.248Intest Res 2016;14(3):248-257ORIGINAL ARTICLE A retrospective analysis of 20-year data of the surgical management of ulcerative colitis patients in Taiwan:  a study of Taiwan Society of Inflammatory Bowel Disease  Chun-Chi Lin1, Shu-Chen Wei2, Been-Ren Lin3, Wen-Sy-Tsai4, Jinn-Shiun Chen4, Tzu-Chi Hsu5,   Wei-Chen Lin6, Tien- Yu Huang7, Te-Hsin Chao8, Hung-Hsin Lin1, Jau-Min Wong2, Jen-Kou Lin1 1Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital and Department of Surgery, National Yang- Ming University, Taipei, 2Department of Internal Medicine, National Taiwan University Hospital, Taipei, 3Division of Colon and Rectal Surgery,  Department of Surgery, National Taiwan University Hospital, Taipei, 4Division of Colorectal Surgery, Chang Gung Memorial Hospital at  Linkou, Taoyuan, 5Division of Colon and Rectal Surgery, Department of Surgery, Mackay Memorial Hospital, Taipei, 6Department of Internal  Medicine, Mackay Memorial Hospital, Taipei, 7Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital,  National Defense Medical Center, Taipei, 8Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital,  Taichung, Taiwan Background/Aims: With the recent progress in medical treatment, surgery still plays a necessary and important role in treat - ing ulcerative colitis (UC) patients.",Non-OADS,/arxiv_data1/oa_pdf/ef/1d/ir-14-248.PMC4945529.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.248 • Intest Res 2016;14(3):248-257 249 www.irjournal.org treating UC patients.,Non-OADS,/arxiv_data1/oa_pdf/ef/1d/ir-14-248.PMC4945529.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.248 • Intest Res 2016;14(3):248-257 251 www.irjournal.org 2.,OADS,/arxiv_data1/oa_pdf/ef/1d/ir-14-248.PMC4945529.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.248 • Intest Res 2016;14(3):248-257 253 www.irjournal.org Table 4.,OADS,/arxiv_data1/oa_pdf/ef/1d/ir-14-248.PMC4945529.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.248 • Intest Res 2016;14(3):248-257 255 www.irjournal.org It has been reported that restorative proctocolectomy with  IP AA, as described first by Parks and Nicholls in 197839 and  Utsunomiya in 1980,40 is the standard of care for patients  with UC who require surgery.32 Moreover, some studies have  showed that subtotal colectomy is a safe surgical option for  acute severe colitis.41 In our series, more patients received  total or subtotal colectomy with rectal preservation than to-tal abdominal proctocolectomy with IP AA (41.4% vs. 25.3%).",Non-OADS,/arxiv_data1/oa_pdf/ef/1d/ir-14-248.PMC4945529.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.248 • Intest Res 2016;14(3):248-257 257 www.irjournal.org 41.,OADS,/arxiv_data1/oa_pdf/ef/1d/ir-14-248.PMC4945529.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.258Intest Res 2016;14(3):258-263ORIGINAL ARTICLE Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea Ho-Su Lee1, Jaewon Choe1, Hyo Jeong Lee1, Sung Wook Hwang2, Sang Hyoung Park2, Dong-Hoon Yang2,  K yung-Jo Kim2, Byong Duk Ye2, Jeong-Sik Byeon2, Seung-Jae Myung2, Yong Sik Yoon3, Chang Sik Yu3,   Jin-Ho Kim2, Suk-K yun Yang2 1Health Screening and Promotion Center, 2Department of Gastroenterology, 3Colon and Rectal Surgery, University of Ulsan College of Medicine,  Asan Medical Center, Seoul, Korea Background/Aims: Accurately diagnosing inflammatory bowel disease (IBD) remains a challenge, but is crucial for providing proper management for affected patients.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/ir-14-258.PMC4945530.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.258 • Intest Res 2016;14(3):258-263 259 www.irjournal.org cally evaluated the difficulties and pitfalls in diagnosing IBD  with its rapid shifts in incidence in this region.,OADS,/arxiv_data1/oa_pdf/74/8f/ir-14-258.PMC4945530.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.258 • Intest Res 2016;14(3):258-263 261 www.irjournal.org 2.,OADS,/arxiv_data1/oa_pdf/74/8f/ir-14-258.PMC4945530.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.258 • Intest Res 2016;14(3):258-263 263 www.irjournal.org 8.,OADS,/arxiv_data1/oa_pdf/74/8f/ir-14-258.PMC4945530.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.264Intest Res 2016;14(3):264-269ORIGINAL ARTICLE Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer Sawan Bopanna1, Maitreyee Roy2,  Prasenjit Das2, S Dattagupta2, V Sreenivas3, V Pratap Mouli1,   Saurabh Kedia1, Rajan Dhingra1, Rajesh Pradhan1, N Suraj Kumar1, Dawesh P Yadav1, Govind Makharia1,  Vineet Ahuja1 Departments of 1Gastroenterology, 2Pathology, and 3Biostatistics, All India Institute of Medical Sciences, New Delhi, India Background/Aims: Recent data suggest that the incidence of ulcerative colitis (UC) related colorectal cancer (CRC) in India is similar to that of West.",Non-OADS,/arxiv_data1/oa_pdf/f7/6d/ir-14-264.PMC4945531.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.264 • Intest Res 2016;14(3):264-269 265 www.irjournal.org et al.4 Thus, even though the risk of sporadic CRC is low in  India, the risk of CRC in our patients with UC is high and  similar to that in patients in the West.",Non-OADS,/arxiv_data1/oa_pdf/f7/6d/ir-14-264.PMC4945531.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.264 • Intest Res 2016;14(3):264-269 267 www.irjournal.org mucosa that appeared unremarkable.17,18 However one study  has shown that most of these flat dysplasias are endoscopi - cally visible.19 In our study, though, we found no areas of ab- normality or flat dysplasia on examination under white light.",Non-OADS,/arxiv_data1/oa_pdf/f7/6d/ir-14-264.PMC4945531.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.264 • Intest Res 2016;14(3):264-269 269 www.irjournal.org 19.,OADS,/arxiv_data1/oa_pdf/f7/6d/ir-14-264.PMC4945531.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.270Intest Res 2016;14(3):270-279ORIGINAL ARTICLE Characteristics and outcomes of endoscopically resected colorectal cancers that arose from sessile serrated adenomas and traditional serrated adenomas Ji Yeon Seo1*, Seung Ho Choi1*, Jaeyoung Chun2, Changhyun Lee1, Ji Min Choi2, Eun Hyo Jin1,   Sung Wook Hwang2, Jong Pil Im2, Sang Gyun Kim2, Joo Sung Kim1,2 1Department of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital,  2Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea Background/Aims: The efficacy and safety of endoscopic resection of colorectal cancer derived from sessile serrated adeno-mas or traditional serrated adenomas are still unknown.",Non-OADS,/arxiv_data1/oa_pdf/b1/49/ir-14-270.PMC4945532.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.270 • Intest Res 2016;14(3):270-279 271 www.irjournal.org pathway are epigenetic DNA promoter hypermethylations  leading to a CpG island methylator phenotype (CIMP) and microsatellite instability (MSI).,OADS,/arxiv_data1/oa_pdf/b1/49/ir-14-270.PMC4945532.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.270 • Intest Res 2016;14(3):270-279 273 www.irjournal.org RESULTS 1.,OADS,/arxiv_data1/oa_pdf/b1/49/ir-14-270.PMC4945532.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.270 • Intest Res 2016;14(3):270-279 275 www.irjournal.org Table 2.,OADS,/arxiv_data1/oa_pdf/b1/49/ir-14-270.PMC4945532.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.270 • Intest Res 2016;14(3):270-279 277 www.irjournal.org had a higher prevalence of high-grade dysplasia in pre- existing lesions ( P<0.001) than those with CRC-adenomas.,Non-OADS,/arxiv_data1/oa_pdf/b1/49/ir-14-270.PMC4945532.pdf
http://dx.doi.org/10.5217/ir.2016.14.3.270 • Intest Res 2016;14(3):270-279 279 www.irjournal.org 16.,OADS,/arxiv_data1/oa_pdf/b1/49/ir-14-270.PMC4945532.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.280Intest Res 2016;14(3):280-284CASE REPORT Chronic intractable diarrhea caused by gastrointestinal mastocytosis Hyungil Seo1, Sang Hyoung Park2, Jeong-Sik Byeon2, Chang Gok Woo3, Seung-Mo Hong3, Kiju Chang1,  Hoonsub So2, Minseob Kwak2, Wan Soo Kim2, Jeong-Mi Lee2, Dong-Hoon Yang2, K yung-Jo Kim2,   Byong Duk Ye2, Seung-Jae Myung2, Suk-K yun Yang2 Departments of 1Internal Medicine, 2Gastroenterology, and 3Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea As mast cells have been highlighted in the pathogenesis of diarrhea-predominant irritable bowel syndrome, a new term “mas - tocytic enterocolitis” was suggested by Jakate and colleagues to describe an increase in mucosal mast cells in patients with chronic intractable diarrhea and favorable response to treatment with antihistamines.",Non-OADS,/arxiv_data1/oa_pdf/7d/ce/ir-14-280.PMC4945533.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.280 • Intest Res 2016;14(3):280-284 281 www.irjournal.org olmesartan 20 mg/day, and atenolol 50 mg/day) and an oral  hypoglycemic drug (glimepiride 2 mg/day.)",Non-OADS,/arxiv_data1/oa_pdf/7d/ce/ir-14-280.PMC4945533.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.280 • Intest Res 2016;14(3):280-284 283 www.irjournal.org treatment with oral cromolyn, a mast cell stabilizer.",Non-OADS,/arxiv_data1/oa_pdf/7d/ce/ir-14-280.PMC4945533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.285Intest Res 2016;14(3):285-288CASE REPORT High grade anorectal stricture complicating Crohn’s disease: endoscopic treatment using insulated-tip knife Hyung Ku Chon, Ik Sang Shin, Sang Wook Kim, Soo Teik Lee Division of Gastroenterology, Department of Internal Medicine, Chonbuk National University College of Medicine and Hospital, Jeonju, Korea Endoscopic treatments have emerged as an alternative to surgery, in the treatment of benign colorectal stricture.",Non-OADS,/arxiv_data1/oa_pdf/fa/35/ir-14-285.PMC4945534.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.285 • Intest Res 2016;14(3):285-288 287 www.irjournal.org vertent contact of the tip of the conducting cautery, thus po- tentially minimizing the risk of perforation when compared to needle knife used during electrocautery therapy.",Non-OADS,/arxiv_data1/oa_pdf/fa/35/ir-14-285.PMC4945534.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-9100  • eISSN 2288-1956 http://dx.doi.org/10.5217/ir.2016.14.3.289Intest Res 2016;14(3):289-291IMAGES OF THE ISSUE Received May 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/82/d6/ir-14-289.PMC4945535.pdf
"http://dx.doi.org/10.5217/ir.2016.14.3.289 • Intest Res 2016;14(3):289-291 291 www.irjournal.org ity of 66%–83%, even from as much as 1 L of ascitic fluid.1  Therefore, alternative non-invasive diagnostic tools, includ- ing Ziehl–Neelsen staining, PCR and ADA level in the ascitic fluid, and IGRA, are widely used for the rapid detection of tuberculous peritonitis.",Non-OADS,/arxiv_data1/oa_pdf/82/d6/ir-14-289.PMC4945535.pdf
"However, systematic researchusing the genus Colletotrichum  to identify the distributionResearch Article Mycobiology 2016 June, 44(2): 105-111 http://dx.doi.org/10.5941/MYCO.2016.44.2.105 pISSN 1229-8093  eISSN 2092-9323© The Korean Society of Mycology *Corresponding author E-mail: sjchoi@cu.ac.kr (S.-J.",Non-OADS,/arxiv_data1/oa_pdf/79/eb/mb-44-105.PMC4945537.pdf
"were obtained from the Korean Agricultural Culture Collection (KACC, Gene ResourcesCenter, Rural Development Administration, Republic ofKorea; http://www.genebank.go.kr) and Center for FungalGenetic Resources (CFGR, Republic of Korea; http://genebank.snu.ac.kr).",OADS,/arxiv_data1/oa_pdf/79/eb/mb-44-105.PMC4945537.pdf
ELECTRONIC SUPPLEMENTARY MATERIAL Supplementary data including one table can be found withthis article online http://www.mycobiology.or.kr/src/sm/mb-44-105.s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/eb/mb-44-105.PMC4945537.pdf
"The specimen (TPML150908-046) used in this studyResearch Note Mycobiology 2016 June, 44(2): 112-116 http://dx.doi.org/10.5941/MYCO.2016.44.2.112 pISSN 1229-8093  eISSN 2092-9323© The Korean Society of Mycology *Corresponding author E-mail: daehokim@kangwon.ac.kr (D.H. Kim),          jongklee@kangwon.ac.kr (J.K. Lee) Received  June 1, 2016 Revised  June 8, 2016 Accepted  June 13, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/0e/mb-44-112.PMC4945538.pdf
"nov. TPML150908-046 KX260112 KX260114 KX260116 Xylaria cranioides HAST 226 GQ478210 GU300075 GQ844785 X. tuberoides HAST 475 GQ478209 GU300074 GQ844784 X. hypoxylon HAST 95082001 GQ487703 GU300095 GQ844811 aEF, GQ, and GU numbers [11] were obtained from the NCBI GenBank homepage (https://www.ncbi.nlm.nih.gov/genbank/) and KX numbers were sequenced in this study.",OADS,/arxiv_data1/oa_pdf/52/0e/mb-44-112.PMC4945538.pdf
"The other fraction was subjected to Sephadex LH-20 columnchromatography with 70% aqueous methanol as the elutingResearch Note Mycobiology 2016 June, 44(2): 117-120 http://dx.doi.org/10.5941/MYCO.2016.44.2.117 pISSN 1229-8093  eISSN 2092-9323© The Korean Society of Mycology *Corresponding author E-mail: bsyun@jbnu.ac.kr †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/7c/37/mb-44-117.PMC4945539.pdf
"Rice represents the primary foodsource for almost half of the world’s population, providing20% of the total human dietary energy supply (Food andAgriculture Organization [FAO] of the United Nations,http://faostat.fao.org/).",Non-OADS,/arxiv_data1/oa_pdf/4f/65/mb-44-67.PMC4945540.pdf
"While the amount of harvestedrice is increasing annually, consumer intake has gradually declined, decreasing by half between 1985 and 2015 (StatisticsKorea, http://kostat.go.kr/portal/eng/).",Non-OADS,/arxiv_data1/oa_pdf/4f/65/mb-44-67.PMC4945540.pdf
"The highMini-review Mycobiology 2016 June, 44(2): 67-78 http://dx.doi.org/10.5941/MYCO.2016.44.2.67 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: kidkim@korea.ac.kr Received  April 9, 2016 Revised  May 25, 2016 Accepted  June 4, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/65/mb-44-67.PMC4945540.pdf
"According to the IRRIfact sheet on the management of storage fungi (availablefrom http://irri.org/), several factors affect the populationsof storage fungi on harvested rice grains.",Non-OADS,/arxiv_data1/oa_pdf/4f/65/mb-44-67.PMC4945540.pdf
"ThisResearch Article Mycobiology 2016 June, 44(2): 79-84 http://dx.doi.org/10.5941/MYCO.2016.44.2.79 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jckang@gzu.edu.cn Received  December 7, 2015 Revised  March 22, 2016 Accepted  March 27, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/7b/mb-44-79.PMC4945541.pdf
"nov. under Botryosphaeriaceae 81 (Podospora anserina Genome Project, http://podospora.igmors.u- psud.fr/) at the Institute of Genetics and Microbiology(IGM, NTCL code), University Paris-Sud 11, France.",OADS,/arxiv_data1/oa_pdf/8e/7b/mb-44-79.PMC4945541.pdf
7 (http://mafft.cbrc.jp/alignment/server/index.html).,OADS,/arxiv_data1/oa_pdf/8e/7b/mb-44-79.PMC4945541.pdf
Phylogenetic trees were viewed with FigTree v1.4.0 (http://tree.bio.ed.ac.uk/software/figtree/) and the final tree preparedin Adobe Illustrator CS5.,OADS,/arxiv_data1/oa_pdf/8e/7b/mb-44-79.PMC4945541.pdf
Available from: http://www.indexfungorum.org/ Names/Names.asp.,OADS,/arxiv_data1/oa_pdf/8e/7b/mb-44-79.PMC4945541.pdf
"O f t h e  sev e r al fu n g al  pa th o g e n s r e po rt ed  t oattack water hyacinth, some prominent ones are Acremonium zonatum , Cercospora piaropi , Myrothecium roridum , Rhizoctonia solani , Uredo eichhorniae , Helminthosporium/Bipolaris  spp.,Research Article Mycobiology 2016 June, 44(2): 85-92 http://dx.doi.org/10.5941/MYCO.2016.44.2.85 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: sanjaibiotech@yahoo.com Received  February 9, 2016 Revised  March 4, 2016 Accepted  April 16, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/0e/mb-44-85.PMC4945542.pdf
5 (http://www.genecodes.com).,OADS,/arxiv_data1/oa_pdf/4c/0e/mb-44-85.PMC4945542.pdf
"The identification of this genusis largely based on the host and the biogeography location,Research Article Mycobiology 2016 June, 44(2): 93-98 http://dx.doi.org/10.5941/MYCO.2016.44.2.93 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: gswangyan101@163.com Received  April 26, 2016 Revised  May 30, 2016 Accepted  June 7, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/49/mb-44-93.PMC4945543.pdf
The ITS sequencesfrom NCBI were aligned using MAFFT v. 7 (http://mafft.cbrc.jp/alignment/server/index.,OADS,/arxiv_data1/oa_pdf/56/49/mb-44-93.PMC4945543.pdf
"which were isolated from the clinical specimens collected at the DankookResearch Article Mycobiology 2016 June, 44(2): 99-104 http://dx.doi.org/10.5941/MYCO.2016.44.2.99 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: nerowolf@naver.com Received  May 16, 2016 Revised  May 31, 2016 Accepted  June 22, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/db/mb-44-99.PMC4945544.pdf
In accordance with theclassification method by International Commission of thetaxonomy of Fungi (http://www.fungaltaxonomy.org/).,Non-OADS,/arxiv_data1/oa_pdf/8c/db/mb-44-99.PMC4945544.pdf
"*Correspondence: fettiplace@wisc.edu Editor: Brian Salzberg Biophysical Journal 111, 3–9, July 12, 2016 3http://dx.doi.org/10.1016/j.bpj.2016.05.032 /C2112016 Biophysical Society.",OADS,/arxiv_data1/oa_pdf/0a/4a/main.PMC4945579.pdf
(~100) have precluded biochemical approaches that were successfully used to isolate components of the transductionmachinery in other sensory systems such as photoreceptors.Isolating the hair-cell transduction complex has largelyrelied on the analysis of mutations underlying various typesof hereditary deafness ( http://hereditaryhearingloss.org ).,Non-OADS,/arxiv_data1/oa_pdf/0a/4a/main.PMC4945579.pdf
"China 6Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul 135-081, Republic of Korea 7Department of Cell Biology, Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA 8Co-ﬁrst author *Correspondence: inhyun.park@yale.edu http://dx.doi.org/10.1016/j.stemcr.2016.05.014 SUMMARY Reprogramming to pluripotency after overexpression of OCT4, SOX2, KLF4, and MYC is accompanied by global genomic and epige- nomic changes.",Non-OADS,/arxiv_data1/oa_pdf/e3/b7/main.PMC4945581.pdf
43 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/b7/main.PMC4945581.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and four tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",OADS,/arxiv_data1/oa_pdf/e3/b7/main.PMC4945581.pdf
"Sparks,1 Polina Y. Pulyanina,1and Nicole I. zur Nieden1,* 1Department of Cell Biology & Neuroscience and Stem Cell Center, College of Natural and Agricultural Sciences, University of California Riverside, 1113 Biological Sciences Building, Riverside, CA 92521, USA 2Co-ﬁrst author *Correspondence: nicole.zurnieden@ucr.edu http://dx.doi.org/10.1016/j.stemcr.2016.06.006 SUMMARY Embryonic stem cells (ESCs), which are derived from a peri-implantation embryo, are routinely cultured in medium containing diabetic glucose (Glc) concentrations.",OADS,/arxiv_data1/oa_pdf/97/f3/main.PMC4945584.pdf
55 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/f3/main.PMC4945584.pdf
"Post hoc Tu-key honest signiﬁcant difference tests were performed when more than two groups were compared, and the ANOVA yielded asigniﬁcant F ratio to determine statistical differences among two individual groups ( http://faculty.vassar.edu/lowry/anova1u.",Non-OADS,/arxiv_data1/oa_pdf/97/f3/main.PMC4945584.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/97/f3/main.PMC4945584.pdf
"Stem Cell Reports Report Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis Talia Velasco-Hernandez,1,2,*Petter Sa ¨we´n,2David Bryder,2and Jo ¨rg Cammenga1,2,3,4,5,* 1Division of Molecular Medicine and Gene Therapy 2Division of Molecular Hematology Lund Stem Cell Center, Lund University, Lund 22184, Sweden 3Department of Hematology, Skanes University Hospital, Lund 22184, Sweden 4Department of Hematology, Linko ¨ping University Hospital, Linko ¨ping 58183, Sweden 5Department of Clinical and Experimental Medicine, Linko ¨ping University, Linko ¨ping 58183, Sweden *Correspondence: talia.velasco@med.lu.se (T.V.-H.), jorg.cammenga@med.lu.se (J.C.) http://dx.doi.org/10.1016/j.stemcr.2016.06.002 SUMMARY Conditional knockout mice are commonly used to study the function of speciﬁc genes in hematopoiesis.",Non-OADS,/arxiv_data1/oa_pdf/1a/97/main.PMC4945592.pdf
11 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/97/main.PMC4945592.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and four ﬁgures and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2016.06.002 .,Non-OADS,/arxiv_data1/oa_pdf/1a/97/main.PMC4945592.pdf
(KOKEn   K-Endosheath <http://www.kokenmpc.co.jp/english/products/medical_plastics/ent/k-endsheath/index.html>)(2016.1.25),Non-OADS,/arxiv_data1/oa_pdf/27/a2/nmc-56-409.PMC4945599.pdf
Annual Report 2014. http://www.artro- clinic.se/info/rapport2014en.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/8a/3a/WIITM-11-27620.PMC4945607.pdf
http://www.worldgastroenterology.org/guidelines/global-guidelines/diverticular-disease/divertic-ular-disease-english.,Non-OADS,/arxiv_data1/oa_pdf/5d/14/WIITM-11-27677.PMC4945609.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/d2/67/bmjqir-u203556-w1603.PMC4945615.pdf
Here we report on an MCB based FISH-banding study complemented with selected locus-specificReceived: 15 September 2015 Revised: 20 October 2015 Accepted: 23 October 2015 Heliyon (2015) e00042 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
These species Article No~e00042 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
"Next-generation sequencing (NGS) technology was applied in some evolutionary studies ( Li et al., 2010; Carbone et al., 2014 ), however, it is difficult to correctly align sequence and assemble genomes which are extremely reshuffled; thus Article No~e00042 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
"Noteworthy, other authors suggested that blocks of segmental duplication locate in close proximity to centromeric satellite DNA; Article No~e00042 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
The datapresented here enabled to follow up the chromosomal evolution among the Article No~e00042 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
"Additional information [19_TD$DIFF]Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.heliyon.2015.e00042 .",OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
"Fan, X., Pinthong, K., Mkrtchyan, H., Siripiyasing, P., Kosyakova, N., Supiwong, W., Tanomtong, A., Chaveerach, A., Liehr, T., de Bello Cioffi, M., Article No~e00042 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
"Liehr, T., Starke, H., Heller, A., Kosyakova, N., Mrasek, K., Gross, M., Karst, C., Steinhaeuser, U., Hunstig, F., Fickelscher, I., Kuechler, A., Trifonov, V., Article No~e00042 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Molecular and classical cytogenetic analyses demonstrate an apomorphic Article No~e00042 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
Article No~e00042 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00042 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/4e/main.PMC4945616.pdf
"[5_TD$DIFF]These findings demonstrate the feasibility of using participants' own smartphones to map social network, whilst identifying current limitations ofReceived: 12 May 2015 Revised: 2 September 2015 Accepted: 6 October 2015 Heliyon (2015) e00037 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
"This approach to define the edges is time consuming, subjective Article No~e00037 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
We used the Bluetooth scanning Article No~e00037 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Hashing Article No~e00037 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
"We hence define a time series x itðÞ¼1;if device i scanned at time t 0;elsewhere/C26 (2) that represents the times device iscanned and xijtðÞ¼1;if device i detected j at time t 0;elsewhere/C26 (3) as the times device idetected device j.Using a time-domain smoothing operator, we can then define connectivity strength between device iand device jin a time-resolved manner as Article No~e00037 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Non- Article No~e00037 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
The horizontal dotted line reflects a scanningrate of 1 scan every 10 min; the dashed line 1 scan every 2 h. Article No~e00037 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
The ability to define time-resolved Article No~e00037 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
[31] Purple Robot: http://tech.cbits.northwestern.edu/purple-robot/ (Accessed on 4.10.2015).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
"[33] R.A. Hanneman, M. Riddle, Introduction to social network methods, University of California Riverside, 2005. http://faculty.ucr.edu/ ∼hanneman/ .",Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
Article No~e00037 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00037 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/87/main.PMC4945619.pdf
http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
2 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"This straightforward  calculation results  in the formula  below, 𝑑=𝑑tr−𝛼[𝛽+𝛾(1+𝑧)−3∕2]1∕6≈𝑑tr−4134(1+ 𝑧)−1∕4(2) 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
4 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"To begin,  recall  that energy levels  of the rotors,  from [3], are given by, 𝐸𝑛=0.325𝐸0 𝑛 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
6 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"In both models, a  7 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This density w ould have been approximately  2.7 ×10−6cm−3thus  8 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
9 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
At  10 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
227) to  11 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"Note that the rotor-attenuated,   critical-density  model and the Standard  Model are fairly  close to each other over  12 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
13 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"Depending  upon  the Mach number  in a given zone,  some  amount of the energy from the tresino   transition  will be carried away in the proton and tresino  streams as components of  14 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"The conservation of energy from the base of the corona  may be written, 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
Note that there is a big diﬀerence   16 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
17 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"Furthermore,  note that these dark matter  and dark  18 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
19 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"), Interstellar Dust from  20 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
"[17] E.L.  W right,  Ned Wright’s  cosmology tutorial,   http://www.astro.ucla.edu/~wright/Distances_details.gif , 2013.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
21 http://dx.doi.org/10.1016/j.heliyon.2015.e00039 2405-8440/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/main.PMC4945623.pdf
The number  of conﬁgurations  of a  http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
"The dual entropy expressions  satisfy  a maximum  entropy principle (MEP) and their values  coincide,  𝑆2[𝑝𝑘] =𝑆1[𝑝𝑘], when the  2 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.",OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
The functional composition Renormalization Group (RG)  ﬁxed-point map is the solution 𝑓∗(𝑥)of 𝑓∗(𝑓∗(𝑥)) =𝜆−1𝑓∗(𝜆𝑥) (5) 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
4 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
Notice that in this ﬁgure  we have used  5 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
"With use of 𝜆−𝑛≡(1 +𝑡)−ln𝜆∕ln2,  𝑡 =2𝑛−1, this subsequence can be expressed as 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
A well-known speciﬁc case of the above is the sequence  of rational   approximations  to the reciprocal  of the golden mean 𝜔gm=(√ 5−1)∕2  ≃ 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
8 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
(17) as 𝑛 →∞ 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
(22) 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
"When the contraction of phase space leads to a se t of conﬁgurations  of  the same measure as the original phase space,  e.g., an interval or ﬁnite collection of  11 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
12 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
13 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
"Article No~e00045 [13] Website of the Santa Fe Institute,   http://www.santafe.edu/about/people/proﬁle/Aaron  Clauset; Aaron  Clause t home page Data and Code,   http://tuvalu.santafe.edu/~aaronc/powerlaws/data.htm , accessed August 29,  2015.",Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
14 http://dx.doi.org/10.1016/j.heliyon.2015.e00045 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/main.PMC4945624.pdf
"Keywords: Materials chemistry, Materials science, Polymers, BiomaterialsReceived: 24 June 2015 Revised: 24 September 2015 Accepted: 15 October 2015 Heliyon (2015) e00038 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
"The influence of curing temperature, molar mass of the PVOH and mass amount of PVOH, on the mechanical properties of paper sheets based on TMP fibers, Article No~e00038 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Ameaningful raise was observed when the temperature was increased from 150 °C Article No~e00038 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
Article No~e00038 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00038 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/b7/main.PMC4945656.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/48/34/10029_2015_Article_1447.PMC4945679.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.AB Uncoated PPM Coated PPM Fig.",Non-OADS,/arxiv_data1/oa_pdf/1f/c6/10029_2016_Article_1481.PMC4945686.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
http://www.socialstyrelsen.se/publikationer2014/ 2014-12-19/Sidor/default.aspx .,Non-OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
"Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012. http://www.cdc.gov/pednss/pdfs/2010-PNSS- Summary-Report-Text%20File.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
"Stockholm, Sweden: National Board of Health and Welfare; 2003. http://www.socialstyrelsen.se/Lists/Artikelkatalog/ Attachments/10655/2003-112-3_20031123.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
http://www.socialstyrelsen.se/publikationer2013/ 2013-8-6 .,Non-OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
"Stockholm, Sweden: Statistics Sweden; 2006. http://www.scb.se/statistik/_publikationer/ BE9999_2006A01_BR_BE96ST0604.pdf .",OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
"Stockholm, Sweden: Statistics Sweden; 2010. http://www.scb.se/statistik/_ publikationer/BE9999_2009A01_BR_BE96BR1003.pdf .",OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
http://apps.who.int/bmi/index.jsp?introPage=intro.,Non-OADS,/arxiv_data1/oa_pdf/f1/2d/kww046.PMC4945704.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.108 Infect Chemother 2016;48(2):108-117 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: April 23, 2016   Revised:  June 4, 2016  Accepted: June 7, 2016 Corresponding Author : Sun Hee Park, MD, PhD, MPH Division of Infectious Diseases, Department of Internal Medicine, Daejeon St Mary’s  Hospital, College of Medicine, The Catholic University of Korea, 64, Daeheung-ro, Jung- gu, Daejeon 34943, Korea Tel: +82-42-220-9296, Fax: +82-42-220-7925  E-mail: sph0103@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.108  •  Infect Chemother 2016;48(2) :108-117 www.icjournal.org 109 Introduction In 2015, there was a nationwide outbreak of Middle East Re - spiratory Syndrome coronavirus (MERS-CoV) infection in Ko - rea, initiated by a single case returning from the Middle East  and eventually, resulting in 186 laboratory-confirmed cases  and 38 deaths [1].",Non-OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.108  •  Infect Chemother 2016;48(2) :108-117 www.icjournal.org 111 infect.,OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.108  •  Infect Chemother 2016;48(2) :108-117 www.icjournal.org 113 3.,Non-OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.108  •  Infect Chemother 2016;48(2) :108-117 www.icjournal.org 115 from symptom onset [30].,Non-OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
Conflicts of Interest No conflicts of interest ORCID Sun Hee Park http://orcid.org/0000-0001-5648-9237 Woo Joo Kim http://orcid.org/0000-0002-4546-3880 Supplementary material Supplementary data including one table can be found with,Non-OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
• Epidemiology of MERS outbreak in Korea www.icjournal.org 116 this article online http://www.icjournal.org/src/sm/ic-48- 108-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
Available  at: http://www.mers.go.kr/mers/html/jsp/Menu_C/list_ C4.jsp?menuIds=&fid=5767&q_type=&q_val - ue=&cid=65327&pageNum=1.,OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.108  •  Infect Chemother 2016;48(2) :108-117 www.icjournal.org 117 MNU1013-MNU1509-MNU1915&fid=5747&q_type=&q_ value=&cid=63292&pageNum=.,OADS,/arxiv_data1/oa_pdf/44/4d/ic-48-108.PMC4945720.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.118 Infect Chemother 2016;48(2):118-126 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: June 17, 2016   Revised:  June 25, 2016  Accepted: June 25, 2016 Corresponding Author : Yeon-Sook Kim, M.D Division of Infectious Diseases, Department of Internal Medicine, Chungnam National  University School of Medicine, Munhwa-ro 282, Jung-gu, Daejeon 35015, Korea Tel: +82-42-280-8109, Fax: +82-42-257-5753,  E-mail: alice@cnuh.co.kr * Won Suk Choi, Cheol-In Kang, Yonjae Kim, and Jae-Phil Choi contributed equally to  this article as co-first authors.",Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
"This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.118  •  Infect Chemother 2016;48(2) :118-126 www.icjournal.org 119 Introduction Middle East respiratory syndrome (MERS), which is caused  by β-coronavirus of the C lineage (MERS-CoV), ranges in se - verity from asymptomatic to a severe respiratory illness with  rapid progression to respiratory failure [1].",Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.118  •  Infect Chemother 2016;48(2) :118-126 www.icjournal.org 121 were identified during the outbreak in the Republic of Korea,  during which confirmatory tests were performed only for sus - pected cases.",Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.118  •  Infect Chemother 2016;48(2) :118-126 www.icjournal.org 123 At admission, 178 (95.7%) of the 186 patients underwent  one or more blood tests (Table 1) including complete blood  counts in 178 (95.7%), C-reactive protein (CRP) analyses in  168 (90.3%), and liver function and blood chemistry tests in  173 (93.0%).",Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.118  •  Infect Chemother 2016;48(2) :118-126 www.icjournal.org 125 ty-associated infections lacking any history of contact with  MERS-CoV were found in this outbreak.,Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
ORCID Yeon-Sook Kim  http://orcid.org/0000-0003-1142-5488 Jae-Phil Choi  http://orcid.org/0000-0003-4805-7930  References  1.,Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
Available at: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
Available at:  http://www.who.int/csr/disease/coronavirus infections/ en/.,Non-OADS,/arxiv_data1/oa_pdf/96/38/ic-48-118.PMC4945721.pdf
"Infection &  Chemotherapy Received:  August 1, 2014  Revised:  November 2, 2014  Accepted:  November 3, 2014 Corresponding Author : Seong-Yeol Ryu, MD Department of Infectious Disease, Keimyung University School of Medicine, 56 Dalseong- ro, Jung-gu, Daegu 41931, Korea  Tel: +82-53-250-7915, Fax: +82-53-250-7434 E-mail: 121rsy@dsmc.or.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/32/ic-48-127.PMC4945722.pdf
"Five years earlier, the patient was admitted to the hospital  because of this same symptom, and was diagnosed with KFD http://dx.doi.org/10.3947/ic.2016.48.2.127 Infect Chemother 2016;48(2):127-131 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Case Report",Non-OADS,/arxiv_data1/oa_pdf/8c/32/ic-48-127.PMC4945722.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.127  •  Infect Chemother 2016;48(2) :127-131 www.icjournal.org 129 was discharged from the hospital and was observed at the  outpatient clinic with continuation of HC for 4 months.,Non-OADS,/arxiv_data1/oa_pdf/8c/32/ic-48-127.PMC4945722.pdf
ORCID Miri Hyun  http://orcid.org/0000-0003-0062-342X Seong-Yeol Ryu  http://orcid.org/0000-0002-6023-8550 References   1.,Non-OADS,/arxiv_data1/oa_pdf/8c/32/ic-48-127.PMC4945722.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.127  •  Infect Chemother 2016;48(2) :127-131 www.icjournal.org 131 10.,Non-OADS,/arxiv_data1/oa_pdf/8c/32/ic-48-127.PMC4945722.pdf
"Infection &  Chemotherapy Received:  August 4, 2014  Revised:  November 18, 2014  Accepted:  November 19, 2014   Corresponding Author : Hee Jung Yoon, MD, Ph.D.  Division of Infectious Diseases, Seoul Metropolitan Government Seobuk Hospital, 49 Galhyeonro 7-gil, Eunpyeong-gu, Seoul 03433, KoreaTel: +82-42-611-3096, Fax: +82-42-611-3853E-mail: yhj822@naver.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/9e/ic-48-132.PMC4945723.pdf
He was treated with valganciclovir and the antiretroviral drugs zidovudine/lamivudine (ZDV/3TC) and lopinavir/ritonavir http://dx.doi.org/10.3947/ic.2016.48.2.132 Infect Chemother 2016;48(2):132-135ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Case Report,Non-OADS,/arxiv_data1/oa_pdf/96/9e/ic-48-132.PMC4945723.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.132  •  Infect Chemother 2016;48(2) :132-135 www.icjournal.org 133 (LPVr).,OADS,/arxiv_data1/oa_pdf/96/9e/ic-48-132.PMC4945723.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.132  •  Infect Chemother 2016;48(2) :132-135 www.icjournal.org 135 of an  infectious,  immunologic or idiopathic cause.",Non-OADS,/arxiv_data1/oa_pdf/96/9e/ic-48-132.PMC4945723.pdf
ORCID Hee Jung Yoon  http://orcid.org/0000-0001-9860-4774 References    1.,Non-OADS,/arxiv_data1/oa_pdf/96/9e/ic-48-132.PMC4945723.pdf
"Infection &  Chemotherapy Received:  August 26, 2014  Revised:  November 12, 2014  Accepted:  November 12, 2014   Corresponding Author : In-Gyu Bae, MD Department of Internal Medicine, Gyeongsang National University School of Medicine,  79 Gangnam-ro, Jinju 52727, Korea Tel: +82-55-750-8055 Fax: +82-55-758-9122 E-mail: ttezebae@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/ac/ic-48-136.PMC4945724.pdf
Her past medical http://dx.doi.org/10.3947/ic.2016.48.2.136 Infect Chemother 2016;48(2):136-139 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Case Report,Non-OADS,/arxiv_data1/oa_pdf/e8/ac/ic-48-136.PMC4945724.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.136  •  Infect Chemother 2016;48(2) :136-139 www.icjournal.org 137 history included 7 years of controlled type 2 diabetes mellitus  treated with oral hypoglycemic drugs.,Non-OADS,/arxiv_data1/oa_pdf/e8/ac/ic-48-136.PMC4945724.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.136  •  Infect Chemother 2016;48(2) :136-139 www.icjournal.org 139 sive infection and should be considered when this microbe is  isolated from blood cultures in patients with UTI, especially in  patients with urinary tract obstruction due to urinary stones  or pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/e8/ac/ic-48-136.PMC4945724.pdf
ORCID Jaehyung Hur  http://orcid.org/0000-0001-7556-1070  In-Gyu Bae  http://orcid.org/0000-0002-9929-2271 References    1.,Non-OADS,/arxiv_data1/oa_pdf/e8/ac/ic-48-136.PMC4945724.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.140 Infect Chemother 2016;48(2):140-142 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Hyuck Lee, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, Dong-A University  Hospital, 26 Daesingongwon-ro, Seo-gu, Busan 49201, Korea Tel: +82-51-240-5047, Fax: +82-51-243-5047  E-mail: hleeid@dau.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/7a/ic-48-140.PMC4945725.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.140  •  Infect Chemother 2016;48(2) :140-142 www.icjournal.org 141 of drug dose establishment, which is aimed at optimizing the  clinical outcomes [3].",Non-OADS,/arxiv_data1/oa_pdf/7a/7a/ic-48-140.PMC4945725.pdf
ORCID Hyuck Lee  http://orcid.org/0000-0002-4115-0748 References     1.,Non-OADS,/arxiv_data1/oa_pdf/7a/7a/ic-48-140.PMC4945725.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.143 Infect Chemother 2016;48(2):143-144 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Young Ah Kim, MD Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital,  100 Ilsan-ro, Ilsan-donggu, Goyang 10444, Korea Tel: +82-31-900-0908, Fax: +82-31-900-0925 E-mail: yakim@nhimc.or.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/d1/ic-48-143.PMC4945726.pdf
ORCID Young Ah Kim  http://orcid.org/0000-0002-9624-0126References   1.,Non-OADS,/arxiv_data1/oa_pdf/2c/d1/ic-48-143.PMC4945726.pdf
Available: http://www.trekds.com/products/sensititre/c_ pltformats.asp.,Non-OADS,/arxiv_data1/oa_pdf/2c/d1/ic-48-143.PMC4945726.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.145 Infect Chemother 2016;48(2):145-146 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Myoung-don Oh, MD Department of Internal Medicine, Seoul National University College of Medicine, 101  Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-2945, Fax: 82-2-762-9662  E-mail: mdohmd@snu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/06/ic-48-145.PMC4945727.pdf
ORCID Myoung-don Oh http://orcid.org/0000-0002-2344-7695References   1.,Non-OADS,/arxiv_data1/oa_pdf/69/06/ic-48-145.PMC4945727.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.147 Infect Chemother 2016;48(2):147-149 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Byung Chul Chun, MD, PhD Department of Preventive Medicine, Korea University College of Medicine,  73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea Tel: +82-2-2286-1169, Fax: +82-2-927-7220 E-mail: chun@korea.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/7b/ic-48-147.PMC4945728.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.147  •  Infect Chemother 2016;48(2) :147-149 www.icjournal.org 149 terventions such as advising an entire population to reduce  the behaviors associated with transmission [7, 11].",Non-OADS,/arxiv_data1/oa_pdf/d2/7b/ic-48-147.PMC4945728.pdf
ORCID Byung Chul Chun  http://orcid.org/0000-0001-6576-8916 Reference   1.,Non-OADS,/arxiv_data1/oa_pdf/d2/7b/ic-48-147.PMC4945728.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.71 Infect Chemother 2016;48(2):71-74 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received:  June 19, 2016 Corresponding Author : Woo Joo Kim, MD, PhD Division of Infectious Disease, Department of Internal Medicine,  Korea University  College of Medicine, Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308,  Korea  Tel: +82-2-2626-3051, Fax: +82-2-2626-1105 E-mail: wjkim@korea.ac.kr  * The Rapid response team: Hee Jung Yoon, Jun Yong Choi, Tae Hyong Kim, Young Hwa Choi, Hong Bin Kim,  Ji Hyun Yoon, Jacob Lee, Joong Sik Eom, Joon Young Song, Sang-Oh Lee, Won Sup Oh, HeeJin Cheong,  Young Goo Song, Jung Hyun Choi, and Woo Joo Kim.",Non-OADS,/arxiv_data1/oa_pdf/af/3f/ic-48-71.PMC4945729.pdf
"This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/3f/ic-48-71.PMC4945729.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.71  •  Infect Chemother 2016;48(2):7 1-74 www.icjournal.org 73 1) A hospital On June 2nd, after discovering the 16th patient on the 5th  floor, all patients exposed by the 16th patient was isolated in  the cohort room on the 5th floor.",Non-OADS,/arxiv_data1/oa_pdf/af/3f/ic-48-71.PMC4945729.pdf
ORCID Jacob Lee  http://orcid.org/0000-0002-7041-065X Woo Joo Kim  http://orcid.org/0000-0002-4546-3880  References   1.,Non-OADS,/arxiv_data1/oa_pdf/af/3f/ic-48-71.PMC4945729.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.75 Infect Chemother 2016;48(2):75-80 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: June 23, 2016 Corresponding Author : Tae Hyong Kim, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang  University Seoul Hospital, Soonchunhyang University College of Medicine, 59 Dae - sagwan-ro, Yongsan-gu, Seoul 04401, Korea Tel: +82-2-709-9194, Fax: +82-2-709-9083 E-mail: geuncom@schmc.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/31/ic-48-75.PMC4945730.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.75  •  Infect Chemother 2016;48(2):7 5-80 www.icjournal.org 77 relatively few secondary infections.,Non-OADS,/arxiv_data1/oa_pdf/49/31/ic-48-75.PMC4945730.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.75  •  Infect Chemother 2016;48(2):7 5-80 www.icjournal.org 79 4.,Non-OADS,/arxiv_data1/oa_pdf/49/31/ic-48-75.PMC4945730.pdf
ORCID Min Huok Jeon  http://orcid.org/0000-0002-9452-4379 Tae Hyong Kim  http://orcid.org/0000-0003-2920-9038 Reference   1.,Non-OADS,/arxiv_data1/oa_pdf/49/31/ic-48-75.PMC4945730.pdf
Avail - able at: http://www.healthmaporg/site/diseasedaily/arti - cle/mers-outbreak-south-korea-6715.,Non-OADS,/arxiv_data1/oa_pdf/49/31/ic-48-75.PMC4945730.pdf
Available at: http://www.nih.go.kr/CDC/cms/ cmsFileDownload.jsp?fid=22&cid=65345&fieldName=at - tach1&index=1.,OADS,/arxiv_data1/oa_pdf/49/31/ic-48-75.PMC4945730.pdf
Available at: http://www.laborplus.co.kr/ news/articleView.html?idxno=9945.,Non-OADS,/arxiv_data1/oa_pdf/49/31/ic-48-75.PMC4945730.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.81 Infect Chemother 2016;48(2):81-90 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: February 1, 2016  Revised:  March 21, 2016  Accepted: March 22, 2016 Corresponding Author : Ali El Solh, MD, MPH Medical Research, Bldg.",Non-OADS,/arxiv_data1/oa_pdf/41/bb/ic-48-81.PMC4945731.pdf
"20 (151) VISN02, VA Western New York Healthcare System,  3495 Bailey Avenue, Buffalo, NY 14215-1199, USA Tel: +716-862-7392, Fax: +716-862-6525  E-mail: pea@buffalo.edu This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/bb/ic-48-81.PMC4945731.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.81  •  Infect Chemother 2016;48(2):8 1-90 www.icjournal.org 83 agents and clinical and microbiological outcomes, emergence  of resistance, adverse events and mortality.",Non-OADS,/arxiv_data1/oa_pdf/41/bb/ic-48-81.PMC4945731.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.81  •  Infect Chemother 2016;48(2):8 1-90 www.icjournal.org 85 schedule for each study.,Non-OADS,/arxiv_data1/oa_pdf/41/bb/ic-48-81.PMC4945731.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.81  •  Infect Chemother 2016;48(2):8 1-90 www.icjournal.org 87 tinuous infusion was associated with higher eradication rate  and lower bacterial persistence in comparison with higher in - termittent dosage without difference in the rate of resistance,  colonization, or superinfection.",Non-OADS,/arxiv_data1/oa_pdf/41/bb/ic-48-81.PMC4945731.pdf
ORCID Ali A. El-Solh  http://orcid.org/0000-0003-4237-8776 References    1.,Non-OADS,/arxiv_data1/oa_pdf/41/bb/ic-48-81.PMC4945731.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.81  •  Infect Chemother 2016;48(2):8 1-90 www.icjournal.org 89 nonrandomized, open-label, historical chart review.",OADS,/arxiv_data1/oa_pdf/41/bb/ic-48-81.PMC4945731.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.91 Infect Chemother 2016;48(2):91-98ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: February 19, 2016,  Revised:  April 12, 2016,  Accepted: April 15, 2016 Corresponding Author : Kyungwon Lee, MD, PhD Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine,  50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2228-2446, Fax: +82-2-313-0956 E-mail: leekcp@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/69/ic-48-91.PMC4945732.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.91  •  Infect Chemother 2016;48(2):9 1-98 www.icjournal.org 93 4.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/ic-48-91.PMC4945732.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.91  •  Infect Chemother 2016;48(2):9 1-98 www.icjournal.org 95 4.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/ic-48-91.PMC4945732.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.91  •  Infect Chemother 2016;48(2):9 1-98 www.icjournal.org 97 most frequently recovered organism with predictable suscep - tibility patterns.,OADS,/arxiv_data1/oa_pdf/aa/69/ic-48-91.PMC4945732.pdf
ORCID Kyungwon Lee  http://orcid.org/0000-0003-3788-2134 Jieun Kim  http://orcid.org/0000-0002-6498-5801 References   1.,Non-OADS,/arxiv_data1/oa_pdf/aa/69/ic-48-91.PMC4945732.pdf
Available at: https://www.kihasa.re.kr/web/pub -,Non-OADS,/arxiv_data1/oa_pdf/aa/69/ic-48-91.PMC4945732.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.2.99 Infect Chemother 2016;48(2):99-107 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: March 12 , 2016   Revised:  April 20, 2016  Accepted: April 27, 2016 Corresponding Author : Yeon-Sook Kim, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, Chungnam National  University School of Medicine, Munhwa-ro 282, Jung-gu, Daejeon 35015, Korea Tel: +82-42-280-8109, Fax: +82-42-257-5753  E-mail: alice@cnuh.co.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.99  •  Infect Chemother 2016;48(2):9 9-107 www.icjournal.org 101 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.99  •  Infect Chemother 2016;48(2):9 9-107 www.icjournal.org 103 utes).,OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.2.99  •  Infect Chemother 2016;48(2):9 9-107 www.icjournal.org 105 ers returning from the Middle East, and infection control prac - tices be properly implemented for patients with respiratory  infections.",Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
ORCID Sun Hee Park  http://orcid.org/0000-0001-5648-9237 Yeon-Sook Kim  http://orcid.org/0000-0003-1142-5488 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
"• Hospital outbreaks of MERS in Daejeon, Korea www.icjournal.org 106 Younghee Jung  http://orcid.org/0000-0002-9034-7635 Soo young Choi  http://orcid.org/0000-0001-5541-4479 Nam-Hyuk Cho  http://orcid.org/0000-0003-3673-6397 Hye Won Jeong  http://orcid.org/0000-0002-1063-8476 Jung Yeon Heo  http://orcid.org/0000-0002-6548-1939 Ji Hyun Yoon  http://orcid.org/0000-0001-7523-2699 Jacob Lee  http://orcid.org/0000-0002-7041-065X Shinhye Cheon  http://orcid.org/0000-0002-1783-121X Kyung Mok Sohn  http://orcid.org/0000-0002-3237-044X Supplementary material Supplementary data including two tables and two figures  can be foundwith this article online http://www.icjournal.org/ src/sm/ic-48-99-s001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
Available  at: http://www.mers.go.kr/mers/html/jsp/Menu_C/list_ C4.jsp?menuIds=&fid=5767&q_type=&q_value=&cid=  65327&pageNum=1.,OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
Available  at: http://www.mers.go.kr/mers/html/jsp/Menu_C/list_ C1.jsp.,Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
Available  at: http://www.who.int/csr/disease/coronavirus_infec - tions/WHO_interim_recommendations_lab_detection_ MERSCoV_092014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
Available at: http://cdc.go.kr/CDC/info/CdcK - rHealth0295.jsp?menuIds=HOME001-MNU1132- MNU1013-MNU1509-MNU1915&fid=5747&q_type=&q_ value=&cid=63292&pageNum=.,OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
  http://dx.doi.org/10.3947/ic.2016.48.2.99  •  Infect Chemother 2016;48(2):9 9-107 www.icjournal.org 107 6.0.,OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d0/ca/ic-48-99.PMC4945733.pdf
We also present the top 20 rankedReceived: 22 July 2015 Revised: 12 October 2015 Accepted: 27 October 2015 Heliyon (2015) e00044 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
In this manuscript we combine data from an expert elicitation process with Article No~e00044 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"With so many islandsand a limited budget for management, prioritising management actions, Article No~e00044 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Initial weed lists for Parks and Article No~e00044 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Barrow island).Parks and Wildlife tenure data Article No~e00044 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Kendall's tau results (0.56 –0.68) revealed that island rank Article No~e00044 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Ranked variable Weighted variable Assigned weight % changed rank tau z p-value Scenario 1 Equal weight for all decision criteria 0.5 –– – – Conservation value ΔScenario 1 to 38.6 0.95 34.7 <0.001 Maximum representation 0.1 Effective maximum rarity 0.9 ΔScenario 1 to 40.3 0.98 35.8 <0.001 Maximum representation 0.9 Effective maximum rarity 0.1 Logistics score ΔScenario 1 to 97.9 0.68 24.8 <0.001 Island area 0.9 Ruggedness 0.1 Travel 0.1 Tenure 0.1 ΔScenario 1 to 99.3 0.56 20.5 <0.001 Island area 0.1 Ruggedness 0.9 Travel 0.1 Tenure 0.1 Scenario 3 ΔScenario 1 to 98.5 0.6 21.8 <0.001 Island area 0.1 Ruggedness 0.1 Travel 0.9 Tenure 0.1 ΔScenario 1 to 99.3 0.62 22.7 <0.001 Island area 0.1 Ruggedness 0.1 Travel 0.1 Tenure 0.9 (Continued ) Article No~e00044 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
(Continued ) Ranked variable Weighted variable Assigned weight % changed rank tau z p-value Island Rank Scenario 4 ΔScenario 1 to 98.5 0.64 23.4 <0.001 Conservation value 0.9Logistics Score 0.1 ΔScenario 1 to 100 0.49 17.8 <0.001 Conservation value 0.1 Logistics Score 0.9 Ranked island-weed combinationsΔScenario 1 to 80.6 0.94 19.6 <0.001 Island 0.1 Weed 0.9 ΔScenario 1 to 99.5 0.68 14.3 <0.001 Island 0.9 Weed 0.1 Article No~e00044 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Rank Scenario 1 –Equal weight Scenario 2 –Sum Scenario 3 –Travel Scenario 4 –Conservation value 1 West Lewis South - Aerva javanica Thevenard West Lewis South - Aerva javanica West Lewis South - Aerva javanica 2 West Lewis South - Opuntia stricta West Lewis South West Lewis South - Opuntia stricta West Lewis South - Opuntia stricta 3 East Lewis - Aerva javanica Varanus East Lewis - Aerva javanica West Lewis South - Cenchrus ciliaris 4 East Lewis - Opuntia stricta Angel East Lewis - Opuntia stricta West Lewis South - Flaveria trinervia 5 Doole - Aerva javanica Rosemary Doole - Aerva javanica West Lewis South - Malvastrum americanum 6 Hermite - Aerva javanica Legendre Dolphin - Aerva javanica East Lewis - Aerva javanica 7 Alpha - Aerva javanica Hermite Enderby - Aerva javanica East Lewis - Opuntia stricta 8 Enderby - Aerva javanica East Lewis Dixon - Aerva javanica East Lewis - Cenchrus ciliaris 9 Dolphin - Aerva javanica Barrow Angel - Aerva javanica Hermite - Aerva javanica 10 Delambre - Aerva javanica North Muiron Angel - Passiflora foetida Serrurier - Cenchrus ciliaris 11 Potter - Aerva javanica South Muiron Hermite - Aerva javanica Serrurier - Flaveria trinervia 12 Gidley - Aerva javanica Dolphin Delambre - Aerva javanica Doole - Aerva javanica 13 Rosemary - Phoenix dactylifera Jarman Gidley - Aerva javanica North West - Flaveria trinervia 14 Rosemary - Tamarix aphylla Enderby Rosemary - Phoenix dactylifera Trimouille - Flaveria trinervia 15 Angel - Aerva javanica Boodie Rosemary - Tamarix aphylla Hermite - Cenchrus ciliaris 16 Angel - Passiflora foetida Airlie Alpha - Aerva javanica Hermite - Flaveria trinervia 17 Dixon - Aerva javanica Alpha Malus Large - Aerva javanica Hermite - Malvastrum americanum 18 Malus Large - Aerva javanica West Moore Finucane - Aerva javanica Alpha - Aerva javanica 19 Finucane - Aerva javanica Serrurier Potter - Aerva javanica Boodie - Cenchrus ciliaris 20 Fortescue - Aerva javanica Potter Legendre - Aerva javanica Boodie - Malvastrum americanum Article No~e00044 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
By Article No~e00044 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"Kleynhans, A. Symes, J. Chanson, M. Hoffman, Global indicators of biological Article No~e00044 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"Weed prioritisation process, Department of Parks and Wildlife, Western Australia, 2013. accessed 21.05.14 http://www.dpaw.wa.gov.au/plants-and-animals/ plants/weeds/156-how-does-dpaw-manage-weeds .",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"[23] Department of Agriculture and Food, Western Australian Organism List (WAOL), at https://www.agric.wa.gov.au/bam/western-australian-organism- list-waol , (2014), accessed 30.01.15.",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"[24] Global Invasive Species Database, 100 of the world's worst invasive alien species, at http://www.issg.org/database/species/search.asp?st=100ss , (2005), accessed 30.10.15.",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"[28] Australian National Herbarium, Australian Plant Name Index –APNI, at http://www.anbg.gov.au/apni/ , (2014), accessed 30.01.15.",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"[31] K. Bettink, G. Keighery, Environmental Weed Census and Prioritisation, Swan NRM Region, 2008. accessed 23.10.15 http://www.dpaw.wa.gov.au/ images/documents/conservation-management/off-road-conservation/urban-nature/reports/swan_environmental_weed_assessment_2008_summary.pdf .",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
"Robertson, L. Stafford, Article No~e00044 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
Article No~e00044 22 http://dx.doi.org/10.1016/j.heliyon.2015.e00044 2405-8440/Crown Copyright © 2015 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC4945735.pdf
The thick plaques of composites exhibited oxo-degradation in the presence of pro-oxidant with silica and silicate composites with 2.5 wt% additive having 100 % degree of embrittlement in 15 –16 months at 30 °C.Received: 20 July 2015 Revised: 11 October 2015 Accepted: 16 November 2015 Heliyon (2015) e00050 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Mn-stearate was the pro-oxidant Article No~e00050 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
The masterbatch contained a proprietary metal ion based Article No~e00050 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
"4 a, both blends exhibited semi-circular shape indicating the miscible phase morphology in the blends, Article No~e00050 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
"Polymer/Nanocomposite Peak melting point, Tm[°C]Peak crystallization temperature, Tc[°C]Enthalpy, ΔH [J/g] Additive 120 90 102 Pure PE 138 117 147 PE + 1 % additive 138 117 158 PE + 2.5 % additive 137 116 160 PE + 1 % additive + 5 % silica 138 116 160PE + 2.5 % additive + 5 % silica 140 115 161 PE + 1 % additive + 5 % silicate 136 116 162 PE + 2.5 % additive + 5 % silicate 137 115 166 PE + 1 % additive + 5 % graphene 138 115 164 PE + 2.5 % additive + 5 % graphene 137 115 169 Article No~e00050 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
"[25] Wells Plastics, Oxo-biodegradable additive masterbatches (online), Available from: http://www.wellsplastics.com/httdocs/resources/ Wells_Reverte_Brochure.pdf (2014) (Accessed: 25.04.14).",Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
Article No~e00050 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00050 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/main.PMC4945736.pdf
"Keywords: Protein modification, Proteins, Visible spectrophotometry, Electrochemistry, Spectroscopy, Chemistry, Analytical chemistry, Biochemistry, VoltammetryReceived: 1 September 2015 Revised: 5 November 2015 Accepted: 7 December 2015 Heliyon (2015) e00053 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
The tetrabutylammonium salts of Article No~e00053 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
"Electrochemical A three-electrode cell consisting of glassy carbon working electrode, Ag/AgCl reference electrode (containing 1 M KCl as internal electrolyte) and gold-wire Article No~e00053 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Size-exclusion chromatography BSA and BSA-Tpp samples containing 40 μg of protein were suspended in 25 mM phosphate buffer (pH 6.8) and centrifuged at 10 000 × g.The supernatant was Article No~e00053 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This reflects the increase of the interaction strength between the anion Article No~e00053 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
"Differential pulse voltammograms representing oxidation of 0.1 mM Tpp obtained on glassy carbon electrode in DMSO solution containing various supporting electrolytes, all at theconcentration of 0.01 M. Article No~e00053 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
"Optical characterization We assessed the influence of proteins on optical properties oftetraphenylporphyrin, reflected in shifts of the absorption or fluorescence Article No~e00053 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
6 A demonstrates the gel Article No~e00053 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
The application of more than one detection technique contributesto the improvement of the reliability of the analysis and broadening of the range Article No~e00053 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
"Yin, Electrochemiluminescent biosensor of ATP using tetrahedron structured DNA and a functional oligonucleotide Article No~e00053 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
Article No~e00053 22 http://dx.doi.org/10.1016/j.heliyon.2015.e00053 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/16/main.PMC4945755.pdf
http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
These elements  provide the HRP’s knowledge and capabilities  to  2 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
Controlling for current  employment  status   3 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"The  most recent report [24] on cancer  SMR  in the LSAH  for 1980–2009 still indicates   much lower  risk of cancer  among astronauts  (SMR=0.47, 95% CI: 0.19–0.97)   4 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
Type of WorkerAll causesAll cancersBuccal cavityEsophagusStomachColonRectumLiverPancreasRespiratoryLarynxLungBoneMelanomaNon-melanomaFemale breastProstateBladderKidneyCNSThyroidNon-Hodgkin’sHodgkin’sMultiple myelomaLeukemia US Astronauts [24] 0.59 0.37 Aircrew [25] 0.56 0.69 0.27 0.5 0.57 0.92 0.83 0.96 0.84 0.83 0.69 0.43 1.57 0.93 1.23 0.74 0.77 1.14 1.060.66 0.67 1.14 0.91 Aircrew-female [26] 0.8 0.78 0.83 0.65 0.58 0.63 0.46 0.82 0.36 1.11 0.67 0.82 1.49 0.99 Aircrew-male [26] 1.09 0.9 1.7 1.11 0.46 0.71 0.72 0.61 1.44 0.75 1.93 9.67 1.09 1.59 0.94 2.28 1.32 Aircrew [27] 0.64 0.68 0.54 0.58 0.48 1.07 0.8 0.86 0.85 0.63 0.53 1.78 0.94 0.59 1.2 1.480.71 0.86 1.05 Aircrew [28] 0.63 0.61 0.86 0.57 1.23 0.25 1.49 1.52 1.22 1.42 0.62 0.86 Aircrew-female [29] 0.79 0.79 0.73 0.75 0.86 0.57 1.28 0.82 1.66 2.15 0.79 Aircrew-male [29] 1.1 0.71 1.97 0.63 1.04 1.26 1.62 0.77 2.41 0.78 Aircrew [30] 0.32 1.29 0.6 Aircrew [30] 0.39 0.67 0.27 Cockpit [31] 0.49 0.64 0.68 0.85 0.5 1.28 0.33 0.98 0.96 0.79 2.13 1.27 0.61 Cabin-female [31] 0.83 0.95 0.91 1.18 1.09 1.17 1.07 1.17 1.18 1.19 0.88 Cabin-male [31] 1.03 0.89 1.41 0.31 0.63 1.02 1.53 0.74 1.42 4.24 1.55 Cockpit-male [32] 0.48 0.56 0.16 0.46 0.57 0.8 0.6 0.7 1.16 0.87 0.29 0.47 1.26 0.52 0.49 1.68 1.60.68 0.69 Cockpit-male [33] 0.7 0.6 2.4 0.9 5.9 1.2 0.8 0.1 4 1 1.8 0.9 Nuclear fuels [34] 0.91 0.93 0.86 1 1.02 0.93 1.09 0.83 0.82 0.93 0.86 0.88 0.64 0.88 0.86 0.84 0.9 0.82 0.87 0.91 1.140.85 1.09 0.95 0.91 Nuclear fuels [35] 0.55 0.7 0.56 0.53 1.48 0.44 0.99 0.62 0.55 1.08 0.46 0.76 0.84 1.32 1.06 0.96 Nuclear power [36] 0.41 0.65 0.81 0.75 0.62 1.19 0.6 0.79 0.85 0.63 1.07 Nuclear power [37] 0.5 0.65 0.49 0.7 0.93 0.59 0.64 0.74 1.23 Nuclear power [38] 0.59 0.73 0.37 0.63 0.85 0.88 0.57 0.69 0.6 2.41 1.27 0.87 0.63 1.15 1.12 0.7 1.56 1.57 0.7 Nuclear power [39] 0.7 0.96 0.8 0.93 0.72 0.74 0.89 1 0.7 0.6 1.221.07 0.71 0.83 1.23 Nuclear power [40] 0.54 0.65 0.37 0.67 0.72 0.72 0.4 1.1 0.38 0.59 0.8 0.33 0.65 1.71 0.26 Nuclear weapons-no lag [41] 0.22 0.81 0.98 1.27 2.1 1.23 1.5 0.91 0.84 2.19 1.36 1.9 0.69 1.71 0.32 7.40.53 0.57 0.62 0.42 Nuclear weapons-10 yr lag [41] 0.31 1.03 1.01 0.92 2.09 1.37 1.24 0.92 0.84 1.36 1.51 2.23 0.7 2.39 0 11.050.9 0.5 0.97 0.38 Nuclear weapons [42] 0.9 0.97 0.1 0.6 0.91 0.92 0.96 0.92 0.63 0.91 0.39 1.11 1.01 0.87 0.85 1.08 0.62 0.90.97 0.56 1.15 0.77 Nuclear power/weapons [43] 0.99 0.98 1.03 1 0.98 0.95 0.99 0.98 0.96 0.98 0.99 1.06 1.04 0.630.95 1.04 1.1 Nuclear weapons (ORNL) [44] 0.82 1.41 1.08 1.11 0.71 0.91 0.92 1.11 1 0.88 1.07 0.96 0.94 0.85 0.91 Nuclear weapons (SR) [44] 0.51 0.75 0.69 0.84 0.63 0.84 0.5 0.67 0.87 0.88 0.76 1.15 0.9 0.98 0.78 1.02 Nuclear weapons (HAN) [44] 0.64 0.78 0.77 0.88 0.85 0.94 0.41 0.82 0.62 1.03 1.09 0.83 0.82 0.98 1.110.99 1.02 0.8 Nuclear weapons (IDS) [44] 0.74 0.57 0.59 0.86 0.65 0.91 0.43 0.88 0.85 1.02 0.84 0.68 1.02 0.91 0.78 1.1 Nuclear weapons [44] 0.49 0.69 0.77 0.71 0.63 0.87 0.58 0.67 0.76 1.06 0.84 0.88 0.94 1.141.07 0.74 0.9 Chernobyl (nonexposed) [45] 0.83 0.74 0.96 0.59 0.94 0.71 0.82 0.82 0.51 0.85 0 1.17 1 0.82 0.77 1.08 0.67 0.91.14 0.84 1.2 0.76 Chernobyl (combined) [45] 1.06 1.48 1.45 0.6 0.85 1.33 1.28 1.12 0.92 1.05 1.1 0.95 1.03 1 1.02 1.08 0.51 0.90.58 0 1.06 0.8 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
6 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"The rate of incidence or mortality,   speciﬁc to age, gender,  and other explanatory variables,  is represented  by models  of  two forms: 𝜆(𝑑,𝑎,𝑡,𝐳)=𝜆(𝑎,𝑡,𝐳)+𝜖(𝑑,𝑎,𝑡), (1) 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Regression coeﬃcients  were derived using Poisson   regression,  for which the gradient  update vector  at each iteration was determined  with the matrix  cross-product Δ̂𝜷=(𝐙T𝐖𝐙)−1𝐙T𝐖𝐲, (5) where  the data matrix  elements 𝑧𝑗𝑘=𝑛𝑗𝑘𝜕𝑔(𝐱∗ 𝑗𝑘;𝜷∗) 𝜕𝜷∗(6) 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Putting together  the  previously  deﬁned parameters,  we have for the EAR model 𝑔(𝐱∗ 𝑗𝑘;𝜷∗)=baseline risk +excess absolute risk =̂𝜆𝑗+𝜖(𝑑,𝑎,𝑡) =̂𝜆𝑗+̂𝜆𝑗𝑘 =e x p { 𝜷𝑇;𝐱}+𝛽𝑘𝑥𝐷exp{𝛽𝑎𝑥30+𝛽𝑡𝑥70}, (11) 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Models  were  assumed to ﬁt if ∑𝑟𝐷was less than the corresponding  d.f., since ∑𝑟𝑃is more  10 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"In one sense,  we are applying radiation  risk  coeﬃcients  obtained from the follow-up of a bona ﬁde exposed cohort to the  sur vival of a theoretically exposed population whose mortality increases   11 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Finally,  th e  hazard  function for radiation-induced cancer  at age 𝑡from exposure   at age 𝑎for the excess  relative  risk (ERR) model is based on the product of the  excess  relative  risk coeﬃcient,  𝜌(𝑑, 𝑎, 𝑡), and the baseline cancer  rate given as 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
13 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"When 𝑛 =1 year, we now have 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
(41) 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
16 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
17 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Random  quantiles  for the number  of cases  (deaths)𝑐(𝑡)(𝑡 =1, 2, … , 100) in each 1-year   18 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
(47) 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
After   20 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Outputs  for the median and 5t h and 95th percentiles  of ELR, PC, and  BLR are provided for the EAR, ERR(EAR), and ERR models  as well as a mixture   model (“MIX”)  where  all 30,000 quantiles  from EAR, ERR(EAR), and ERR  models  were combined,  sorted in ascending  order,  and listed in the form of the  21 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
22 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
The majority of Poisson  regression models   23 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
24 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
The integral product ∫𝑆(𝑡)ℎ𝑐(𝑡)𝑑𝑡based on the rate ℎ𝑐(𝑡)for  nonleukemia was 0.526 without HWE correction and 0.816 with correction for  25 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
26 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
7 reﬂects  the  uncertainties  in ELR of mortality for all cancers  except leukemia (“nonleukemia”)   27 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
9 reﬂects  the uncertainties  in ELR of  28 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
29 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
30 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"As an example,  regarding  th e LSS cancer  mortality data for solid cancers, 88.7%  (47,692/53,782) of the person-year  cross-tabulation table cells (records) have zero deaths,  while for  31 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Several studies  were updates  of previous  investigations,  or novel pooled  studies  of multiple  cohorts,  and therefore the published SMR  values  from those   32 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"698(15.389,27.666) 33 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
34 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"865(0.569,1.157) 35 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
36 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"When compared  with all-cause SMRs,  cancer-speciﬁc SMRs are more sensitive to the constellation  37 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This would reduce the number  of SMR  values  available  38 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
39 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Rather,  our approach is one that implemented  40 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Our investigation attempted  to address the eﬀects  of study replication by  using the majority of published SMR  values  for aviator  and nuclear  worker  studies,   41 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Since lifetime risks of radiation-induced cancer  are  commonly presented in units of risk/Sv,  we did not focus  on historical or future   dosimetry issues  related  to ﬂight (mission) planning  in order  to project  risks for  42 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
43 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
44 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"[11] Human R esearch  Program,  US National Aeronautics  and Space  Administration,  Washington,  USA,  http://www.nasa.gov/hrp , June 1,  2015.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
45 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
46 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
47 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
48 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"[53] Radiation Eﬀects  R esearch  Foundation,  Hiroshima,  Japan,   http://www.rerf.jp/index_e.html , February 28,  2015.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Moriyama,  M. Asano,  L. Guralnick,  RERF  Pathology  Studies,  Hiroshima and Nagasaki,  Report 4,  Autopsy  program and the life  49 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"[65] US N ational Center  for Health Statistics, Atlanta,  USA,   http://www.cdc.gov/nchs/products/life_tables.htm , July 21,  2015.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"[66] US Centers  fo r Disease Control and Prevention,  CDC WONDER, Atlanta,   USA,  http://wonder.cdc.gov/ , July 21,  2015.",Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
50 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
51 http://dx.doi.org/10.1016/j.heliyon.2015.e00048 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/6b/main.PMC4945756.pdf
"Abbreviations C a t G ,c a t h e p s i nG ;D P P 1 ,d i p e p t i d y lp e p t i d a s e1 ;N E ,n e u t r o p hil elastase; NSP, neutrophil serine protease; PPB, plasma protein binding; PR3, proteinase 3 Table of Links TARGETS Enzymes DPP1 Cathepsin G Neutrophil elastase Proteinase 3 This Table lists key protein targets in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the com mon portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016), and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (Alexander et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/dc/34/BPH-173-2390.PMC4945769.pdf
"Available from: http://www.who.int/gho/ncd/mortality_morbidity/en  [14 November 2015];2015 [2] Bloom  DE,  Cafiero  ET,  Jané-Llopis  E,  et  al.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1038/nrcardio.2014.26 ] [PMID: 24663092 ] [4] Mack M, Gopal A.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.ccl.2014.04.003 ] [PMID: 25091961 ] [5] Mozaffarian D, Benjamin EJ, Go AS, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1161/CIR.0000000000000152 ] [PMID: 25520374 ] [6] Kim HJ, Kim Y, Cho Y, Jun B, Oh KW.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.ijcard.2014.03.163 ] [PMID: 24742812 ] [7] Gikas A, Sotiropoulos A, Panagiotakos D, Pastromas V, Papazafiropoulou A, Pappas S. Prevalence trends for myocardial infarction and conventional risk factors among Greek adults (2002-06).",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
[http://dx.doi.org/10.1093/qjmed/hcn076 ] [PMID: 18603596 ],Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.puhe.2014.08.007 ] [PMID: 25369358 ] [9] Panagiotakos DB, Georgousopoulou EN, Pitsavos C, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.ijcard.2014.11.206 ] [PMID: 25463360 ] [10] Gößwald A, Schienkiewitz A, Nowossadeck E, Busch MA.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1186/1471-2458-4-2 ] [PMID: 15028111 ] [13] Gikas A, Sotiropoulos A, Panagiotakos D, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.diabres.2007.09.002 ] [PMID: 17936397 ] [14] Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1001/jama.285.19.2486 ] [PMID: 11368702 ] [15] Prevalence of coronary heart disease--United States, 2006-2010.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.2174/1874192401206010141 ] [PMID: 23230452 ] [18] Koloverou E, Panagiotakos DB, Pitsavos C, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1900/RDS.2014.11.181 ] [PMID: 25396406 ] [19] Eschwege E, Basdevant A, Crine A, Moisan C, Charles MA.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.diabet.2014.11.007 ] [PMID: 25544682 ] [20] Costanian C, Bennett K, Hwalla N, Assaad S, Sibai AM.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.diabres.2014.06.005 ] [PMID: 25005850 ] [21] Satman I, Omer B, Tutuncu Y, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1007/s10654-013-9771-5 ] [PMID: 23407904 ] [22] Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.ijcard.2008.11.033 ] [PMID: 19081646 ] [23] Muntner P, Levitan EB, Brown TM, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2013.04.041 ] [PMID: 23726177 ] [24] Filippidis FT, Vardavas CI, Loukopoulou A, Behrakis P, Connolly GN, Tountas Y.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1093/eurpub/cks148 ] [PMID: 23115328 ] [25] Schoretsaniti S, Filippidis FT, Vardavas CI, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.addbeh.2013.09.015 ] [PMID: 24126207 ] [26] Ifanti AA, Argyriou AA, Kalofonou FH, Kalofonos HP.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
[http://dx.doi.org/10.1016/j.healthpol.2013.05.017 ] [PMID: 23790265 ],Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1056/NEJM200012143432406 ] [PMID: 11114317 ] [28] Kilgore EA, Mandel-Ricci J, Johns M, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.2105/AJPH.2014.301940 ] [PMID: 24825232 ] [29] Tzormpatzakis N, Sleap M. Participation in physical activity and exercise in Greece: a systematic literature review.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1007/s00038-007-6118-6 ] [PMID: 18368999 ] [30] Pitsavos C, Panagiotakos DB, Chrysohoou C, Stefanadis C. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1186/1471-2458-3-32 ] [PMID: 14567760 ] [31] Tucker P, Gilliland J.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.puhe.2007.04.009 ] [PMID: 17920646 ] [32] Filippidis FT, Schoretsaniti S, Dimitrakaki C, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1093/eurpub/cku028 ] [PMID: 24614651 ] [33] Moulopoulos S, Adamopoulos P, Anthopoulos L. The prevalence of coronary heart disease and its risk factors in a representative sample of adult inhabitants of Athens (in Greek, abstract in English).",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
Available  from: http://dlib.statistics.gr/portal/page/portal/ESYE/categoryyears?p_cat=10007369&p_topic=10008001  and  http://www.statistics.gr/  statistics/- /publication/SHE12/  [14 November 2015]; 2015.,OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1586/14737167.2014.859526 ] [PMID: 24308449 ] [39] Salomaa V, Ketonen M, Koukkunen H, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/S0195-668X(02)00421-9 ] [PMID: 12581678 ] [40] Lampe FC, Morris RW, Walker M, Shaper AG, Whincup PH.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1161/JAHA.114.001097 ] [PMID: 25472744 ] [42] Berg J, Björck L, Lappas G, O’Flaherty M, Capewell S, Rosengren A.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1186/1471-2261-14-9 ] [PMID: 24447603 ] [43] Menotti A, Lanti M, Kromhout D, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1007/s10654-007-9176-4 ] [PMID: 17823844 ] [44] Pietinen P, Vartiainen E, Seppänen R, Aro A, Puska P. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1006/pmed.1996.0053 ] [PMID: 8781001 ] [45] Yusuf S, Hawken S, Ounpuu S, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/S0140-6736(04)17018-9 ] [PMID: 15364185 ] [46] Rigotti NA, Pasternak RC.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
[http://dx.doi.org/10.1016/S0733-8651(05)70260-5 ] [PMID: 9072291 ],OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.ijcard.2004.08.040 ] [PMID: 15823631 ] [48] Rogerson MC, Murphy BM, Le Grande MR, Worcester MU.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1097/HCR.0b013e3182a5277c ] [PMID: 24084261 ] [49] Eriksson MK, Franks PW, Eliasson M. A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1371/journal.pone.0005195 ] [PMID: 19365563 ] [50] Wood DA, Kotseva K, Connolly S, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/S0140-6736(08)60868-5 ] [PMID: 18555911 ] [51] Chen L, Pei JH, Kuang J, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.metabol.2014.10.018 ] [PMID: 25467842 ] [52] Spring B, Moller AC, Colangelo LA, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.113.005445 ] [PMID: 24982115 ] [53] Frank L, Kavage S. A national plan for physical activity: the enabling role of the built environment.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1111/obr.12093 ] [PMID: 24102966 ] [55] Campbell NR, Lackland DT, Chockalingam A, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1097/HJH.0000000000000079 ] [PMID: 24430121 ] [56] Menaa F, Menaa A, Menaa B, Tréton J. Trans-fatty acids, dangerous bonds for health?",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1007/s00394-012-0484-4 ] [PMID: 23269652 ] [57] Pastorino S, Richards M, Hardy R, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.pcd.2014.05.003 ] [PMID: 25037637 ] [58] Ahluwalia IB, Tessaro I, Rye S, Parker L. Self-reported and clinical measurement of three chronic disease risks among low-income women in West Virginia.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1089/jwh.2009.1360 ] [PMID: 19951222 ] [59] Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1016/j.jclinepi.2004.04.005 ] [PMID: 15528061 ] [60] Barr EL, Tonkin AM, Welborn TA, Shaw JE.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"[http://dx.doi.org/10.1111/j.1445-5994.2008.01864.x ] [PMID: 19290982 ] [61] Ng SP, Korda R, Clements M, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
[http://dx.doi.org/10.1111/j.1753-6405.2011.00742.x ] [PMID: 22151163 ] © Gikas et al.,OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/TOCMJ-10-69.PMC4945772.pdf
"   Case Rep Gastroenterol 2016;10:315 –322  DOI: 10.1159/000447290   Published online: June 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a4/2c/crg-0010-0315.PMC4945807.pdf
"   Case Rep Gastroenterol 2016;10:332 –337  DOI: 10.1159/000446575   Published online: June 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/34/ff/crg-0010-0332.PMC4945809.pdf
"   Case Rep Gastroenterol 2016;10:323 –331  DOI: 10.1159/000447293   Published online: June 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed unde r the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/22/4f/crg-0010-0323.PMC4945810.pdf
"   Case Rep Neurol 2016;8:134 –139  DOI: 10.1159/000446538   Published online: June 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCo mmercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/25/bc/crn-0008-0134.PMC4945811.pdf
"   Case Rep Gastroenterol 2016;10:308 –314  DOI: 10.1159/000447294   Published online: June 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommerci al 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e3/fe/crg-0010-0308.PMC4945812.pdf
"   Case Rep Gastroenterol 2016;10:338 –343  DOI: 10.1159/000447289   Published online: June 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  Internat ional License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/7e/5a/crg-0010-0338.PMC4945813.pdf
"   Case Rep Neurol 2016;8:140 –144  DOI: 10.1159/000447531   Published online: June 27, 2016 June 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative  Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/98/44/crn-0008-0140.PMC4945814.pdf
The median age of the cohort wasReceived: 8 September 2015 Revised: 31 October 2015 Accepted: 3 December 2015 Heliyon (2016) e00052 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
"The study conforms to the ethicalprinciples contained in the Declaration of Helsinki, and was approved by the Article No~e00052 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
"After surgical intervention, it was mandatory to admit cirrhotic patients to the intensive care unit of the National Cancer Institute of Peru.Patients without cirrhosis, however, were transferred to the intensive care unit at Article No~e00052 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
"The 5-year survival probability estimates for patients with BCLC stages A and B were 50% and 36.8%, Article No~e00052 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
"Feature Parameter Number Percentage Cohort Headcount 253 100 Age Mean ± SD 41.9 ± 21.4 n/a Median 36 n/a Range [3 –89] n/a Interquartile range 39 n/a Gender Female 103 40.7 Male 150 59.3 Cirrhosis Absent 214 84.6 Present 39 15.4 HBsAg Negative 141 55.7 Positive 112 44.3 Anti-HCV* Negative 194 96.5 Positive 7 3.5 Tumor size (cm) Mean ± SD 14.2 ± 5.9 n/a Median 14.5 n/a Range [2 –33] n/a Interquartile range 8.4 n/a <5 15 5.9 [5–10] 53 20.9 >10 185 73.2 Multinodular tumors Present 78 30.8 Bilobar tumors Present 80 31.6 Child-Pugh class** A 30 76.9 B 9 23.1 Vascular invasion Macro 29 11.5 Micro 64 25.3 Negative 160 63.2 Histopathology Trabecular 177 70 Acinar 10 4 Compact 17 6.7 Mixed trabecular and acinar 36 14.2 Sarcomatoid 9 3.5 Fibrolamellar 4 1.6 AFP (ng/mL) Mean ± SD 93,026 ± 241,792 n/a Median 2651 n/a Interquartile range 56,826.8 n/a (Continued ) Article No~e00052 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is why we are convinced that the authority of suchprescribed guidelines should be discussed and their contextual applications Article No~e00052 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This situation is partly due to the lack of alternative therapeutic support after a basic Article No~e00052 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
"[4]J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, et al., Cancer incidence and mortality worldwide: sources, methods and Article No~e00052 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
"[26] A. Guglielmi, A. Ruzzenente, S. Conci, A. Valdegamberi, M. Vitali, F. Bertuzzo, et al., Hepatocellular carcinoma: surgical perspectives beyond Article No~e00052 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
Article No~e00052 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00052 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/c1/main.PMC4945847.pdf
"Thus, as the isatin-based compounds are not susceptible to extrusion from P-gp overexpressing tumor cells, they representReceived: 3 October 2015 Revised: 7 December 2015 Accepted: 24 December 2015 Heliyon (2016) e00060 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
"For example, Article No~e00060 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
"Briefly,1×1 0 5cells/100 μL in PBS (1% w/v BSA) were incubated with either anti-P-gp monoclonal antibody F4 (diluted 1:1000) or a matched mouse isotype control in the absence (MES cell lines) or presence (U937 cell lines) of FcRblock (20% v/v) for 30 min on ice, followed by three washes with ice cold PBS Article No~e00060 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Culture media was removed and the cells washed Article No~e00060 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
All compounds andcontrols were tested at either 40 μM or 200 μM (in 1% DMSO) as per the Article No~e00060 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
"Cell viability The degree of cross resistance to a single concentration of the commercial anticancer agents vinblastine, colchicine, paclitaxel and doxorubicin was Article No~e00060 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
"It was also chosen for the potential to successfully create an MDR phenotype with broad cross-resistance, as cell lines resistant to the Vinca alkaloids have been shown to exhibit decreased sensitivity to a number of structurally unrelated small-molecule anticancer agents, such as Article No~e00060 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
The IC 50values obtained for all 5 isatin-based compounds against the U937VbR and MES-SA/Dx5 MDR sublines were not statistically different to those observed for the parental control Article No~e00060 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Additional information [60_TD$DIFF]Supplementary content related to this article has been published online at : http://dx.doi.org/10.1016/j.heliyon.2015.e00060 .,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 22 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
Article No~e00060 23 http://dx.doi.org/10.1016/j.heliyon.2015.e00060 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/7d/main.PMC4945850.pdf
"Imlay and  Linn (Imlay and Linn,  1986) suggested that perhaps  the amount of the toxic species   was reduced at high concentrations  of H2O2because hydroxyl (or other)  radicals   might be quenched directly  by hydrogen peroxide with the concomitant formation   http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
Mode one killing pronounced near 1 mM concentration of H2O2is caused  2 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
3 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
"In th is  system, it is obvious  that free iron decreases  because there is no way of  recycling;  nevertheless we present a hypothetic simulation considering free iron as  4 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
"Moreover,  concer ning HO∙production,  we do not consider  Haber–Weiss  reaction,  a reaction whose relevance in vivo is questionable  5 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
6 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
7 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
"However,  the identity of the biological reductants in  vivo remains  unclear  (Valko  et al., 2005), Fe3+might also be reduced at varying   8 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
9 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
"By adding 𝑁reduct ants (noted 𝑅𝑖), reduction rate can be written: 𝑣red=𝑁∑ 𝑖=1( 𝑣max,𝑖[Fe]−[Fe2+] [Fe]𝐶𝑖 1∕2[H2O2]+𝐶𝑖 1∕2) Of course,  we cannot ﬁnd the values  of all kinetic constants  in literature  for in vivo system  whereas  it is a crucial  issue; we therefore use an average formula  with only  two constants: 𝑣red=𝑣max𝐶0[H2O2]+𝐶0[Fe]−[Fe2+] [Fe] When [H2O2]→𝐶0, the eﬃciency of the reduction is reduced by half, 𝑣max represents  the maximal rate of Fe3+reduction,  this rate is obtained in a hypothetic  10 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
(2009) report total metabolome concentration of 300 mM  (100 millions  metabolites/cell)   11 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
"Our model is able to reproduce  this phenomenology,  as demonstrated by  12 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
13 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This phenomenon involves  a  decrease  in exogenous  H2O2concentration and consequently  in internal H2O2 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
15 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
16 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
17 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
18 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
19 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
20 http://dx.doi.org/10.1016/j.heliyon.2015.e00049 2405-8440/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/83/main.PMC4945851.pdf
"Moreover, principal component analysis shows divergentgrouping of the metals for the patients and healthy donors, which may be associated with the altered metabolism of the metals in atherosclerosis patients.Received: 29 July 2015 Revised: 8 October 2015 Accepted: 9 December 2015 Heliyon (2016) e00054 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Information aboutthe variations in metal levels in atherosclerosis patients with respect to the Article No~e00054 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Characteristics Atherosclerosis Patients ( [5_TD$DIFF]n= 90)Healthy Donors ( [5_TD$DIFF]n= 90) Age (yrs) Range 30 –62 33 –61 Mean 45.5 46.4 Gender Female 45 (50%) 45 (50%) Male 45 (50%) 45 (50%) Diet Vegetarian 63 (70%) 63 (70%) Non-vegetarian 27 (30%) 27 (30%) Residence Urban 63 (70%) 75 (83%) Rural 27 (30%) 15 (17%) Use of tobacco No use 48 (53%) 48 (53%) Use 42 (47%) 42 (47%) Article No~e00054 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
All reagents used were of ultrahigh purity Article No~e00054 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This Article No~e00054 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
"Shah, Investigation of trace metals in the blood plasma and scalp hair of gastrointestinal cancer Article No~e00054 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
Article No~e00054 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00054 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/b6/main.PMC4945853.pdf
"Inlight of these results, we re-analyzed the TRIM5 α RhPRYSPRY sequence andReceived: 29 October 2015 Revised: 26 November 2015 Accepted: 11 December 2015 Heliyon (2016) e00056 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Another function has recently been attributed to TRIM5 α: the Article No~e00056 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
"To investigate TRIM5 α-CA interactions in a cellular context, we assessed the co-localization of FLAG-tagged WT, I376K-L377K or Article No~e00056 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
"Lysates from the transfected HEK293T cells were incubated with HIV-1CA-NC complexes, then the mixtures were Article No~e00056 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
"Mutating putative SIMs does not hinder the capacity of TRIM5 αRhto trigger K63-linked polyubiquitin chains formation E3 ubiquitin ligase activity associated with the RING domain is essential for the ability of TRIM5 αto promote formation of K63-linked ubiquitin chains [ 26,52] that can then mediate the activation of AP-1 and NF- κB signaling through Article No~e00056 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
PML is heavily SUMOylated and SUMO is a major contributing factor to the formation Article No~e00056 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Analysis of TRIM5 αexon 8 sequences from 34 individual Article No~e00056 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Misfolded proteins are generally degraded by the Article No~e00056 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
(D) TRIM5 αRhexpression levels in cells from the experiment shown Article No~e00056 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
"Moreover, the fact that mutations in the putative SIM1 and SIM4 motifs abolish Article No~e00056 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
These species are already known for their Article No~e00056 22 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
"SIM4 variants were constructed using pMIP-TRIM5 αRhas template and mutations were introduced using the following primers: VKIC, 5 ′-GTGCCCCTCTCTGTGAAAATTTGTCCTGA- TCGTGTTG-3 ′(forward) and 5 ′-GATCAGGACAAATTTTC- ACAGAGAGGGGCACAATGAAAG-3 ′(reverse); VNIC, Article No~e00056 23 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Successfully Article No~e00056 24 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 25 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 26 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Primary and Article No~e00056 27 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 28 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 29 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 30 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 31 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 32 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 33 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
"Ivanov, Recognition of the HIV capsid by the TRIM5 αrestriction factor is mediated by a subset of pre-existing Article No~e00056 34 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 35 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
Article No~e00056 36 http://dx.doi.org/10.1016/j.heliyon.2015.e00056 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/ce/main.PMC4945854.pdf
"This work determined the chemical composition and antioxidant-prooxidant potential of a polyphenolic extract (PPE) and a proanthocyanidin-rich fraction (PRF) of appleskin, along with the contribution of their most abundant individual compounds,Received: 4 December 2015 Revised: 31 January 2016 Accepted: 3 February 2016 Heliyon (2016) e00073 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
The objective of this research was to determine the chemical composition and antioxidant-prooxidant potential of a PPE and a PRF of Red Delicious apple Article No~e00073 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
The main monomers were identified as (+)-catechin (C)and (−)-epicatechin (E) based on the signal of their deprotonated molecules at Article No~e00073 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
"Compounds Rt (min) Molecular ions ( m/z) Fragments ( m/z) UV-Vis(nm) Flavan-3-ols [3_TD$DIFF]Monomers (-)-Epicatechin (E) 28.38 289 - 280 (+)-Catechin (C) 21.45 289 - 280 [4_TD$DIFF]Oligomers Procyanidin B1 (dimer) (PB1) 18.33 577 407, 289 280 Procyanidin B2 (dimer) (PB2) 25.35 577 451,425, 407, 289 280 Procyanidin C1 (trimer) (PC1) 30.93 865 847, 739, 713, 695, 577, 451, 425, 407, 287 280 Trimer 2 (T2) 22.32 865 847, 713, 695, 577, 451, 425, 407, 289, 287 280Trimer 3 (T3) 24.89 865 577, 451, 407, 289, 287 280 Tetramer 1 (TT1) 26.69 1153 983, 863, 739, 577, 575, 407, 289 280 Tetramer 2 (TT2) 32.23 1153 983, 865, 577, 407, 289 280 Tetramer 3 (TT3) 32.67 1153 983, 865, 577, 575, 451, 289, 287 280 Tetramer 4 (TT4) 35.39 1153 865, 863, 739, 577, 575, 425, 289 280 Pentamer 1 (P1) 29.99 1441 1315, 1153, 1151, 863, 575, 450, 289 280 Pentamer 2 (P2) 33.20 1441 1272, 1154, 1027, 865, 575, 407, 289, 280Hexamer (H1) 33.65 1729 1443, 863, 575, 289 280 Heptamer (HP1) 35.83 2017 1730, 1153, 863, 739, 575, 289 280 Unknown 1 (U1) 7.09 447 370, 285 236, 282 Unknown 2 (U2) 9.23 447 384, 285 236, 284 [5_TD$DIFF]Flavonols Kaempferol pentoside(KP) 37.81 417 285, 341 266, 352 Rutin (RU) 38.21 609 301 352Quercetin galactoside (QGO) 38.44 463 301 350 Quercetin glucoside (QGL) 38.67 463 301 352 Quercetin pentoside (QP) 39.27 433 301 352 Quercetin pentoside (QP) 39.83 433 301, 567 354 Quercetin ramnoside (QR) 40.01 447 300 350Ramnetin pentoside (RP) 40.99 447 314 348 [6_TD$DIFF]Dihydrochalcones Phloretin pentoside (FLP) 39.65 567 162, 273 238, 284 Phloridzin (FL) 40.81 435 167, 273 236, 284 [7_TD$DIFF]Phenolic acids Chlorogenic acid (AC) 24.47 353 191, 225 240, 292 [8_TD$DIFF]Anthocyanidins Cyanidin glucoside (CGL) 30.25 447 284 280, 516 Article No~e00073 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Two isomers of quercetin pentoside (QP) were found and Article No~e00073 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
"Quantification of compounds in PPE and PRF of apple skin The total content of PP in PPE is shown in Table 2 as 1635.60 mg/100 g of dry weight (DW), of which 729.20 mg/100 g DW corresponded to flavan-3-ols, Article No~e00073 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Compounds mg/ 100 g DW [9_TD$DIFF]% Flavan-3-ols: 729.20 44.58 (-)-Epicatechin (monomer) 250.21 15.30(+)-Catechin (monomer) 15.59 0.95 [31_TD$DIFF]Procyanidin B1 (dimer) 16.14 0.99 Procyanidin B2 (dimer) 93.54 5.72 Procyanidin C1 (trimer) 64.75 3.96 Trimer 2 57.36 3.51Trimer 3 6.71 0.41 Tetramer 1 63.51 3.88 Tetramer 2 27.68 1.69 Tetramer 3 31.92 1.95 Tetramer 4 1.38 0.08Pentamer 1 5.15 0.31 Pentamer 2 8.77 0.54 Hexamer 38.26 2.34 Heptamer 3.18 0.19 Unknown 1 22.02 1.35 Unknown 2 23.02 1.40 [32_TD$DIFF]Flavonols 701.53 42.89 Kaempferol pentoside 0.47 0.028 Rutin 0.23 0.014Quercetin-galactoside 147.07 8.99 Quercetin-glucoside 159.41 9.75 Quercetin-pentoside 9.37 0.57 Quercetin-pentoside 128.58 7.86 Quercetin-ramnoside 139.06 8.50Ramnetin-pentoside 117.34 7.17 [6_TD$DIFF]Dihydrochalcones 189.70 11.60 Phloridzin-pentoside 54.74 3.35 Phloridzin 134.96 8.25 [7_TD$DIFF]Phenolic acids: Chlorogenic acid 11.50 0.70 [41_TD$DIFF]Anthocyanidins: Cyanidin glucoside 3.64 0.22 [35_TD$DIFF]Total PP 1635.60 100.00 Article No~e00073 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Compounds mg/100 g DW [9_TD$DIFF]% (−)-Epicatechin 93.85 25.63 (+)-Catechin 6.85 1.87 [36_TD$DIFF]Total monomers 100.70 27.50 Procyanidin B1 19.21 5.24Procyanidin B2 86.78 23.69 Procyanidin C1 43.32 11.83 Trimer 2 9.82 2.68 Trimer 3 8.73 2.38 Tetramer 1 21.37 5.84Tetramer 2 26.32 7.19 Tetramer 3 10.34 2.82 Tetramer 4 1.90 0.52 Pentamer 1 6.10 1.66 Pentamer 2 7.33 2.00 Hexamer 22.57 6.16 Heptamer 1.76 0.48 [37_TD$DIFF]Total Oligomers 265.55 72.50 [38_TD$DIFF]Total PRF 366.25 100.00 Article No~e00073 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
"(accessed December 3, 2015) [42_TD$DIFF]http://cleantechnica.com/2013/07/24/bioremediation-gets-a- new-best-friend-applepeels/?utm_source=feedburner&utm_medium= feed&utm_campaign=Feed:+IM-cleantechnica+(CleanTechnica) .",OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
"2013/07/24 (accessed December 3, 2015) [29_TD$DIFF]http://grist.org/list/tomato-and-apple-peels-can- help-purify-water/ .",Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
Article No~e00073 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00073 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/9a/main.PMC4945893.pdf
"Among micro-elements, Ba, Cr, Cu, Li, Mn, Ni, and Pbshowed extremely low concentrations and negligible among-species differences.Received: 30 October 2015 Revised: 2 February 2016 Accepted: 4 February 2016 Heliyon (2016) e00075 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
"However, to date no Article No~e00075 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
"Sample collection Callinectes sapidus andEriphia verrucosa specimens were captured in June 2014 in the Acquatina Lagoon (SE Italy), a non-tidal brackish-water basin Article No~e00075 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Statistical analysis Principal component analysis (PCA) and Permutational multivariate ANOVA (PERMANOVA) were used to explore the multivariate structure and to test Article No~e00075 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Article No~e00075 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
"In general, other comparative studies of proximate parameters among crab species found little or no differences (e.g., Callinectes sapidus [25_TD$DIFF]vs. Portunus pelagicus :Gökoðlu and Yerlikaya, 2003 ;Callinectes pallidus [26_TD$DIFF]vs. Cardisoma Article No~e00075 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Article No~e00075 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
[51_TD$DIFF] Article No~e00075 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
The results of the present investigation are fully consistent with those obtained in a recent study comparing the 1H-NMR metabolomic profile of lipid and Article No~e00075 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Logistic Article No~e00075 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
"Chemical composition, cholesterol, fatty acid and amino Article No~e00075 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Article No~e00075 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Article No~e00075 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Article No~e00075 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
Article No~e00075 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00075 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/cc/main.PMC4945894.pdf
"At both protein and mRNA levels examined by western blot and real-time PCR, the results revealed increased expression of BTG2(B-cell translocation gene 2), p21 ( p21 WAF1/CIPI), and GADD45A (growth arrestReceived: 31 August 2015 Revised: 13 November 2015 Accepted: 10 December 2015 Heliyon (2016) e00055 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
The absorbancemeasurements were taken at a wavelength of 450 nm with the SH-9000 Lab Article No~e00055 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Percentages of apoptotic cells were Article No~e00055 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
The differences between Article No~e00055 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
"[30]R. Boidot, F. Vegran, D. Jacob, S. Chevrier, N. Gangneux, J. Taboureau, et al., The expression of BIRC5 is correlated with loss of specific Article No~e00055 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
Article No~e00055 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00055 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/4b/main.PMC4945895.pdf
"Keywords: S tatistics, Laboratory medicine,  Medical  informatics, Cancer   diagnostics http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
All cases  are  2 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
𝐸=TP+TN TP+TN+FP+FN⋅100 (1) 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
"The errors in  classiﬁcation occurred between ovarian  cancer  and cancer  free classes,  importantly  4 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
5 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
6 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
With the advent of multiplexed  assays  7 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
In this manuscript  we modiﬁed  the classiﬁcation algorithm to select  highest  threshold  probability that preserved  8 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
"Additional  information Data associated with this study has been deposited at:  https://github.com/hendersonmpa/chemokines References [1]P. Kavsak,  M. Henderson,  P. Moretto,  H. Hirte,  K. Evans,  D. Wong,  W. Korz,   S.J.",OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
"Hotte,  Biochip arrays  for the discovery of a biomarker  surrogate in a  9 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.",OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
10 http://dx.doi.org/10.1016/j.heliyon.2015.e00059 2405-8440/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a3/main.PMC4945896.pdf
"Keywords: Agricultural techniques, Data mining, Mass spectroscopy applications, Agricultural engineeringReceived: 4 October 2015 Revised: 10 December 2015 Accepted: 30 December 2015 Heliyon (2016) e00064 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
The room humidity was around Article No~e00064 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
The details of Article No~e00064 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
"Model Treatment LV/EW/( γ,σ2) Calibration Prediction [15_TD$DIFF]Rc RMSEC Rp RMSEP SPA-MLR Raw -/22/- 0.9811 0.0734 0.9833 0.0709 1st-Der -/17/- 0.9692 0.0934 0.9720 0.0898 SPA-PLS Raw 7/22/- 0.9754 0.0837 0.9747 0.0854 1st-Der 5/17/- 0.9703 0.0918 0.9749 0.0860 SPA-LS-SVM Raw -/22/(7.1×104, 171.6) 0.9936 0.0428 0.9962 0.0339 1st-Der -/17/(749.0, 427.7) 0.9907 0.0516 0.9871 0.0613 MC-UVE-MLR Raw -/22/- 0.9706 0.0914 0.9647 0.1009 1st-Der -/22/- 0.9682 0.0949 0.9551 0.1145 MC-UVE-PLS Raw 5/22/- 0.9509 0.1174 0.9554 0.1130 1st-Der 5/22/- 0.9545 0.1131 0.9516 0.1175 MC-UVE-LS-SVM Raw -/22/(143.8, 4.2) 0.9968 0.0306 0.9840 0.0715 1st-Der -/22/(56.8, 19.0) 0.9962 0.0336 0.9832 0.0736 RF-MLR Raw -/22/- 0.9771 0.0807 0.9632 0.1046 1st-Der -/26/- 0.9872 0.0604 0.9634 0.1038 RF-PLS Raw 5/22/- 0.9582 0.1085 0.9569 0.1109 1st-Der 6/26- 0.9759 0.0828 0.9679 0.0960 RF-LS-SVM Raw -/26/(9.9×104,110.3) 0.9903 0.0528 0.9889 0.0569 1st-Der -/26/(4.9×104, 7.5×103) 0.9895 0.0549 0.9730 0.0891 Article No~e00064 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
Article No~e00064 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00064 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/main.PMC4945898.pdf
The release of [3_TD$DIFF]gentamicin sulfate for a period of five days from the nanoclay-enriched hydrogels wouldsupply anti-microbial agents in a sustained and controlled manner and assist in preventing microbial growth and biofilm formation on the titanium implantReceived: 14 October 2015 Revised: 31 December 2015 Accepted: 22 January 2016 Heliyon (2016) e00072 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Surface Article No~e00072 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Halloysite is chemically an aluminosilicate and Article No~e00072 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
If the mammalian cells would adhere or secrete Article No~e00072 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
"In ourmethod of hydrogel preparation, we employed methods to disperse or Article No~e00072 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Scale bar = 100microns in A to D and 1 micron in E and F. Article No~e00072 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
"When considering the matrix production of cells cultured on each hydrogel coating, the most cell supportive hydrogel type was CPC/alginate/chitosan with both proteoglycan and collagen synthesis Article No~e00072 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
http://www.transparencymarketresearch.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
Article No~e00072 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00072 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/18/main.PMC4945899.pdf
"bacoside-A 3(37.5 μg/mg), bacopaside-IIReceived: 29 May 2015 Revised: 5 December 2015 Accepted: 20 January 2016 Heliyon (2016) e00068 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Herbal remedies have been used for a long time for the management and detoxification from drugs of Article No~e00068 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
DPPH antioxidant assay is commonly used for the determination of free radical scavenging property of Article No~e00068 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
"Similarly, chronic use of morphine causes marked inhibition of antioxidant enzymes in the liver ( Zhang et al., 2004 ) which provide favorable conditions for H 2O2toxicity and triggered lipid peroxidation ( Miskevich et al., 2007 ) leading to apoptosis of hepatocytes ( Payabvash et al., 2006 ), increased accumulation of lipids in hepatocytes, deposition of collagen like fibrous material, reduction in the Article No~e00068 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
The hepato- and nephroprotective effect mediated through strong antioxidant potential of Bacopa monnieri might be one of the mechanism and additional mechanisms responsible for the reduction in opioid induced toxicity cannot be Article No~e00068 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Bacopa monnieri : and its constituents is Article No~e00068 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Stability studies of crude plant material of Bacopa monnieri and quantitative Article No~e00068 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
Article No~e00068 30 http://dx.doi.org/10.1016/j.heliyon.2016.e00068 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/main.PMC4945900.pdf
"Results: Contrasts of network interactions revealed the PTSD group were hyperconnected compared to controls in the phase-locking response in the 2 –24 Hz range for angry faces, but not for happy faces when contrasting groups.Hyperconnectivity in PTSD was greatest in the posterior cingulate, rightReceived: 4 August 2015 Revised: 11 December 2015 Accepted: 30 December 2015 Heliyon 2 (2016) e00063 http://dx.doi.org/10.1016/j.heliyon.2015.e00063 2405-8440/Crown Copyright © 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/3f/eb/main.PMC4945901.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/eb/main.PMC4945901.pdf
Despite imaging studies reporting atypical activity in PTSD ( Morey Article No~e00063 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00063 2405-8440/Crown Copyright © 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/3f/eb/main.PMC4945901.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/eb/main.PMC4945901.pdf
